data_1ijp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ijp _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.38 -45.67 92.7 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -57.33 -39.48 75.94 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.4 mtm -68.63 -38.36 80.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -58.18 -45.99 86.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.941 1.246 . . . . 0.0 114.016 166.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.87 -45.2 93.69 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.64 -54.4 32.48 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.893 0.877 . . . . 0.0 113.32 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -36.51 -62.15 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 160.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.96 -48.43 76.52 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.801 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.02 68.64 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -48.04 69.8 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.08 86.66 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 164.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.255 53.5 t -56.65 -50.69 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 119.947 1.249 . . . . 0.0 113.115 164.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -43.65 67.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 165.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.277 0.0 OUTLIER -56.93 -39.0 73.68 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.66 56.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 118.399 2.119 . . . . 0.0 118.399 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -47.37 -47.84 57.43 Favored Pre-proline 0 CA--C 1.58 2.107 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.14 -30.88 11.07 Favored 'Trans proline' 0 C--N 1.372 1.808 0 N-CA-C 120.81 3.35 . . . . 0.0 120.81 167.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -28.78 66.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.7 mm -85.63 -59.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 CA-C-N 118.803 0.729 . . . . 0.0 110.036 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.53 -65.15 3.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 118.204 2.041 . . . . 0.0 118.204 -168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.55 -24.05 62.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.15 70.65 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.75 -34.98 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 118.24 -0.886 . . . . 0.0 113.075 159.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.88 -66.18 2.94 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 120.106 1.321 . . . . 0.0 115.595 170.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.44 -66.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 118.227 1.013 . . . . 0.0 113.065 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.04 -59.69 9.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 117.92 1.928 . . . . 0.0 117.92 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.3 -45.68 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 117.012 -1.47 . . . . 0.0 111.693 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.3 -6.07 57.04 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 121.801 2.091 . . . . 0.0 115.088 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 -42.34 17.28 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-N 121.054 1.752 . . . . 0.0 116.436 147.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.03 -53.54 43.76 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 119.383 1.592 . . . . 0.0 116.948 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.28 -36.77 73.8 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 167.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -52.12 -51.68 56.33 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.06 -34.72 76.97 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.51 -43.87 65.35 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 156.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.17 -45.74 95.48 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 117.036 1.574 . . . . 0.0 117.036 166.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.56 85.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.63 89.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 167.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -66.53 -62.32 1.52 Allowed 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -149.36 116.58 3.7 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.18 -12.1 33.18 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 N-CA-C 119.544 2.863 . . . . 0.0 119.544 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.39 62.56 0.81 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.23 0.923 . . . . 0.0 110.689 164.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -96.06 153.48 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.824 0.821 . . . . 0.0 112.643 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mp -66.51 -58.1 10.9 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-O 115.728 -2.082 . . . . 0.0 110.658 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.77 -20.17 34.19 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 124.854 2.769 . . . . 0.0 119.03 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.93 -51.67 66.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 121.106 1.776 . . . . 0.0 114.275 160.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.04 -30.63 71.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -61.91 -59.17 5.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.732 1.151 . . . . 0.0 113.587 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -58.27 -46.38 86.14 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -43.72 93.53 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -48.81 -46.51 41.95 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 162.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.84 -14.48 61.09 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.889 2.551 . . . . 0.0 117.889 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.08 -55.53 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.311 1.414 . . . . 0.0 110.369 160.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.298 12.4 p -68.44 -55.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 85.4 mmm -57.92 -36.42 72.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.03 -74.33 0.38 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.354 164.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.88 -13.64 0.79 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -87.36 -28.89 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -50.03 -51.2 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.846 2.112 . . . . 0.0 112.833 152.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.85 -67.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.41 -55.31 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 120.125 1.329 . . . . 0.0 114.182 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.41 53.2 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.9 mmt -68.45 -36.59 79.24 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.296 0.4 OUTLIER -65.18 -50.99 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.664 1.574 . . . . 0.0 112.813 174.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.72 73.3 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.59 -49.2 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.776 1.171 . . . . 0.0 112.534 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.73 -39.51 55.29 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.35 -43.5 94.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.726 1.763 . . . . 0.0 113.112 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.37 -54.67 5.44 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 161.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 -48.75 64.99 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -40.76 -47.96 2.94 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.34 -40.82 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.379 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.02 -49.89 72.44 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.3 t80 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 t30 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.94 -47.74 85.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -57.58 -37.04 72.51 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.2 mtt -65.41 -42.41 92.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -57.58 -44.31 85.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -64.99 -44.34 89.61 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -50.58 51.41 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.994 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.98 -63.52 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 157.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.26 -46.85 66.25 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.568 -168.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.57 60.33 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 161.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.72 64.52 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.44 77.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.263 58.3 t -57.85 -50.17 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.711 1.141 . . . . 0.0 113.431 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.93 -36.33 76.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -31.3 71.73 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 167.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.45 -32.37 42.68 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.8 tp -38.07 -46.98 2.74 Favored Pre-proline 0 CA--C 1.582 2.173 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -47.0 -32.15 12.5 Favored 'Trans proline' 0 C--N 1.374 1.897 0 N-CA-C 120.326 3.164 . . . . 0.0 120.326 166.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.53 -30.96 67.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.72 -59.31 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.914 0 C-N-CA 123.657 0.783 . . . . 0.0 109.708 162.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.68 -62.26 4.94 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -167.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.24 62.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.9 -46.0 72.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.43 -35.18 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 118.045 -0.979 . . . . 0.0 113.13 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.99 -67.72 2.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.281 1.401 . . . . 0.0 115.174 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 11.0 mm -44.22 -73.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 166.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.12 -55.6 27.0 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 118.528 2.171 . . . . 0.0 118.528 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.22 -44.08 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 116.993 -1.479 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.33 22.0 mt -75.74 -35.59 60.16 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 121.927 2.149 . . . . 0.0 112.516 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.17 94.29 Favored Glycine 0 N--CA 1.492 2.391 0 CA-C-N 122.684 2.493 . . . . 0.0 118.365 160.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.72 -53.5 44.75 Favored Glycine 0 CA--C 1.553 2.409 0 CA-C-N 119.255 1.527 . . . . 0.0 116.59 164.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -50.75 -45.13 58.67 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 165.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.94 -44.46 82.53 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.261 2.6 tm? -66.44 -38.85 88.31 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 118.251 -0.881 . . . . 0.0 113.047 172.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.7 -39.01 61.57 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 165.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -39.71 98.35 Favored Glycine 0 CA--C 1.55 2.229 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 159.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.15 68.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.29 69.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -59.05 2.75 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.483 1.038 . . . . 0.0 112.272 170.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.78 119.78 6.96 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.717 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 -5.78 16.16 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 N-CA-C 119.467 2.833 . . . . 0.0 119.467 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -125.8 61.29 1.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.192 0.905 . . . . 0.0 110.859 161.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mt -76.9 156.24 32.23 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 121.133 -0.979 . . . . 0.0 112.577 169.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.89 -57.39 9.71 Favored Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.007 -1.949 . . . . 0.0 110.706 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -55.41 -21.26 29.16 Favored 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 124.847 2.767 . . . . 0.0 118.919 165.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tt -66.03 -52.58 47.87 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.678 1.127 . . . . 0.0 113.975 164.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.54 -29.28 70.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.54 -51.3 70.04 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 159.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.261 3.9 m -75.99 -32.94 59.69 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -54.28 -50.54 67.05 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 159.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -49.23 -45.14 44.17 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 162.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -63.26 -32.89 74.41 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mt -58.43 -52.02 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 119.377 0.99 . . . . 0.0 111.861 163.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.22 -58.74 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 124.073 0.949 . . . . 0.0 112.302 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -56.67 -24.38 48.39 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 171.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.22 -82.22 0.08 OUTLIER Glycine 0 C--N 1.355 1.606 0 CA-C-O 116.567 -2.24 . . . . 0.0 111.526 163.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.388 1.6 pt? -58.5 -2.83 0.23 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.26 -40.04 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 159.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -50.03 -44.62 51.44 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.321 1.873 . . . . 0.0 113.666 155.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.9 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 167.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.17 -58.27 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-N 121.03 1.741 . . . . 0.0 113.637 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.9 65.85 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.8 tpp -66.62 -39.67 88.44 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.271 4.8 tt -59.58 -60.3 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.794 1.179 . . . . 0.0 112.997 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -33.86 75.16 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.53 -56.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.679 1.127 . . . . 0.0 111.981 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.04 -33.09 65.48 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.74 -43.18 99.48 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.146 1.473 . . . . 0.0 113.158 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.79 -54.08 6.92 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.929 1.932 . . . . 0.0 117.929 162.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.34 -49.26 70.08 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.95 -47.7 2.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 164.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.1 -42.33 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 C-N-CA 123.943 0.897 . . . . 0.0 112.306 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.53 -48.05 72.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.6 t80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-N 119.518 1.053 . . . . 0.0 113.786 -179.465 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -40.63 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.66 -37.89 74.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.3 mtm -69.13 -38.22 78.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.24 -45.97 86.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.035 1.288 . . . . 0.0 114.324 164.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.62 -42.09 99.38 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -66.27 -55.01 18.16 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.969 0.908 . . . . 0.0 113.321 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -36.68 -64.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 161.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtt -64.88 -49.92 68.61 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.606 -173.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.75 64.24 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 166.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.07 -57.24 8.16 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 121.482 1.946 . . . . 0.0 114.879 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -37.41 78.53 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 77.2 t -65.89 -51.96 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 120.416 1.462 . . . . 0.0 113.574 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 ttt -63.04 -44.76 94.97 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 10.5 mmt -89.4 -9.84 48.76 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.38 -37.82 62.67 Favored Glycine 0 CA--C 1.55 2.226 0 CA-C-N 120.187 1.358 . . . . 0.0 115.895 161.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -41.5 -57.94 3.41 Favored Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 115.227 -2.32 . . . . 0.0 116.364 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -53.38 -24.54 27.97 Favored 'Trans proline' 0 C--N 1.373 1.86 0 N-CA-C 120.719 3.315 . . . . 0.0 120.719 170.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.96 84.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 165.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.86 -53.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 123.87 0.868 . . . . 0.0 111.776 163.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.86 -60.16 8.77 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 118.688 2.235 . . . . 0.0 118.688 -173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.29 -16.73 60.93 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.8 -46.76 77.44 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 160.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.66 -33.14 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 158.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.84 -52.94 35.82 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mm -56.2 -62.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.233 1.517 . . . . 0.0 113.037 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.24 -58.7 10.21 Favored Glycine 0 CA--C 1.552 2.37 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.24 -49.73 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.602 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.257 20.3 mt -77.73 -21.29 52.11 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.737 2.062 . . . . 0.0 115.096 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.0 59.9 Favored Glycine 0 CA--C 1.551 2.31 0 CA-C-N 121.16 1.8 . . . . 0.0 117.043 156.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.06 -50.93 53.33 Favored Glycine 0 CA--C 1.554 2.493 0 N-CA-C 116.804 1.481 . . . . 0.0 116.804 165.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -55.07 -37.78 67.19 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 164.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.39 -44.48 76.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 166.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.277 2.5 tm? -67.12 -43.5 82.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -52.78 -41.97 64.6 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 166.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.45 86.93 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 162.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.47 -37.29 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.82 1.81 . . . . 0.0 114.777 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.26 -39.55 87.17 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 163.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -70.84 -60.13 2.41 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.25 118.52 2.86 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 117.769 -1.11 . . . . 0.0 108.589 171.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.31 -3.1 8.18 Favored 'Trans proline' 0 CA--C 1.566 2.113 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.19 62.29 1.62 Allowed 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 119.488 1.04 . . . . 0.0 110.952 155.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.78 162.73 22.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 111.572 166.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 64.9 mt -63.19 -57.62 19.86 Favored Pre-proline 0 CA--C 1.584 2.258 0 CA-C-O 115.788 -2.053 . . . . 0.0 111.189 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -54.13 -24.59 33.84 Favored 'Trans proline' 0 CA--C 1.567 2.155 0 CA-C-N 124.811 2.754 . . . . 0.0 119.134 165.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.52 -50.57 62.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.262 1.392 . . . . 0.0 113.967 165.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.3 -33.91 71.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -58.22 -54.12 50.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 163.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -68.39 -38.3 81.19 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.303 3.6 pp0? -63.62 -41.11 98.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.99 -47.11 65.05 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -64.27 -31.18 72.29 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -57.04 -51.4 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.842 1.201 . . . . 0.0 112.216 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.71 -67.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.282 0.0 OUTLIER -58.86 -33.62 70.66 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.94 -72.28 0.63 Allowed Glycine 0 C--N 1.353 1.522 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.273 166.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.5 tp -50.02 -21.23 1.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -71.79 -38.14 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 163.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -51.06 -61.46 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 120.891 1.678 . . . . 0.0 111.787 161.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.86 -68.69 0.14 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.71 -55.33 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 119.834 1.197 . . . . 0.0 113.684 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.409 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 24.4 mmt -61.36 -51.68 67.8 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.974 174.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.295 2.1 tp -52.73 -50.24 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 121.018 1.735 . . . . 0.0 115.18 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.59 76.8 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.9 -57.26 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 119.898 1.226 . . . . 0.0 112.733 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.44 63.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.23 -42.13 99.03 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.416 1.608 . . . . 0.0 113.43 164.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -55.94 5.82 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 117.68 1.832 . . . . 0.0 117.68 161.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.61 -49.51 76.3 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -42.77 -47.23 5.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -73.17 -42.97 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.528 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.4 mtt -55.26 -53.2 59.07 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 176.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.42 -49.94 73.5 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -58.8 -39.83 82.3 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.49 -45.17 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.08 -36.29 83.83 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.334 3.5 pp -67.47 -43.04 81.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.27 -46.85 86.95 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -41.41 -58.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.705 1.602 . . . . 0.0 114.911 164.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ttt -74.93 -42.91 56.79 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.967 -1.016 . . . . 0.0 113.216 -169.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.97 -36.92 18.66 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 159.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.49 14.59 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 -34.18 70.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 57.9 t -59.93 -50.92 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.667 1.121 . . . . 0.0 112.896 164.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 41.0 ttm -55.74 -39.6 71.38 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.279 0.0 OUTLIER -59.39 -32.96 70.63 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 167.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.62 -30.23 40.74 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.7 tp -37.82 -49.37 2.91 Favored Pre-proline 0 CA--C 1.581 2.17 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -54.77 -21.77 26.85 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 N-CA-C 120.265 3.14 . . . . 0.0 120.265 170.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -32.72 67.96 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.26 -56.08 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 C-N-CA 123.437 0.695 . . . . 0.0 109.865 160.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -66.05 3.04 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 118.643 2.217 . . . . 0.0 118.643 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.4 -13.22 60.13 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.41 -51.49 56.47 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 164.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.8 -33.09 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 158.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.54 -67.85 1.8 Allowed Glycine 0 N--CA 1.482 1.763 0 CA-C-N 120.193 1.36 . . . . 0.0 116.19 168.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.2 mm -54.65 -70.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 118.266 1.033 . . . . 0.0 112.438 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.26 -54.22 37.3 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.16 -59.89 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.531 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.31 -1.84 28.67 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.43 -34.58 1.73 Allowed Glycine 0 N--CA 1.48 1.616 0 CA-C-O 116.725 -2.153 . . . . 0.0 117.326 154.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.55 -58.64 12.86 Favored Glycine 0 N--CA 1.49 2.262 0 CA-C-N 122.192 2.996 . . . . 0.0 115.524 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.57 -46.1 73.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 167.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -72.32 -49.45 34.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.37 -35.77 81.19 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 116.76 -1.591 . . . . 0.0 112.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -53.54 -38.37 63.75 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 123.039 2.654 . . . . 0.0 116.047 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.71 -36.0 81.67 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 161.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 5.02 47.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.3 -19.75 66.1 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 165.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -56.34 -46.72 79.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -127.06 112.7 21.77 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.57 -10.03 24.75 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.28 60.93 0.82 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.317 0.962 . . . . 0.0 110.626 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.04 157.98 16.48 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.142 0.977 . . . . 0.0 112.051 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.288 3.6 mp -67.49 -57.47 10.29 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.216 -1.85 . . . . 0.0 109.357 169.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.95 -24.69 1.34 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 N-CA-C 121.472 3.605 . . . . 0.0 121.472 156.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.51 -50.21 68.28 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 121.664 2.029 . . . . 0.0 113.398 162.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.23 -32.1 69.66 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 167.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -66.77 -52.82 39.73 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 120.097 1.317 . . . . 0.0 113.39 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.1 p -57.78 -47.0 83.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -53.32 -47.48 69.25 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.36 -45.84 72.84 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 166.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -52.99 -37.07 61.1 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 169.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -50.39 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 C-N-CA 123.848 0.859 . . . . 0.0 112.78 169.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.63 -45.36 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.882 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.58 -27.31 69.1 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 178.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -60.58 7.0 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 118.103 -1.387 . . . . 0.0 111.909 160.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -8.2 0.38 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 170.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 0.3 OUTLIER -92.66 -23.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 162.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.02 -50.08 48.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.965 1.711 . . . . 0.0 112.938 148.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.03 -71.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 165.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.01 -56.03 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 121.183 1.81 . . . . 0.0 114.531 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.42 50.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.2 mmt -65.79 -39.81 91.33 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.265 5.6 tt -62.23 -59.81 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.926 1.239 . . . . 0.0 113.534 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.74 -37.19 84.15 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.04 -50.4 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.889 1.222 . . . . 0.0 112.252 170.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.17 -45.5 61.56 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.76 -42.21 97.86 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.26 1.03 . . . . 0.0 112.825 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.84 -52.42 6.69 Favored Glycine 0 CA--C 1.55 2.261 0 N-CA-C 118.111 2.005 . . . . 0.0 118.111 160.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.16 -54.66 26.29 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -34.73 -49.47 0.42 Allowed 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 162.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.3 p -83.6 -41.78 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.8 mtt -60.14 -38.69 83.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 162.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 t30 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.31 -52.68 62.7 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.979 0.912 . . . . 0.0 113.024 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.42 -34.89 73.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 168.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.2 mtp -62.8 -41.96 99.51 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.64 -40.15 93.88 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.7 -46.41 90.49 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -51.2 50.41 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.014 0.925 . . . . 0.0 113.312 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.21 -60.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 157.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.33 -46.8 69.24 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.671 -170.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.19 -36.02 60.49 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 162.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.29 -48.3 43.4 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -43.24 62.87 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 161.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.79 -48.04 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 163.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -26.5 66.16 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 164.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.4 -36.55 63.02 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.8 tp -42.8 -54.53 8.5 Favored Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 170.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -56.14 -32.22 86.24 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 125.357 2.949 . . . . 0.0 118.858 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.36 69.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.23 -57.84 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 118.626 0.648 . . . . 0.0 110.356 160.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.77 -66.55 2.46 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -167.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.93 -11.74 59.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 118.445 2.757 . . . . 0.0 118.445 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.31 69.64 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 158.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.68 -29.81 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 158.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.91 -60.82 7.52 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-N 119.902 1.228 . . . . 0.0 116.152 166.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -48.27 -69.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-N 118.285 1.042 . . . . 0.0 112.898 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.6 -54.4 37.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -172.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.5 -46.92 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 117.327 -1.321 . . . . 0.0 111.433 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.252 13.5 mt -70.27 -42.54 71.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.483 1.947 . . . . 0.0 112.345 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.11 92.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 165.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -53.95 41.46 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 119.289 1.545 . . . . 0.0 116.584 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.12 -39.16 74.57 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -56.78 -43.66 81.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.269 2.4 tm? -67.69 -38.84 84.22 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.28 0.945 . . . . 0.0 113.135 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.95 -39.24 65.75 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 121.103 1.774 . . . . 0.0 115.513 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.03 -29.74 75.6 Favored Glycine 0 CA--C 1.55 2.268 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 160.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.06 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 119.635 1.717 . . . . 0.0 114.777 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.93 -39.45 71.71 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 162.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.23 -57.32 7.82 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 167.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.5 123.61 2.48 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.941 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 -4.94 15.05 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.56 63.96 1.44 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.462 1.028 . . . . 0.0 110.674 157.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -91.1 166.46 12.97 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.852 0.861 . . . . 0.0 112.244 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 3.8 mp -66.82 -62.31 3.99 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 115.603 -2.142 . . . . 0.0 109.762 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -51.49 -21.21 10.05 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 N-CA-C 119.705 2.925 . . . . 0.0 119.705 164.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.88 -59.97 3.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.003 1.274 . . . . 0.0 113.446 166.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -64.91 -28.67 69.69 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -55.46 -58.82 6.17 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.12 0.873 . . . . 0.0 112.927 162.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -72.02 -28.28 63.28 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.26 -52.58 60.95 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 161.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.03 -38.74 68.34 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 166.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -54.93 -44.1 73.95 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 165.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 mt -57.9 -44.94 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.437 1.017 . . . . 0.0 113.048 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.63 -59.05 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.846 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER -59.33 -34.97 72.99 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 176.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.03 -69.88 1.17 Allowed Glycine 0 C--N 1.355 1.624 0 CA-C-O 117.801 -1.555 . . . . 0.0 112.357 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.52 -14.34 0.11 Allowed 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 171.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.51 -38.34 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 164.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -50.85 -47.82 60.23 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.13 1.786 . . . . 0.0 113.565 156.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -44.8 -67.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.12 -58.04 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.022 1.283 . . . . 0.0 113.17 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 -51.82 64.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.04 -36.07 77.31 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.308 0.4 OUTLIER -66.01 -50.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 120.574 1.534 . . . . 0.0 113.109 173.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.67 92.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.24 -51.7 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.858 1.208 . . . . 0.0 112.528 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 -41.99 84.9 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.03 -43.31 99.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 119.272 1.536 . . . . 0.0 113.65 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.41 -57.73 3.67 Favored Glycine 0 CA--C 1.55 2.24 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 160.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.49 -48.53 48.47 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -40.21 -47.78 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 164.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.88 -39.18 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.821 0 CA-C-O 118.421 -0.8 . . . . 0.0 112.624 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 79.9 mtp -58.12 -47.6 82.8 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 N--CA 1.494 1.752 0 CA-C-N 120.14 1.337 . . . . 0.0 113.591 -178.298 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 CA--C 1.57 1.715 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.7 -53.68 31.1 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -58.72 -39.79 81.86 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.77 -41.53 95.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.02 -41.91 98.6 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 167.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.28 -44.8 95.03 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.59 -54.44 32.02 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -36.6 -63.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 161.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.7 mtp -64.61 -50.42 67.24 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.284 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.16 62.65 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.49 -64.96 0.74 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 116.964 -1.494 . . . . 0.0 114.126 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.61 -35.73 31.7 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.107 2.632 . . . . 0.0 118.107 168.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.271 70.4 t -62.43 -53.1 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.775 1.171 . . . . 0.0 113.552 166.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.15 -28.52 58.31 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 165.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 0.6 OUTLIER -84.1 -13.78 52.09 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 173.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.51 -32.88 36.49 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 156.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 tp -39.25 -45.35 3.37 Favored Pre-proline 0 CA--C 1.582 2.19 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -44.53 -33.11 6.26 Favored 'Trans proline' 0 C--N 1.375 1.948 0 CA-C-N 126.176 3.242 . . . . 0.0 120.184 165.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.71 64.33 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.49 -57.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 118.826 0.739 . . . . 0.0 110.256 160.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -62.96 4.84 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.52 -23.7 61.05 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.61 -48.4 66.92 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -57.1 -31.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 159.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.53 -65.13 3.5 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.887 1.221 . . . . 0.0 115.79 167.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -47.66 -73.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 117.945 0.873 . . . . 0.0 113.013 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -56.08 27.21 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 118.5 2.16 . . . . 0.0 118.5 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -81.35 -46.98 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 117.475 -1.25 . . . . 0.0 112.45 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.279 17.5 mt -75.6 -35.7 60.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.181 1.81 . . . . 0.0 112.703 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.81 65.59 Favored Glycine 0 N--CA 1.491 2.318 0 CA-C-N 121.718 2.054 . . . . 0.0 118.005 163.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.33 -53.49 44.47 Favored Glycine 0 N--CA 1.491 2.339 0 CA-C-N 119.561 1.681 . . . . 0.0 116.289 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.99 -43.52 66.5 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.698 2.111 . . . . 0.0 116.698 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -44.3 85.47 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 171.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.276 2.4 tm? -66.56 -38.57 87.37 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.766 1.167 . . . . 0.0 113.231 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 164.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.36 89.04 Favored Glycine 0 CA--C 1.551 2.306 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 160.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -32.05 66.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.15 62.47 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -62.17 1.6 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 119.322 0.965 . . . . 0.0 112.196 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.89 114.96 5.99 Favored Pre-proline 0 CA--C 1.568 1.656 0 CA-C-O 117.961 -1.018 . . . . 0.0 108.303 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.65 -2.02 11.89 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 N-CA-C 119.298 2.768 . . . . 0.0 119.298 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -129.9 62.39 1.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.418 1.008 . . . . 0.0 110.153 159.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.0 162.65 20.33 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 111.48 165.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.258 43.5 mm -67.1 -58.64 8.81 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-O 115.841 -2.028 . . . . 0.0 111.166 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -54.87 -20.55 22.96 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 CA-C-N 124.909 2.789 . . . . 0.0 119.292 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.8 -54.07 31.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 119.755 1.162 . . . . 0.0 113.646 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.29 -22.28 66.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -57.01 -58.18 9.3 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.669 1.122 . . . . 0.0 113.378 157.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -66.66 -33.11 74.92 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -52.41 -51.28 59.93 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 160.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.71 -39.57 74.1 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -54.56 -38.92 67.22 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 165.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mt -59.0 -48.83 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 119.392 0.996 . . . . 0.0 112.799 165.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.96 -56.81 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.28 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.262 0.0 OUTLIER -58.35 -31.91 68.04 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 176.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.67 -67.84 1.87 Allowed Glycine 0 C--N 1.355 1.627 0 CA-C-O 117.545 -1.697 . . . . 0.0 111.125 166.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.8 tp -46.53 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -80.93 -40.92 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 125.526 1.53 . . . . 0.0 113.823 166.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -49.82 -36.21 25.71 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 121.236 1.834 . . . . 0.0 115.264 158.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.16 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 117.439 -1.267 . . . . 0.0 113.373 160.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.66 -55.96 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-N 120.92 1.691 . . . . 0.0 114.818 -165.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.4 -59.51 5.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.418 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 20.3 mmt -61.27 -49.6 76.42 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 116.641 -1.647 . . . . 0.0 113.994 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.291 5.9 tt -51.43 -56.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 121.508 1.958 . . . . 0.0 114.651 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.85 79.75 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -59.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.617 1.099 . . . . 0.0 113.172 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.2 -17.94 63.76 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 119.614 2.606 . . . . 0.0 119.614 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.66 -43.67 83.93 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.626 2.213 . . . . 0.0 112.074 159.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.36 -51.98 6.27 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 157.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.14 -51.53 66.11 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -42.75 -47.93 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 167.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.56 -40.4 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.661 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -58.59 -49.8 76.15 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.1 t80 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 178.555 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.01 -51.1 51.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.726 0.81 . . . . 0.0 113.032 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -58.74 -40.95 85.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.2 mtt -64.71 -44.1 91.32 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.11 -38.04 87.41 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.63 -47.81 83.73 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.82 -48.58 81.14 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -43.08 -58.92 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.6 -39.64 73.69 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.32 67.1 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 166.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.98 40.48 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 165.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.62 -44.82 37.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 165.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.16 -51.38 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 C-N-CA 124.209 1.003 . . . . 0.0 113.065 166.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -44.12 72.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -28.39 67.67 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 169.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.65 -37.3 40.47 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 167.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.7 tp -37.34 -52.7 2.34 Favored Pre-proline 0 CA--C 1.582 2.199 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.43 -25.72 59.23 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 125.273 2.919 . . . . 0.0 119.45 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.13 69.69 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -86.33 -55.34 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 CA-C-N 118.739 0.7 . . . . 0.0 110.57 160.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.62 -65.25 3.45 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.63 -13.63 59.85 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.6 -48.69 68.73 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 161.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.7 mm -59.01 -29.6 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 158.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.39 -62.42 6.2 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 120.04 1.291 . . . . 0.0 115.771 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.4 mm -54.32 -65.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 119.037 1.418 . . . . 0.0 112.948 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.05 -56.9 18.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.62 -58.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.793 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.5 mt -75.63 3.49 9.48 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.32 -36.33 1.64 Allowed Glycine 0 N--CA 1.481 1.695 0 CA-C-O 117.176 -1.902 . . . . 0.0 116.749 155.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -59.51 10.68 Favored Glycine 0 N--CA 1.492 2.388 0 CA-C-N 121.305 2.552 . . . . 0.0 115.923 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.86 -43.21 80.95 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 167.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.08 -42.32 72.92 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.255 3.0 tm? -71.14 -36.73 72.19 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.655 1.116 . . . . 0.0 112.549 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -52.18 -39.32 59.92 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 121.776 2.08 . . . . 0.0 115.942 163.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.76 -31.7 73.39 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 118.4 2.12 . . . . 0.0 118.4 161.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -23.58 54.94 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -20.0 15.44 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 118.809 2.892 . . . . 0.0 118.809 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -58.54 -34.93 71.56 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -154.03 129.72 5.25 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-N 119.997 1.271 . . . . 0.0 109.072 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 2.97 3.55 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.7 64.02 1.58 Allowed 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.168 0.894 . . . . 0.0 110.163 152.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.82 172.91 7.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.571 1.177 . . . . 0.0 112.867 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.49 -56.89 30.83 Favored Pre-proline 0 CA--C 1.581 2.155 0 CA-C-O 115.319 -2.277 . . . . 0.0 110.897 163.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.11 -15.13 21.66 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 CA-C-N 125.349 2.946 . . . . 0.0 119.51 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.5 -49.65 52.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.771 1.623 . . . . 0.0 113.662 161.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.93 -29.42 70.21 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -67.66 -45.58 74.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.502 165.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.41 ' HG1' ' CD1' ' A' ' 55' ' ' ILE 0.295 1.2 t -58.81 -47.01 86.26 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 122.131 2.241 . . . . 0.0 114.973 172.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.23 -49.32 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.55 -58.17 9.2 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -61.02 -39.27 89.13 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' CD1' ' HG1' ' A' ' 51' ' ' THR . 59.0 mt -64.59 -43.47 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.39 169.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.77 -47.64 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 120.558 1.526 . . . . 0.0 113.223 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 75.2 mmm -53.0 -43.94 66.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.3 -67.51 2.09 Favored Glycine 0 C--N 1.356 1.646 0 CA-C-O 117.731 -1.594 . . . . 0.0 112.262 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.72 -2.63 0.15 Allowed 'General case' 0 CA--C 1.583 2.227 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.93 -25.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.106 1.362 . . . . 0.0 113.726 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -50.88 -43.85 59.64 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 122.087 2.221 . . . . 0.0 113.528 148.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.19 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 159.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.04 -55.94 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.729 1.604 . . . . 0.0 114.559 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 -54.62 33.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.46 -34.44 75.95 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.285 6.8 tt -62.88 -60.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 120.42 1.464 . . . . 0.0 113.45 171.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.53 97.22 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.78 -52.17 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.318 0.963 . . . . 0.0 112.299 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.14 87.84 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.88 -43.35 83.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.486 1.143 . . . . 0.0 113.294 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.14 -48.44 10.15 Favored Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.181 2.032 . . . . 0.0 118.181 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.96 -56.19 6.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -40.67 -45.94 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 164.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.06 -43.96 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.503 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.12 -50.47 58.75 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 174.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 . . . . . 0 CA--C 1.556 1.199 0 CA-C-O 121.239 0.543 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.94 -45.48 93.49 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.367 1.067 . . . . 0.0 113.861 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.8 -29.3 70.06 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 168.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 45.0 mtm -62.92 -43.67 98.17 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.127 1.33 . . . . 0.0 114.404 163.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.81 -33.43 72.99 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.89 -50.89 70.37 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 168.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.94 -49.31 75.27 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -34.29 -67.27 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 163.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.5 ttt -73.36 -39.29 65.3 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.803 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -37.93 31.03 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.479 2.399 . . . . 0.0 117.479 160.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.78 24.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.76 71.97 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 60.0 t -60.45 -49.75 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.83 1.196 . . . . 0.0 113.145 166.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.8 tpp -58.42 -39.23 79.21 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 166.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -58.37 -30.32 66.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 166.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.88 36.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 170.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 tt -35.88 -50.48 1.56 Allowed Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 167.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -46.87 -30.08 9.04 Favored 'Trans proline' 0 CA--C 1.563 1.934 0 N-CA-C 120.808 3.349 . . . . 0.0 120.808 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.65 -31.86 66.72 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 168.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -85.66 -56.31 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 C-N-CA 123.727 0.811 . . . . 0.0 110.09 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.3 -63.62 4.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -169.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.66 63.61 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.597 2.814 . . . . 0.0 118.597 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.1 74.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 165.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.5 -32.96 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 159.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.7 -64.8 3.79 Favored Glycine 0 N--CA 1.485 1.909 0 CA-C-N 119.804 1.183 . . . . 0.0 115.864 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.48 -69.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 118.533 1.166 . . . . 0.0 112.703 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.46 -54.6 36.43 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 118.634 2.214 . . . . 0.0 118.634 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.38 -45.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.313 17.8 mt -74.84 -38.54 61.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.99 2.177 . . . . 0.0 112.379 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.81 94.64 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-N 122.176 2.262 . . . . 0.0 118.489 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.41 -52.28 53.71 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 119.384 1.592 . . . . 0.0 116.713 166.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -50.78 -45.37 59.05 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 164.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -54.65 -49.08 71.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.21 -33.63 76.2 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.21 -43.22 67.04 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.75 94.35 Favored Glycine 0 CA--C 1.549 2.213 0 N-CA-C 117.537 1.775 . . . . 0.0 117.537 165.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.07 88.47 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.39 96.4 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.0 -62.68 1.68 Allowed 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -151.16 120.62 3.56 Favored Pre-proline 0 CA--C 1.566 1.577 0 C-N-CA 124.481 1.112 . . . . 0.0 108.096 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 -13.75 38.19 Favored 'Trans proline' 0 CA--C 1.572 2.385 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 168.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -97.62 31.62 2.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.27 144.58 25.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.551 -1.343 . . . . 0.0 113.951 -160.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 67.1 mt -68.28 -57.07 9.46 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-O 115.723 -2.084 . . . . 0.0 111.114 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.48 -19.02 34.36 Favored 'Trans proline' 0 CA--C 1.571 2.339 0 CA-C-N 124.995 2.82 . . . . 0.0 119.171 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.95 -54.2 34.38 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.371 1.441 . . . . 0.0 113.437 161.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.42 -34.26 70.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -57.94 -48.07 81.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.0 m -80.67 -33.72 35.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 117.389 -1.291 . . . . 0.0 114.212 -172.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.336 3.1 pp0? -62.47 -38.46 89.9 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 122.0 2.182 . . . . 0.0 116.649 159.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -51.2 -44.47 61.58 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 158.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -67.0 -29.91 69.87 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.61 -48.09 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-N 119.867 1.212 . . . . 0.0 111.928 162.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.55 -52.51 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.571 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 80.1 mmm -55.09 -40.6 70.61 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.94 -69.21 1.36 Allowed Glycine 0 C--N 1.356 1.668 0 CA-C-O 117.404 -1.775 . . . . 0.0 112.157 166.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -4.44 0.26 Allowed 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.34 -25.33 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.093 163.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -49.71 -50.08 45.38 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 122.537 2.426 . . . . 0.0 112.905 148.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.83 -68.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -65.11 -59.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 121.163 1.801 . . . . 0.0 113.129 -173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.87 66.46 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.82 -35.53 74.88 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.415 HG13 ' SD ' ' A' ' 17' ' ' MET 0.256 4.8 tt -58.35 -57.53 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.944 1.702 . . . . 0.0 113.166 169.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.06 79.17 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.33 -51.49 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.059 1.3 . . . . 0.0 112.506 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.53 -38.88 68.91 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.96 -44.55 84.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.182 1.491 . . . . 0.0 113.299 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.6 -47.75 12.57 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.84 -53.62 47.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -45.12 -44.73 10.79 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.5 -40.8 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.905 0.882 . . . . 0.0 113.058 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -54.22 -42.44 69.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 164.137 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.89 -50.78 69.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -60.7 -40.01 90.65 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.6 mmt -66.58 -41.85 87.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.34 -41.42 89.14 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 165.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.0 mt -62.62 -45.51 92.55 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.9 -56.41 13.47 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -33.15 -65.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 158.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.19 -48.01 59.02 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.036 -167.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.35 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -61.1 2.38 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.537 1.971 . . . . 0.0 114.772 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.91 72.8 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.357 2.355 . . . . 0.0 117.357 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 79.0 t -66.17 -52.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.703 1.592 . . . . 0.0 113.328 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.95 89.13 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.4 mmt -83.83 -12.86 54.99 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.79 59.51 Favored Glycine 0 CA--C 1.548 2.107 0 CA-C-N 120.201 1.364 . . . . 0.0 115.981 164.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -40.33 -55.53 4.1 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.56 -24.87 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 124.124 3.216 . . . . 0.0 120.177 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.1 89.06 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 121.117 1.781 . . . . 0.0 115.443 165.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.79 -52.67 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 C-N-CA 123.928 0.891 . . . . 0.0 111.964 165.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.58 -59.1 10.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.552 2.181 . . . . 0.0 118.552 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.57 -13.47 60.67 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.34 -46.44 70.17 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 160.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.03 -37.7 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 123.606 0.762 . . . . 0.0 113.025 156.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.58 48.45 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 163.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.41 -63.62 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-N 120.463 2.131 . . . . 0.0 111.815 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.42 -51.83 56.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 119.257 2.463 . . . . 0.0 119.257 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.77 -45.93 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.9 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.55 -50.05 64.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.757 1.617 . . . . 0.0 112.043 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.72 -39.35 76.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -54.29 39.17 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-N 119.075 1.438 . . . . 0.0 116.529 167.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -48.56 -47.25 39.55 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 164.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.9 -51.79 66.36 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.309 1.444 . . . . 0.0 114.698 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.33 -31.72 71.33 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.33 -43.86 67.99 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 155.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.83 97.13 Favored Glycine 0 CA--C 1.551 2.307 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.61 80.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.35 79.08 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -69.97 -66.06 0.64 Allowed 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -145.56 112.42 4.64 Favored Pre-proline 0 CA--C 1.568 1.659 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.7 2.67 5.03 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 N-CA-C 119.519 2.854 . . . . 0.0 119.519 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -131.62 64.67 1.58 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.12 0.873 . . . . 0.0 110.333 157.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 163.77 17.87 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 121.835 0.826 . . . . 0.0 111.53 168.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.256 4.0 mp -66.81 -59.06 8.42 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.849 -2.024 . . . . 0.0 110.48 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -52.62 -23.99 21.45 Favored 'Trans proline' 0 CA--C 1.57 2.299 0 N-CA-C 119.345 2.787 . . . . 0.0 119.345 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.69 -56.01 12.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 168.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.48 -27.53 68.56 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 160.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.2 m -76.27 -33.46 59.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -51.76 -52.33 49.53 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 158.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -51.04 -44.44 61.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -62.9 -36.84 84.68 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -59.15 -54.36 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.871 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.313 10.2 p -60.96 -49.04 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.679 1.581 . . . . 0.0 114.371 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.17 -43.32 87.42 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.83 -69.04 1.39 Allowed Glycine 0 N--CA 1.479 1.548 0 CA-C-O 118.866 -0.964 . . . . 0.0 114.034 165.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.86 -19.63 0.4 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -90.03 -21.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -51.17 -62.62 1.5 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 122.479 2.399 . . . . 0.0 111.178 152.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.4 -65.03 0.42 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.72 -57.38 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.071 0.85 . . . . 0.0 113.05 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.18 75.03 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 mmt -63.71 -52.65 59.64 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.921 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.289 0.4 OUTLIER -57.36 -41.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 121.101 1.773 . . . . 0.0 114.311 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.54 83.57 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.83 -54.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.25 1.386 . . . . 0.0 112.705 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.61 -40.9 90.48 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 118.745 2.258 . . . . 0.0 118.745 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.77 -42.83 84.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.938 1.369 . . . . 0.0 114.015 163.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.05 -54.88 4.35 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 161.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.16 -49.89 68.09 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -42.79 -40.94 3.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -83.86 -32.92 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.3 mmt -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 CA--C 1.578 2.049 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 161.518 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 t30 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.76 -49.5 76.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -58.72 -39.75 81.73 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -65.64 -45.71 82.0 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.21 -33.75 76.52 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.72 -50.35 69.46 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 tp -56.66 -51.62 68.02 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -37.89 -73.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.227 1.811 . . . . 0.0 115.69 163.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.29 -40.22 71.01 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -167.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.7 65.05 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 117.079 2.252 . . . . 0.0 117.079 162.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.31 64.08 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.626 2.012 . . . . 0.0 115.509 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -36.07 82.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.42 -53.46 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 120.728 1.604 . . . . 0.0 113.068 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.7 -52.13 53.89 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -87.16 -16.44 35.41 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.55 -25.39 67.91 Favored Glycine 0 N--CA 1.491 2.344 0 CA-C-N 121.176 1.807 . . . . 0.0 117.486 163.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 tp -50.17 -46.35 82.73 Favored Pre-proline 0 CA--C 1.578 2.05 0 CA-C-O 115.211 -2.328 . . . . 0.0 117.081 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.05 -27.15 2.49 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 121.564 3.64 . . . . 0.0 121.564 164.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.68 74.23 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 164.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.52 -52.66 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 C-N-CA 123.952 0.901 . . . . 0.0 110.904 162.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.91 -66.74 1.36 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 -16.35 61.32 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 119.258 3.059 . . . . 0.0 119.258 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.0 -51.69 51.86 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.8 mt -54.56 -40.28 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 123.418 0.687 . . . . 0.0 112.807 160.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.11 -59.41 6.95 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-O 117.759 -1.578 . . . . 0.0 116.321 167.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 mm -41.83 -51.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.44 -59.9 6.18 Favored Glycine 0 CA--C 1.552 2.351 0 N-CA-C 118.261 2.065 . . . . 0.0 118.261 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.23 -42.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.81 -55.45 34.04 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.444 1.098 . . . . 0.0 112.367 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.42 -39.94 30.04 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 162.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.27 -53.76 43.54 Favored Glycine 0 CA--C 1.554 2.474 0 CA-C-N 119.448 1.624 . . . . 0.0 117.091 166.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -51.57 -49.07 62.8 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -57.58 -42.6 83.46 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.317 0.5 OUTLIER -72.57 -38.96 67.78 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 119.601 1.091 . . . . 0.0 112.58 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.33 -39.27 66.89 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 161.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.21 93.28 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 117.409 1.723 . . . . 0.0 117.409 159.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -37.58 65.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.845 1.823 . . . . 0.0 115.069 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.32 93.34 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 165.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -71.34 -54.08 12.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -154.9 120.1 2.61 Favored Pre-proline 0 CA--C 1.565 1.52 0 CA-C-O 117.674 -1.155 . . . . 0.0 109.106 174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.22 -6.26 12.82 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 N-CA-C 119.676 2.914 . . . . 0.0 119.676 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.63 58.01 1.24 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.19 0.904 . . . . 0.0 111.381 163.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.02 158.9 24.97 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 0.0 113.547 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 4.1 mp -64.36 -57.78 16.25 Favored Pre-proline 0 CA--C 1.582 2.189 0 CA-C-O 116.006 -1.949 . . . . 0.0 110.914 169.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -52.78 -21.59 15.49 Favored 'Trans proline' 0 CA--C 1.57 2.305 0 CA-C-N 125.022 2.829 . . . . 0.0 119.137 164.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.65 -53.33 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.98 -37.32 74.0 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -53.37 -51.59 62.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 162.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.268 5.3 m -86.87 -28.01 23.1 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -170.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.282 10.0 pt20 -61.71 -40.75 96.12 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 121.724 2.056 . . . . 0.0 115.912 157.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.87 -48.29 64.11 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 159.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.21 -40.78 97.25 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.02 -46.25 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 124.962 1.305 . . . . 0.0 114.184 166.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.77 -61.83 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 117.838 -1.077 . . . . 0.0 111.813 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.31 0.0 OUTLIER -65.64 -31.55 72.64 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -176.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.37 -65.72 3.18 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.914 -1.116 . . . . 0.0 113.448 164.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -11.99 5.64 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.32 0.4 OUTLIER -81.81 -22.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 159.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -49.1 -63.15 1.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 121.06 1.755 . . . . 0.0 111.096 151.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.3 -63.96 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -66.95 -54.49 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.568 1.531 . . . . 0.0 113.783 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 -49.92 75.56 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -68.5 -43.38 76.98 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.286 0.4 OUTLIER -57.09 -44.21 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 121.954 2.161 . . . . 0.0 113.31 173.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.12 76.0 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.31 -54.1 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 120.249 1.386 . . . . 0.0 112.793 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.85 -43.79 93.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.45 -48.69 74.09 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.498 1.149 . . . . 0.0 113.919 163.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -51.58 7.81 Favored Glycine 0 CA--C 1.548 2.099 0 N-CA-C 118.621 2.209 . . . . 0.0 118.621 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.33 -54.73 13.09 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -35.02 -54.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 160.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 2.2 p -74.28 -35.94 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 87.7 mmm -62.5 -30.61 71.4 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 163.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 169.796 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -97.93 -78.94 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.7 -42.81 95.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.38 -45.67 92.7 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -57.33 -39.48 75.94 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.4 mtm -68.63 -38.36 80.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -58.18 -45.99 86.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.941 1.246 . . . . 0.0 114.016 166.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.87 -45.2 93.69 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.64 -54.4 32.48 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.893 0.877 . . . . 0.0 113.32 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -36.51 -62.15 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 160.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.96 -48.43 76.52 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.801 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.02 68.64 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -48.04 69.8 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.08 86.66 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 164.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.255 53.5 t -56.65 -50.69 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 119.947 1.249 . . . . 0.0 113.115 164.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -43.65 67.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 165.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.277 0.0 OUTLIER -56.93 -39.0 73.68 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.66 56.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 118.399 2.119 . . . . 0.0 118.399 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -47.37 -47.84 57.43 Favored Pre-proline 0 CA--C 1.58 2.107 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.14 -30.88 11.07 Favored 'Trans proline' 0 C--N 1.372 1.808 0 N-CA-C 120.81 3.35 . . . . 0.0 120.81 167.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -28.78 66.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.7 mm -85.63 -59.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 CA-C-N 118.803 0.729 . . . . 0.0 110.036 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.53 -65.15 3.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 118.204 2.041 . . . . 0.0 118.204 -168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.55 -24.05 62.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.15 70.65 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.75 -34.98 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 118.24 -0.886 . . . . 0.0 113.075 159.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.88 -66.18 2.94 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 120.106 1.321 . . . . 0.0 115.595 170.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.44 -66.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 118.227 1.013 . . . . 0.0 113.065 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.04 -59.69 9.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 117.92 1.928 . . . . 0.0 117.92 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.3 -45.68 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 117.012 -1.47 . . . . 0.0 111.693 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.3 -6.07 57.04 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 121.801 2.091 . . . . 0.0 115.088 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 -42.34 17.28 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-N 121.054 1.752 . . . . 0.0 116.436 147.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.03 -53.54 43.76 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 119.383 1.592 . . . . 0.0 116.948 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.28 -36.77 73.8 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 167.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -52.12 -51.68 56.33 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.06 -34.72 76.97 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.51 -43.87 65.35 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 156.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.17 -45.74 95.48 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 117.036 1.574 . . . . 0.0 117.036 166.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.56 85.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.63 89.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 167.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -66.53 -62.32 1.52 Allowed 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -149.36 116.58 3.7 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.18 -12.1 33.18 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 N-CA-C 119.544 2.863 . . . . 0.0 119.544 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.39 62.56 0.81 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.23 0.923 . . . . 0.0 110.689 164.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -96.06 153.48 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.824 0.821 . . . . 0.0 112.643 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mp -66.51 -58.1 10.9 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-O 115.728 -2.082 . . . . 0.0 110.658 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.77 -20.17 34.19 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 124.854 2.769 . . . . 0.0 119.03 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.93 -51.67 66.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 121.106 1.776 . . . . 0.0 114.275 160.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.04 -30.63 71.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -61.91 -59.17 5.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.732 1.151 . . . . 0.0 113.587 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -58.27 -46.38 86.14 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -43.72 93.53 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -48.81 -46.51 41.95 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 162.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.84 -14.48 61.09 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.889 2.551 . . . . 0.0 117.889 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.08 -55.53 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.311 1.414 . . . . 0.0 110.369 160.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.298 12.4 p -68.44 -55.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 85.4 mmm -57.92 -36.42 72.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.03 -74.33 0.38 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.354 164.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.88 -13.64 0.79 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -87.36 -28.89 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -50.03 -51.2 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.846 2.112 . . . . 0.0 112.833 152.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.85 -67.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.41 -55.31 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 120.125 1.329 . . . . 0.0 114.182 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.41 53.2 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.9 mmt -68.45 -36.59 79.24 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.296 0.4 OUTLIER -65.18 -50.99 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.664 1.574 . . . . 0.0 112.813 174.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.72 73.3 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.59 -49.2 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.776 1.171 . . . . 0.0 112.534 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.73 -39.51 55.29 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.35 -43.5 94.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.726 1.763 . . . . 0.0 113.112 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.37 -54.67 5.44 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 161.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 -48.75 64.99 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -40.76 -47.96 2.94 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.34 -40.82 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.379 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.02 -49.89 72.44 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -75.85 -55.89 5.19 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.81 -51.17 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.27 -59.94 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 119.343 0.974 . . . . 0.0 111.37 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 123.369 1.557 . . . . 0.0 113.48 174.149 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 119.078 -0.486 . . . . 0.0 111.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.263 9.7 tp10 65.91 80.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -63.83 -25.62 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.94 -47.74 85.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -57.58 -37.04 72.51 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.2 mtt -65.41 -42.41 92.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -57.58 -44.31 85.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -64.99 -44.34 89.61 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -50.58 51.41 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.994 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.98 -63.52 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 157.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.26 -46.85 66.25 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.568 -168.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.57 60.33 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 161.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.72 64.52 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.44 77.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.263 58.3 t -57.85 -50.17 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.711 1.141 . . . . 0.0 113.431 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.93 -36.33 76.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -31.3 71.73 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 167.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.45 -32.37 42.68 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.8 tp -38.07 -46.98 2.74 Favored Pre-proline 0 CA--C 1.582 2.173 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -47.0 -32.15 12.5 Favored 'Trans proline' 0 C--N 1.374 1.897 0 N-CA-C 120.326 3.164 . . . . 0.0 120.326 166.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.53 -30.96 67.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.72 -59.31 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.914 0 C-N-CA 123.657 0.783 . . . . 0.0 109.708 162.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.68 -62.26 4.94 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -167.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.24 62.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.9 -46.0 72.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.43 -35.18 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 118.045 -0.979 . . . . 0.0 113.13 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.99 -67.72 2.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.281 1.401 . . . . 0.0 115.174 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 11.0 mm -44.22 -73.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 166.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.12 -55.6 27.0 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 118.528 2.171 . . . . 0.0 118.528 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.22 -44.08 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 116.993 -1.479 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.33 22.0 mt -75.74 -35.59 60.16 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 121.927 2.149 . . . . 0.0 112.516 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.17 94.29 Favored Glycine 0 N--CA 1.492 2.391 0 CA-C-N 122.684 2.493 . . . . 0.0 118.365 160.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.72 -53.5 44.75 Favored Glycine 0 CA--C 1.553 2.409 0 CA-C-N 119.255 1.527 . . . . 0.0 116.59 164.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -50.75 -45.13 58.67 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 165.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.94 -44.46 82.53 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.261 2.6 tm? -66.44 -38.85 88.31 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 118.251 -0.881 . . . . 0.0 113.047 172.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.7 -39.01 61.57 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 165.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -39.71 98.35 Favored Glycine 0 CA--C 1.55 2.229 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 159.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.15 68.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.29 69.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -59.05 2.75 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.483 1.038 . . . . 0.0 112.272 170.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.78 119.78 6.96 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.717 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 -5.78 16.16 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 N-CA-C 119.467 2.833 . . . . 0.0 119.467 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -125.8 61.29 1.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.192 0.905 . . . . 0.0 110.859 161.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mt -76.9 156.24 32.23 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 121.133 -0.979 . . . . 0.0 112.577 169.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.89 -57.39 9.71 Favored Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.007 -1.949 . . . . 0.0 110.706 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -55.41 -21.26 29.16 Favored 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 124.847 2.767 . . . . 0.0 118.919 165.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tt -66.03 -52.58 47.87 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.678 1.127 . . . . 0.0 113.975 164.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.54 -29.28 70.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.54 -51.3 70.04 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 159.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.261 3.9 m -75.99 -32.94 59.69 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -54.28 -50.54 67.05 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 159.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -49.23 -45.14 44.17 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 162.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -63.26 -32.89 74.41 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mt -58.43 -52.02 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 119.377 0.99 . . . . 0.0 111.861 163.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.22 -58.74 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 124.073 0.949 . . . . 0.0 112.302 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -56.67 -24.38 48.39 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 171.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.22 -82.22 0.08 OUTLIER Glycine 0 C--N 1.355 1.606 0 CA-C-O 116.567 -2.24 . . . . 0.0 111.526 163.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.388 1.6 pt? -58.5 -2.83 0.23 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.26 -40.04 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 159.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -50.03 -44.62 51.44 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.321 1.873 . . . . 0.0 113.666 155.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.9 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 167.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.17 -58.27 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-N 121.03 1.741 . . . . 0.0 113.637 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.9 65.85 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.8 tpp -66.62 -39.67 88.44 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.271 4.8 tt -59.58 -60.3 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.794 1.179 . . . . 0.0 112.997 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -33.86 75.16 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.53 -56.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.679 1.127 . . . . 0.0 111.981 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.04 -33.09 65.48 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.74 -43.18 99.48 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.146 1.473 . . . . 0.0 113.158 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.79 -54.08 6.92 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.929 1.932 . . . . 0.0 117.929 162.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.34 -49.26 70.08 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.95 -47.7 2.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 164.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.1 -42.33 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 C-N-CA 123.943 0.897 . . . . 0.0 112.306 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.53 -48.05 72.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -78.03 -66.3 0.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.518 1.053 . . . . 0.0 113.786 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.04 28.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.71 -57.7 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 119.472 1.033 . . . . 0.0 111.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 122.861 1.315 . . . . 0.0 110.821 172.44 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.269 0.0 OUTLIER -108.47 -66.31 1.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.486 0.715 . . . . 0.0 110.904 174.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -66.62 -43.33 85.04 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -40.63 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.66 -37.89 74.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.3 mtm -69.13 -38.22 78.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.24 -45.97 86.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.035 1.288 . . . . 0.0 114.324 164.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.62 -42.09 99.38 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -66.27 -55.01 18.16 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.969 0.908 . . . . 0.0 113.321 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -36.68 -64.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 161.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtt -64.88 -49.92 68.61 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.606 -173.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.75 64.24 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 166.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.07 -57.24 8.16 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 121.482 1.946 . . . . 0.0 114.879 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -37.41 78.53 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 77.2 t -65.89 -51.96 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 120.416 1.462 . . . . 0.0 113.574 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 ttt -63.04 -44.76 94.97 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 10.5 mmt -89.4 -9.84 48.76 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.38 -37.82 62.67 Favored Glycine 0 CA--C 1.55 2.226 0 CA-C-N 120.187 1.358 . . . . 0.0 115.895 161.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -41.5 -57.94 3.41 Favored Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 115.227 -2.32 . . . . 0.0 116.364 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -53.38 -24.54 27.97 Favored 'Trans proline' 0 C--N 1.373 1.86 0 N-CA-C 120.719 3.315 . . . . 0.0 120.719 170.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.96 84.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 165.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.86 -53.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 123.87 0.868 . . . . 0.0 111.776 163.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.86 -60.16 8.77 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 118.688 2.235 . . . . 0.0 118.688 -173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.29 -16.73 60.93 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.8 -46.76 77.44 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 160.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.66 -33.14 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 158.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.84 -52.94 35.82 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mm -56.2 -62.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.233 1.517 . . . . 0.0 113.037 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.24 -58.7 10.21 Favored Glycine 0 CA--C 1.552 2.37 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.24 -49.73 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.602 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.257 20.3 mt -77.73 -21.29 52.11 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.737 2.062 . . . . 0.0 115.096 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.0 59.9 Favored Glycine 0 CA--C 1.551 2.31 0 CA-C-N 121.16 1.8 . . . . 0.0 117.043 156.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.06 -50.93 53.33 Favored Glycine 0 CA--C 1.554 2.493 0 N-CA-C 116.804 1.481 . . . . 0.0 116.804 165.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -55.07 -37.78 67.19 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 164.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.39 -44.48 76.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 166.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.277 2.5 tm? -67.12 -43.5 82.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -52.78 -41.97 64.6 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 166.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.45 86.93 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 162.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.47 -37.29 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.82 1.81 . . . . 0.0 114.777 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.26 -39.55 87.17 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 163.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -70.84 -60.13 2.41 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.25 118.52 2.86 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 117.769 -1.11 . . . . 0.0 108.589 171.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.31 -3.1 8.18 Favored 'Trans proline' 0 CA--C 1.566 2.113 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.19 62.29 1.62 Allowed 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 119.488 1.04 . . . . 0.0 110.952 155.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.78 162.73 22.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 111.572 166.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 64.9 mt -63.19 -57.62 19.86 Favored Pre-proline 0 CA--C 1.584 2.258 0 CA-C-O 115.788 -2.053 . . . . 0.0 111.189 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -54.13 -24.59 33.84 Favored 'Trans proline' 0 CA--C 1.567 2.155 0 CA-C-N 124.811 2.754 . . . . 0.0 119.134 165.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.52 -50.57 62.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.262 1.392 . . . . 0.0 113.967 165.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.3 -33.91 71.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -58.22 -54.12 50.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 163.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -68.39 -38.3 81.19 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.303 3.6 pp0? -63.62 -41.11 98.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.99 -47.11 65.05 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -64.27 -31.18 72.29 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -57.04 -51.4 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.842 1.201 . . . . 0.0 112.216 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.71 -67.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.282 0.0 OUTLIER -58.86 -33.62 70.66 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.94 -72.28 0.63 Allowed Glycine 0 C--N 1.353 1.522 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.273 166.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.5 tp -50.02 -21.23 1.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -71.79 -38.14 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 163.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -51.06 -61.46 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 120.891 1.678 . . . . 0.0 111.787 161.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.86 -68.69 0.14 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.71 -55.33 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 119.834 1.197 . . . . 0.0 113.684 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.409 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 24.4 mmt -61.36 -51.68 67.8 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.974 174.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.295 2.1 tp -52.73 -50.24 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 121.018 1.735 . . . . 0.0 115.18 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.59 76.8 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.9 -57.26 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 119.898 1.226 . . . . 0.0 112.733 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.44 63.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.23 -42.13 99.03 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.416 1.608 . . . . 0.0 113.43 164.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -55.94 5.82 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 117.68 1.832 . . . . 0.0 117.68 161.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.61 -49.51 76.3 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -42.77 -47.23 5.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -73.17 -42.97 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.528 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.4 mtt -55.26 -53.2 59.07 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -76.87 -30.92 56.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.74 99.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.75 -61.1 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 119.079 0.854 . . . . 0.0 111.545 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 125.086 2.374 . . . . 0.0 108.782 175.237 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.31 -76.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -61.83 -34.67 76.36 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.42 -49.94 73.5 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -58.8 -39.83 82.3 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.49 -45.17 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.08 -36.29 83.83 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.334 3.5 pp -67.47 -43.04 81.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.27 -46.85 86.95 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -41.41 -58.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.705 1.602 . . . . 0.0 114.911 164.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ttt -74.93 -42.91 56.79 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.967 -1.016 . . . . 0.0 113.216 -169.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.97 -36.92 18.66 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 159.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.49 14.59 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 -34.18 70.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 57.9 t -59.93 -50.92 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.667 1.121 . . . . 0.0 112.896 164.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 41.0 ttm -55.74 -39.6 71.38 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.279 0.0 OUTLIER -59.39 -32.96 70.63 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 167.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.62 -30.23 40.74 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.7 tp -37.82 -49.37 2.91 Favored Pre-proline 0 CA--C 1.581 2.17 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -54.77 -21.77 26.85 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 N-CA-C 120.265 3.14 . . . . 0.0 120.265 170.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -32.72 67.96 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.26 -56.08 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 C-N-CA 123.437 0.695 . . . . 0.0 109.865 160.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -66.05 3.04 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 118.643 2.217 . . . . 0.0 118.643 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.4 -13.22 60.13 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.41 -51.49 56.47 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 164.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.8 -33.09 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 158.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.54 -67.85 1.8 Allowed Glycine 0 N--CA 1.482 1.763 0 CA-C-N 120.193 1.36 . . . . 0.0 116.19 168.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.2 mm -54.65 -70.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 118.266 1.033 . . . . 0.0 112.438 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.26 -54.22 37.3 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.16 -59.89 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.531 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.31 -1.84 28.67 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.43 -34.58 1.73 Allowed Glycine 0 N--CA 1.48 1.616 0 CA-C-O 116.725 -2.153 . . . . 0.0 117.326 154.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.55 -58.64 12.86 Favored Glycine 0 N--CA 1.49 2.262 0 CA-C-N 122.192 2.996 . . . . 0.0 115.524 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.57 -46.1 73.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 167.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -72.32 -49.45 34.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.37 -35.77 81.19 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 116.76 -1.591 . . . . 0.0 112.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -53.54 -38.37 63.75 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 123.039 2.654 . . . . 0.0 116.047 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.71 -36.0 81.67 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 161.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 5.02 47.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.3 -19.75 66.1 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 165.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -56.34 -46.72 79.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -127.06 112.7 21.77 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.57 -10.03 24.75 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.28 60.93 0.82 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.317 0.962 . . . . 0.0 110.626 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.04 157.98 16.48 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.142 0.977 . . . . 0.0 112.051 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.288 3.6 mp -67.49 -57.47 10.29 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.216 -1.85 . . . . 0.0 109.357 169.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.95 -24.69 1.34 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 N-CA-C 121.472 3.605 . . . . 0.0 121.472 156.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.51 -50.21 68.28 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 121.664 2.029 . . . . 0.0 113.398 162.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.23 -32.1 69.66 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 167.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -66.77 -52.82 39.73 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 120.097 1.317 . . . . 0.0 113.39 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.1 p -57.78 -47.0 83.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -53.32 -47.48 69.25 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.36 -45.84 72.84 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 166.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -52.99 -37.07 61.1 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 169.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -50.39 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 C-N-CA 123.848 0.859 . . . . 0.0 112.78 169.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.63 -45.36 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.882 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.58 -27.31 69.1 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 178.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -60.58 7.0 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 118.103 -1.387 . . . . 0.0 111.909 160.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -8.2 0.38 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 170.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 0.3 OUTLIER -92.66 -23.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 162.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.02 -50.08 48.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.965 1.711 . . . . 0.0 112.938 148.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.03 -71.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 165.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.01 -56.03 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 121.183 1.81 . . . . 0.0 114.531 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.42 50.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.2 mmt -65.79 -39.81 91.33 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.265 5.6 tt -62.23 -59.81 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.926 1.239 . . . . 0.0 113.534 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.74 -37.19 84.15 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.04 -50.4 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.889 1.222 . . . . 0.0 112.252 170.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.17 -45.5 61.56 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.76 -42.21 97.86 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.26 1.03 . . . . 0.0 112.825 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.84 -52.42 6.69 Favored Glycine 0 CA--C 1.55 2.261 0 N-CA-C 118.111 2.005 . . . . 0.0 118.111 160.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.16 -54.66 26.29 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -34.73 -49.47 0.42 Allowed 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 162.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.3 p -83.6 -41.78 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.8 mtt -60.14 -38.69 83.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.31 -50.93 70.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 162.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 71.23 86.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.184 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.415 54.1 t 73.72 -62.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 125.319 1.448 . . . . 0.0 114.666 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 123.195 1.474 . . . . 0.0 113.27 -179.395 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.62 -74.38 0.57 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.238 0.615 . . . . 0.0 109.927 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -149.42 -49.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.859 0.863 . . . . 0.0 112.959 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.31 -52.68 62.7 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.979 0.912 . . . . 0.0 113.024 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.42 -34.89 73.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 168.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.2 mtp -62.8 -41.96 99.51 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.64 -40.15 93.88 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.7 -46.41 90.49 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -51.2 50.41 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.014 0.925 . . . . 0.0 113.312 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.21 -60.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 157.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.33 -46.8 69.24 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.671 -170.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.19 -36.02 60.49 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 162.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.29 -48.3 43.4 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -43.24 62.87 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 161.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.79 -48.04 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 163.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -26.5 66.16 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 164.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.4 -36.55 63.02 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.8 tp -42.8 -54.53 8.5 Favored Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 170.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -56.14 -32.22 86.24 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 125.357 2.949 . . . . 0.0 118.858 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.36 69.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.23 -57.84 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 118.626 0.648 . . . . 0.0 110.356 160.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.77 -66.55 2.46 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -167.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.93 -11.74 59.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 118.445 2.757 . . . . 0.0 118.445 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.31 69.64 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 158.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.68 -29.81 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 158.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.91 -60.82 7.52 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-N 119.902 1.228 . . . . 0.0 116.152 166.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -48.27 -69.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-N 118.285 1.042 . . . . 0.0 112.898 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.6 -54.4 37.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -172.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.5 -46.92 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 117.327 -1.321 . . . . 0.0 111.433 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.252 13.5 mt -70.27 -42.54 71.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.483 1.947 . . . . 0.0 112.345 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.11 92.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 165.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -53.95 41.46 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 119.289 1.545 . . . . 0.0 116.584 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.12 -39.16 74.57 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -56.78 -43.66 81.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.269 2.4 tm? -67.69 -38.84 84.22 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.28 0.945 . . . . 0.0 113.135 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.95 -39.24 65.75 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 121.103 1.774 . . . . 0.0 115.513 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.03 -29.74 75.6 Favored Glycine 0 CA--C 1.55 2.268 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 160.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.06 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 119.635 1.717 . . . . 0.0 114.777 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.93 -39.45 71.71 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 162.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.23 -57.32 7.82 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 167.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.5 123.61 2.48 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.941 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 -4.94 15.05 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.56 63.96 1.44 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.462 1.028 . . . . 0.0 110.674 157.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -91.1 166.46 12.97 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.852 0.861 . . . . 0.0 112.244 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 3.8 mp -66.82 -62.31 3.99 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 115.603 -2.142 . . . . 0.0 109.762 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -51.49 -21.21 10.05 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 N-CA-C 119.705 2.925 . . . . 0.0 119.705 164.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.88 -59.97 3.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.003 1.274 . . . . 0.0 113.446 166.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -64.91 -28.67 69.69 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -55.46 -58.82 6.17 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.12 0.873 . . . . 0.0 112.927 162.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -72.02 -28.28 63.28 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.26 -52.58 60.95 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 161.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.03 -38.74 68.34 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 166.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -54.93 -44.1 73.95 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 165.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 mt -57.9 -44.94 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.437 1.017 . . . . 0.0 113.048 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.63 -59.05 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.846 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER -59.33 -34.97 72.99 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 176.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.03 -69.88 1.17 Allowed Glycine 0 C--N 1.355 1.624 0 CA-C-O 117.801 -1.555 . . . . 0.0 112.357 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.52 -14.34 0.11 Allowed 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 171.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.51 -38.34 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 164.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -50.85 -47.82 60.23 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.13 1.786 . . . . 0.0 113.565 156.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -44.8 -67.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.12 -58.04 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.022 1.283 . . . . 0.0 113.17 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 -51.82 64.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.04 -36.07 77.31 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.308 0.4 OUTLIER -66.01 -50.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 120.574 1.534 . . . . 0.0 113.109 173.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.67 92.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.24 -51.7 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.858 1.208 . . . . 0.0 112.528 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 -41.99 84.9 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.03 -43.31 99.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 119.272 1.536 . . . . 0.0 113.65 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.41 -57.73 3.67 Favored Glycine 0 CA--C 1.55 2.24 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 160.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.49 -48.53 48.47 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -40.21 -47.78 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 164.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.88 -39.18 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.821 0 CA-C-O 118.421 -0.8 . . . . 0.0 112.624 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 79.9 mtp -58.12 -47.6 82.8 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -77.85 -67.71 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.14 1.337 . . . . 0.0 113.591 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.59 -47.39 32.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.18 -57.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 119.592 1.087 . . . . 0.0 111.86 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 122.888 1.327 . . . . 0.0 110.865 172.377 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.271 26.5 ptt? . . . . . 0 CA--C 1.558 1.256 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.43 -57.79 4.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.903 0.774 . . . . 0.0 112.931 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.14 -26.91 66.64 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.7 -53.68 31.1 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -58.72 -39.79 81.86 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.77 -41.53 95.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.02 -41.91 98.6 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 167.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.28 -44.8 95.03 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.59 -54.44 32.02 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -36.6 -63.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 161.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.7 mtp -64.61 -50.42 67.24 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.284 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.16 62.65 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.49 -64.96 0.74 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 116.964 -1.494 . . . . 0.0 114.126 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.61 -35.73 31.7 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.107 2.632 . . . . 0.0 118.107 168.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.271 70.4 t -62.43 -53.1 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.775 1.171 . . . . 0.0 113.552 166.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.15 -28.52 58.31 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 165.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 0.6 OUTLIER -84.1 -13.78 52.09 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 173.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.51 -32.88 36.49 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 156.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 tp -39.25 -45.35 3.37 Favored Pre-proline 0 CA--C 1.582 2.19 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -44.53 -33.11 6.26 Favored 'Trans proline' 0 C--N 1.375 1.948 0 CA-C-N 126.176 3.242 . . . . 0.0 120.184 165.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.71 64.33 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.49 -57.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 118.826 0.739 . . . . 0.0 110.256 160.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -62.96 4.84 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.52 -23.7 61.05 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.61 -48.4 66.92 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -57.1 -31.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 159.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.53 -65.13 3.5 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.887 1.221 . . . . 0.0 115.79 167.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -47.66 -73.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 117.945 0.873 . . . . 0.0 113.013 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -56.08 27.21 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 118.5 2.16 . . . . 0.0 118.5 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -81.35 -46.98 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 117.475 -1.25 . . . . 0.0 112.45 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.279 17.5 mt -75.6 -35.7 60.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.181 1.81 . . . . 0.0 112.703 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.81 65.59 Favored Glycine 0 N--CA 1.491 2.318 0 CA-C-N 121.718 2.054 . . . . 0.0 118.005 163.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.33 -53.49 44.47 Favored Glycine 0 N--CA 1.491 2.339 0 CA-C-N 119.561 1.681 . . . . 0.0 116.289 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.99 -43.52 66.5 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.698 2.111 . . . . 0.0 116.698 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -44.3 85.47 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 171.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.276 2.4 tm? -66.56 -38.57 87.37 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.766 1.167 . . . . 0.0 113.231 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 164.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.36 89.04 Favored Glycine 0 CA--C 1.551 2.306 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 160.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -32.05 66.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.15 62.47 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -62.17 1.6 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 119.322 0.965 . . . . 0.0 112.196 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.89 114.96 5.99 Favored Pre-proline 0 CA--C 1.568 1.656 0 CA-C-O 117.961 -1.018 . . . . 0.0 108.303 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.65 -2.02 11.89 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 N-CA-C 119.298 2.768 . . . . 0.0 119.298 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -129.9 62.39 1.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.418 1.008 . . . . 0.0 110.153 159.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.0 162.65 20.33 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 111.48 165.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.258 43.5 mm -67.1 -58.64 8.81 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-O 115.841 -2.028 . . . . 0.0 111.166 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -54.87 -20.55 22.96 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 CA-C-N 124.909 2.789 . . . . 0.0 119.292 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.8 -54.07 31.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 119.755 1.162 . . . . 0.0 113.646 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.29 -22.28 66.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -57.01 -58.18 9.3 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.669 1.122 . . . . 0.0 113.378 157.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -66.66 -33.11 74.92 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -52.41 -51.28 59.93 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 160.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.71 -39.57 74.1 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -54.56 -38.92 67.22 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 165.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mt -59.0 -48.83 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 119.392 0.996 . . . . 0.0 112.799 165.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.96 -56.81 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.28 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.262 0.0 OUTLIER -58.35 -31.91 68.04 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 176.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.67 -67.84 1.87 Allowed Glycine 0 C--N 1.355 1.627 0 CA-C-O 117.545 -1.697 . . . . 0.0 111.125 166.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.8 tp -46.53 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -80.93 -40.92 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 125.526 1.53 . . . . 0.0 113.823 166.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -49.82 -36.21 25.71 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 121.236 1.834 . . . . 0.0 115.264 158.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.16 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 117.439 -1.267 . . . . 0.0 113.373 160.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.66 -55.96 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-N 120.92 1.691 . . . . 0.0 114.818 -165.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.4 -59.51 5.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.418 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 20.3 mmt -61.27 -49.6 76.42 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 116.641 -1.647 . . . . 0.0 113.994 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.291 5.9 tt -51.43 -56.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 121.508 1.958 . . . . 0.0 114.651 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.85 79.75 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -59.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.617 1.099 . . . . 0.0 113.172 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.2 -17.94 63.76 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 119.614 2.606 . . . . 0.0 119.614 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.66 -43.67 83.93 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.626 2.213 . . . . 0.0 112.074 159.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.36 -51.98 6.27 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 157.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.14 -51.53 66.11 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -42.75 -47.93 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 167.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.56 -40.4 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.661 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -58.59 -49.8 76.15 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.02 -44.53 38.92 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.91 -51.43 26.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.4 126.92 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 123.209 1.481 . . . . 0.0 108.613 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 CA--C 1.558 1.265 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -98.56 -75.28 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.464 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -62.49 -32.59 73.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.01 -51.1 51.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.726 0.81 . . . . 0.0 113.032 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -58.74 -40.95 85.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.2 mtt -64.71 -44.1 91.32 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.11 -38.04 87.41 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.63 -47.81 83.73 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.82 -48.58 81.14 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -43.08 -58.92 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.6 -39.64 73.69 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.32 67.1 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 166.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.98 40.48 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 165.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.62 -44.82 37.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 165.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.16 -51.38 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 C-N-CA 124.209 1.003 . . . . 0.0 113.065 166.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -44.12 72.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -28.39 67.67 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 169.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.65 -37.3 40.47 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 167.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.7 tp -37.34 -52.7 2.34 Favored Pre-proline 0 CA--C 1.582 2.199 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.43 -25.72 59.23 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 125.273 2.919 . . . . 0.0 119.45 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.13 69.69 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -86.33 -55.34 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 CA-C-N 118.739 0.7 . . . . 0.0 110.57 160.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.62 -65.25 3.45 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.63 -13.63 59.85 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.6 -48.69 68.73 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 161.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.7 mm -59.01 -29.6 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 158.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.39 -62.42 6.2 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 120.04 1.291 . . . . 0.0 115.771 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.4 mm -54.32 -65.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 119.037 1.418 . . . . 0.0 112.948 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.05 -56.9 18.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.62 -58.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.793 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.5 mt -75.63 3.49 9.48 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.32 -36.33 1.64 Allowed Glycine 0 N--CA 1.481 1.695 0 CA-C-O 117.176 -1.902 . . . . 0.0 116.749 155.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -59.51 10.68 Favored Glycine 0 N--CA 1.492 2.388 0 CA-C-N 121.305 2.552 . . . . 0.0 115.923 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.86 -43.21 80.95 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 167.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.08 -42.32 72.92 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.255 3.0 tm? -71.14 -36.73 72.19 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.655 1.116 . . . . 0.0 112.549 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -52.18 -39.32 59.92 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 121.776 2.08 . . . . 0.0 115.942 163.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.76 -31.7 73.39 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 118.4 2.12 . . . . 0.0 118.4 161.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -23.58 54.94 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -20.0 15.44 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 118.809 2.892 . . . . 0.0 118.809 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -58.54 -34.93 71.56 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -154.03 129.72 5.25 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-N 119.997 1.271 . . . . 0.0 109.072 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 2.97 3.55 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.7 64.02 1.58 Allowed 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.168 0.894 . . . . 0.0 110.163 152.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.82 172.91 7.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.571 1.177 . . . . 0.0 112.867 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.49 -56.89 30.83 Favored Pre-proline 0 CA--C 1.581 2.155 0 CA-C-O 115.319 -2.277 . . . . 0.0 110.897 163.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.11 -15.13 21.66 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 CA-C-N 125.349 2.946 . . . . 0.0 119.51 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.5 -49.65 52.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.771 1.623 . . . . 0.0 113.662 161.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.93 -29.42 70.21 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -67.66 -45.58 74.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.502 165.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.41 ' HG1' ' CD1' ' A' ' 55' ' ' ILE 0.295 1.2 t -58.81 -47.01 86.26 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 122.131 2.241 . . . . 0.0 114.973 172.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.23 -49.32 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.55 -58.17 9.2 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -61.02 -39.27 89.13 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' CD1' ' HG1' ' A' ' 51' ' ' THR . 59.0 mt -64.59 -43.47 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.39 169.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.77 -47.64 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 120.558 1.526 . . . . 0.0 113.223 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 75.2 mmm -53.0 -43.94 66.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.3 -67.51 2.09 Favored Glycine 0 C--N 1.356 1.646 0 CA-C-O 117.731 -1.594 . . . . 0.0 112.262 166.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.72 -2.63 0.15 Allowed 'General case' 0 CA--C 1.583 2.227 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.93 -25.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.106 1.362 . . . . 0.0 113.726 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -50.88 -43.85 59.64 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 122.087 2.221 . . . . 0.0 113.528 148.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.19 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 159.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.04 -55.94 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.729 1.604 . . . . 0.0 114.559 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 -54.62 33.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.46 -34.44 75.95 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.285 6.8 tt -62.88 -60.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 120.42 1.464 . . . . 0.0 113.45 171.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.53 97.22 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.78 -52.17 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.318 0.963 . . . . 0.0 112.299 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.14 87.84 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.88 -43.35 83.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.486 1.143 . . . . 0.0 113.294 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.14 -48.44 10.15 Favored Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.181 2.032 . . . . 0.0 118.181 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.96 -56.19 6.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -40.67 -45.94 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 164.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.06 -43.96 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.503 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.12 -50.47 58.75 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.82 -38.68 80.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.33 -43.74 96.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 172.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.27 -61.19 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 119.028 0.831 . . . . 0.0 111.558 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 125.137 2.398 . . . . 0.0 108.367 174.581 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -116.59 -74.57 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.143 0.577 . . . . 0.0 110.651 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -145.11 -65.42 0.33 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.321 1.048 . . . . 0.0 112.149 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.94 -45.48 93.49 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.367 1.067 . . . . 0.0 113.861 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.8 -29.3 70.06 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 168.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 45.0 mtm -62.92 -43.67 98.17 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.127 1.33 . . . . 0.0 114.404 163.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.81 -33.43 72.99 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.89 -50.89 70.37 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 168.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.94 -49.31 75.27 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -34.29 -67.27 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 163.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.5 ttt -73.36 -39.29 65.3 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.803 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -37.93 31.03 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.479 2.399 . . . . 0.0 117.479 160.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.78 24.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.76 71.97 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 60.0 t -60.45 -49.75 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.83 1.196 . . . . 0.0 113.145 166.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.8 tpp -58.42 -39.23 79.21 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 166.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -58.37 -30.32 66.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 166.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.88 36.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 170.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 tt -35.88 -50.48 1.56 Allowed Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 167.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -46.87 -30.08 9.04 Favored 'Trans proline' 0 CA--C 1.563 1.934 0 N-CA-C 120.808 3.349 . . . . 0.0 120.808 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.65 -31.86 66.72 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 168.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -85.66 -56.31 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 C-N-CA 123.727 0.811 . . . . 0.0 110.09 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.3 -63.62 4.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -169.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.66 63.61 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.597 2.814 . . . . 0.0 118.597 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.1 74.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 165.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.5 -32.96 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 159.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.7 -64.8 3.79 Favored Glycine 0 N--CA 1.485 1.909 0 CA-C-N 119.804 1.183 . . . . 0.0 115.864 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.48 -69.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 118.533 1.166 . . . . 0.0 112.703 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.46 -54.6 36.43 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 118.634 2.214 . . . . 0.0 118.634 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.38 -45.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.313 17.8 mt -74.84 -38.54 61.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.99 2.177 . . . . 0.0 112.379 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.81 94.64 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-N 122.176 2.262 . . . . 0.0 118.489 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.41 -52.28 53.71 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 119.384 1.592 . . . . 0.0 116.713 166.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -50.78 -45.37 59.05 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 164.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -54.65 -49.08 71.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.21 -33.63 76.2 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.21 -43.22 67.04 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.75 94.35 Favored Glycine 0 CA--C 1.549 2.213 0 N-CA-C 117.537 1.775 . . . . 0.0 117.537 165.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.07 88.47 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.39 96.4 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.0 -62.68 1.68 Allowed 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -151.16 120.62 3.56 Favored Pre-proline 0 CA--C 1.566 1.577 0 C-N-CA 124.481 1.112 . . . . 0.0 108.096 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 -13.75 38.19 Favored 'Trans proline' 0 CA--C 1.572 2.385 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 168.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -97.62 31.62 2.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.27 144.58 25.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.551 -1.343 . . . . 0.0 113.951 -160.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 67.1 mt -68.28 -57.07 9.46 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-O 115.723 -2.084 . . . . 0.0 111.114 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.48 -19.02 34.36 Favored 'Trans proline' 0 CA--C 1.571 2.339 0 CA-C-N 124.995 2.82 . . . . 0.0 119.171 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.95 -54.2 34.38 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.371 1.441 . . . . 0.0 113.437 161.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.42 -34.26 70.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -57.94 -48.07 81.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.0 m -80.67 -33.72 35.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 117.389 -1.291 . . . . 0.0 114.212 -172.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.336 3.1 pp0? -62.47 -38.46 89.9 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 122.0 2.182 . . . . 0.0 116.649 159.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -51.2 -44.47 61.58 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 158.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -67.0 -29.91 69.87 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.61 -48.09 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-N 119.867 1.212 . . . . 0.0 111.928 162.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.55 -52.51 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.571 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 80.1 mmm -55.09 -40.6 70.61 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.94 -69.21 1.36 Allowed Glycine 0 C--N 1.356 1.668 0 CA-C-O 117.404 -1.775 . . . . 0.0 112.157 166.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -4.44 0.26 Allowed 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.34 -25.33 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.093 163.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -49.71 -50.08 45.38 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 122.537 2.426 . . . . 0.0 112.905 148.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.83 -68.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -65.11 -59.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 121.163 1.801 . . . . 0.0 113.129 -173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.87 66.46 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.82 -35.53 74.88 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.415 HG13 ' SD ' ' A' ' 17' ' ' MET 0.256 4.8 tt -58.35 -57.53 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.944 1.702 . . . . 0.0 113.166 169.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.06 79.17 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.33 -51.49 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.059 1.3 . . . . 0.0 112.506 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.53 -38.88 68.91 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.96 -44.55 84.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.182 1.491 . . . . 0.0 113.299 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.6 -47.75 12.57 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.84 -53.62 47.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -45.12 -44.73 10.79 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.5 -40.8 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.905 0.882 . . . . 0.0 113.058 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -54.22 -42.44 69.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.38 -50.15 75.08 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 164.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 64.09 78.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.673 1.189 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.429 52.4 t 73.6 -35.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 124.996 2.331 . . . . 0.0 111.402 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.555 1.138 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -93.02 -76.27 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.989 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.52 -35.65 76.47 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.89 -50.78 69.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -60.7 -40.01 90.65 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.6 mmt -66.58 -41.85 87.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.34 -41.42 89.14 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 165.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.0 mt -62.62 -45.51 92.55 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.9 -56.41 13.47 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -33.15 -65.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 158.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.19 -48.01 59.02 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.036 -167.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.35 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -61.1 2.38 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.537 1.971 . . . . 0.0 114.772 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.91 72.8 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.357 2.355 . . . . 0.0 117.357 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 79.0 t -66.17 -52.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.703 1.592 . . . . 0.0 113.328 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.95 89.13 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.4 mmt -83.83 -12.86 54.99 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.79 59.51 Favored Glycine 0 CA--C 1.548 2.107 0 CA-C-N 120.201 1.364 . . . . 0.0 115.981 164.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -40.33 -55.53 4.1 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.56 -24.87 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 124.124 3.216 . . . . 0.0 120.177 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.1 89.06 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 121.117 1.781 . . . . 0.0 115.443 165.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.79 -52.67 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 C-N-CA 123.928 0.891 . . . . 0.0 111.964 165.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.58 -59.1 10.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.552 2.181 . . . . 0.0 118.552 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.57 -13.47 60.67 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.34 -46.44 70.17 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 160.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.03 -37.7 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 123.606 0.762 . . . . 0.0 113.025 156.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.58 48.45 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 163.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.41 -63.62 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-N 120.463 2.131 . . . . 0.0 111.815 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.42 -51.83 56.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 119.257 2.463 . . . . 0.0 119.257 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.77 -45.93 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.9 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.55 -50.05 64.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.757 1.617 . . . . 0.0 112.043 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.72 -39.35 76.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -54.29 39.17 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-N 119.075 1.438 . . . . 0.0 116.529 167.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -48.56 -47.25 39.55 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 164.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.9 -51.79 66.36 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.309 1.444 . . . . 0.0 114.698 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.33 -31.72 71.33 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.33 -43.86 67.99 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 155.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.83 97.13 Favored Glycine 0 CA--C 1.551 2.307 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.61 80.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.35 79.08 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -69.97 -66.06 0.64 Allowed 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -145.56 112.42 4.64 Favored Pre-proline 0 CA--C 1.568 1.659 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.7 2.67 5.03 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 N-CA-C 119.519 2.854 . . . . 0.0 119.519 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -131.62 64.67 1.58 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.12 0.873 . . . . 0.0 110.333 157.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 163.77 17.87 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 121.835 0.826 . . . . 0.0 111.53 168.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.256 4.0 mp -66.81 -59.06 8.42 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.849 -2.024 . . . . 0.0 110.48 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -52.62 -23.99 21.45 Favored 'Trans proline' 0 CA--C 1.57 2.299 0 N-CA-C 119.345 2.787 . . . . 0.0 119.345 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.69 -56.01 12.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 168.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.48 -27.53 68.56 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 160.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.2 m -76.27 -33.46 59.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -51.76 -52.33 49.53 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 158.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -51.04 -44.44 61.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -62.9 -36.84 84.68 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -59.15 -54.36 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.871 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.313 10.2 p -60.96 -49.04 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.679 1.581 . . . . 0.0 114.371 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.17 -43.32 87.42 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.83 -69.04 1.39 Allowed Glycine 0 N--CA 1.479 1.548 0 CA-C-O 118.866 -0.964 . . . . 0.0 114.034 165.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.86 -19.63 0.4 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -90.03 -21.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -51.17 -62.62 1.5 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 122.479 2.399 . . . . 0.0 111.178 152.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.4 -65.03 0.42 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.72 -57.38 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.071 0.85 . . . . 0.0 113.05 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.18 75.03 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 mmt -63.71 -52.65 59.64 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.921 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.289 0.4 OUTLIER -57.36 -41.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 121.101 1.773 . . . . 0.0 114.311 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.54 83.57 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.83 -54.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.25 1.386 . . . . 0.0 112.705 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.61 -40.9 90.48 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 118.745 2.258 . . . . 0.0 118.745 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.77 -42.83 84.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.938 1.369 . . . . 0.0 114.015 163.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.05 -54.88 4.35 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 161.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.16 -49.89 68.09 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -42.79 -40.94 3.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -83.86 -32.92 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.3 mmt -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -71.03 -13.54 62.02 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.26 . . 65.47 56.69 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.442 12.5 p 40.57 74.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.812 -166.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptp . . . . . 0 CA--C 1.556 1.194 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.69 70.26 0.57 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.744 1.217 . . . . 0.0 113.119 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -58.63 -34.66 71.42 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.76 -49.5 76.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -58.72 -39.75 81.73 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -65.64 -45.71 82.0 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.21 -33.75 76.52 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.72 -50.35 69.46 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 tp -56.66 -51.62 68.02 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -37.89 -73.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.227 1.811 . . . . 0.0 115.69 163.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.29 -40.22 71.01 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -167.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.7 65.05 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 117.079 2.252 . . . . 0.0 117.079 162.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.31 64.08 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.626 2.012 . . . . 0.0 115.509 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -36.07 82.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.42 -53.46 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 120.728 1.604 . . . . 0.0 113.068 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.7 -52.13 53.89 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -87.16 -16.44 35.41 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.55 -25.39 67.91 Favored Glycine 0 N--CA 1.491 2.344 0 CA-C-N 121.176 1.807 . . . . 0.0 117.486 163.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 tp -50.17 -46.35 82.73 Favored Pre-proline 0 CA--C 1.578 2.05 0 CA-C-O 115.211 -2.328 . . . . 0.0 117.081 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.05 -27.15 2.49 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 121.564 3.64 . . . . 0.0 121.564 164.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.68 74.23 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 164.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.52 -52.66 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 C-N-CA 123.952 0.901 . . . . 0.0 110.904 162.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.91 -66.74 1.36 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 -16.35 61.32 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 119.258 3.059 . . . . 0.0 119.258 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.0 -51.69 51.86 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.8 mt -54.56 -40.28 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 123.418 0.687 . . . . 0.0 112.807 160.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.11 -59.41 6.95 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-O 117.759 -1.578 . . . . 0.0 116.321 167.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 mm -41.83 -51.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.44 -59.9 6.18 Favored Glycine 0 CA--C 1.552 2.351 0 N-CA-C 118.261 2.065 . . . . 0.0 118.261 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.23 -42.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.81 -55.45 34.04 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.444 1.098 . . . . 0.0 112.367 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.42 -39.94 30.04 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 162.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.27 -53.76 43.54 Favored Glycine 0 CA--C 1.554 2.474 0 CA-C-N 119.448 1.624 . . . . 0.0 117.091 166.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -51.57 -49.07 62.8 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -57.58 -42.6 83.46 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.317 0.5 OUTLIER -72.57 -38.96 67.78 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 119.601 1.091 . . . . 0.0 112.58 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.33 -39.27 66.89 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 161.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.21 93.28 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 117.409 1.723 . . . . 0.0 117.409 159.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -37.58 65.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.845 1.823 . . . . 0.0 115.069 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.32 93.34 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 165.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -71.34 -54.08 12.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -154.9 120.1 2.61 Favored Pre-proline 0 CA--C 1.565 1.52 0 CA-C-O 117.674 -1.155 . . . . 0.0 109.106 174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.22 -6.26 12.82 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 N-CA-C 119.676 2.914 . . . . 0.0 119.676 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.63 58.01 1.24 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.19 0.904 . . . . 0.0 111.381 163.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.02 158.9 24.97 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 0.0 113.547 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 4.1 mp -64.36 -57.78 16.25 Favored Pre-proline 0 CA--C 1.582 2.189 0 CA-C-O 116.006 -1.949 . . . . 0.0 110.914 169.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -52.78 -21.59 15.49 Favored 'Trans proline' 0 CA--C 1.57 2.305 0 CA-C-N 125.022 2.829 . . . . 0.0 119.137 164.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.65 -53.33 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.98 -37.32 74.0 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -53.37 -51.59 62.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 162.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.268 5.3 m -86.87 -28.01 23.1 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -170.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.282 10.0 pt20 -61.71 -40.75 96.12 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 121.724 2.056 . . . . 0.0 115.912 157.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.87 -48.29 64.11 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 159.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.21 -40.78 97.25 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.02 -46.25 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 124.962 1.305 . . . . 0.0 114.184 166.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.77 -61.83 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 117.838 -1.077 . . . . 0.0 111.813 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.31 0.0 OUTLIER -65.64 -31.55 72.64 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -176.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.37 -65.72 3.18 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.914 -1.116 . . . . 0.0 113.448 164.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -11.99 5.64 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.32 0.4 OUTLIER -81.81 -22.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 159.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -49.1 -63.15 1.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 121.06 1.755 . . . . 0.0 111.096 151.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.3 -63.96 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -66.95 -54.49 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.568 1.531 . . . . 0.0 113.783 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 -49.92 75.56 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -68.5 -43.38 76.98 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.286 0.4 OUTLIER -57.09 -44.21 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 121.954 2.161 . . . . 0.0 113.31 173.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.12 76.0 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.31 -54.1 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 120.249 1.386 . . . . 0.0 112.793 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.85 -43.79 93.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.45 -48.69 74.09 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.498 1.149 . . . . 0.0 113.919 163.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -51.58 7.81 Favored Glycine 0 CA--C 1.548 2.099 0 N-CA-C 118.621 2.209 . . . . 0.0 118.621 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.33 -54.73 13.09 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -35.02 -54.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 160.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 2.2 p -74.28 -35.94 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 87.7 mmm -62.5 -30.61 71.4 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 163.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.91 -52.82 7.77 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.37 61.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.65 121.96 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 163.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 123.119 1.438 . . . . 0.0 112.666 -169.693 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.38 -45.67 92.7 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -57.33 -39.48 75.94 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.4 mtm -68.63 -38.36 80.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -58.18 -45.99 86.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.941 1.246 . . . . 0.0 114.016 166.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.87 -45.2 93.69 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.64 -54.4 32.48 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.893 0.877 . . . . 0.0 113.32 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -36.51 -62.15 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 160.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.96 -48.43 76.52 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.801 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.02 68.64 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -48.04 69.8 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.08 86.66 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 164.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.255 53.5 t -56.65 -50.69 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 119.947 1.249 . . . . 0.0 113.115 164.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -43.65 67.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 165.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.277 0.0 OUTLIER -56.93 -39.0 73.68 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.064 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.66 56.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 118.399 2.119 . . . . 0.0 118.399 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -47.37 -47.84 57.43 Favored Pre-proline 0 CA--C 1.58 2.107 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.14 -30.88 11.07 Favored 'Trans proline' 0 C--N 1.372 1.808 0 N-CA-C 120.81 3.35 . . . . 0.0 120.81 167.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -28.78 66.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.7 mm -85.63 -59.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 CA-C-N 118.803 0.729 . . . . 0.0 110.036 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.53 -65.15 3.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 118.204 2.041 . . . . 0.0 118.204 -168.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.55 -24.05 62.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.15 70.65 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.75 -34.98 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 118.24 -0.886 . . . . 0.0 113.075 159.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.88 -66.18 2.94 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 120.106 1.321 . . . . 0.0 115.595 170.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.44 -66.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 118.227 1.013 . . . . 0.0 113.065 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.04 -59.69 9.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 117.92 1.928 . . . . 0.0 117.92 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.3 -45.68 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 117.012 -1.47 . . . . 0.0 111.693 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.3 -6.07 57.04 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 121.801 2.091 . . . . 0.0 115.088 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 -42.34 17.28 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-N 121.054 1.752 . . . . 0.0 116.436 147.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.03 -53.54 43.76 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 119.383 1.592 . . . . 0.0 116.948 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.28 -36.77 73.8 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 167.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -52.12 -51.68 56.33 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.06 -34.72 76.97 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.51 -43.87 65.35 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 156.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.17 -45.74 95.48 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 117.036 1.574 . . . . 0.0 117.036 166.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.56 85.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.63 89.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 167.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -66.53 -62.32 1.52 Allowed 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -149.36 116.58 3.7 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.18 -12.1 33.18 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 N-CA-C 119.544 2.863 . . . . 0.0 119.544 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.39 62.56 0.81 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.23 0.923 . . . . 0.0 110.689 164.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -96.06 153.48 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.824 0.821 . . . . 0.0 112.643 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mp -66.51 -58.1 10.9 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-O 115.728 -2.082 . . . . 0.0 110.658 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.77 -20.17 34.19 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 124.854 2.769 . . . . 0.0 119.03 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.93 -51.67 66.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 121.106 1.776 . . . . 0.0 114.275 160.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.04 -30.63 71.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -61.91 -59.17 5.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.732 1.151 . . . . 0.0 113.587 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -58.27 -46.38 86.14 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -43.72 93.53 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -48.81 -46.51 41.95 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 162.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.84 -14.48 61.09 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.889 2.551 . . . . 0.0 117.889 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.08 -55.53 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.311 1.414 . . . . 0.0 110.369 160.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.298 12.4 p -68.44 -55.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 85.4 mmm -57.92 -36.42 72.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -60.03 -74.33 0.38 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.354 164.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.88 -13.64 0.79 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -87.36 -28.89 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -50.03 -51.2 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.846 2.112 . . . . 0.0 112.833 152.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.85 -67.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.41 -55.31 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 120.125 1.329 . . . . 0.0 114.182 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.41 53.2 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.9 mmt -68.45 -36.59 79.24 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.296 0.4 OUTLIER -65.18 -50.99 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.664 1.574 . . . . 0.0 112.813 174.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.72 73.3 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.59 -49.2 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.776 1.171 . . . . 0.0 112.534 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.73 -39.51 55.29 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.35 -43.5 94.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.726 1.763 . . . . 0.0 113.112 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.37 -54.67 5.44 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 161.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 -48.75 64.99 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -40.76 -47.96 2.94 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.34 -40.82 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.379 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.02 -49.89 72.44 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.3 t80 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 t30 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.94 -47.74 85.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -57.58 -37.04 72.51 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.2 mtt -65.41 -42.41 92.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -57.58 -44.31 85.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -64.99 -44.34 89.61 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -50.58 51.41 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.994 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.98 -63.52 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 157.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.26 -46.85 66.25 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.568 -168.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.57 60.33 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 161.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.72 64.52 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.44 77.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.263 58.3 t -57.85 -50.17 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.711 1.141 . . . . 0.0 113.431 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.93 -36.33 76.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -31.3 71.73 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 167.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.45 -32.37 42.68 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.8 tp -38.07 -46.98 2.74 Favored Pre-proline 0 CA--C 1.582 2.173 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -47.0 -32.15 12.5 Favored 'Trans proline' 0 C--N 1.374 1.897 0 N-CA-C 120.326 3.164 . . . . 0.0 120.326 166.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.53 -30.96 67.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.72 -59.31 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.914 0 C-N-CA 123.657 0.783 . . . . 0.0 109.708 162.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.68 -62.26 4.94 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -167.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.88 -24.24 62.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.9 -46.0 72.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.43 -35.18 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 118.045 -0.979 . . . . 0.0 113.13 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.99 -67.72 2.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.281 1.401 . . . . 0.0 115.174 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 11.0 mm -44.22 -73.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 166.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.12 -55.6 27.0 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 118.528 2.171 . . . . 0.0 118.528 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.22 -44.08 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 116.993 -1.479 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.33 22.0 mt -75.74 -35.59 60.16 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 121.927 2.149 . . . . 0.0 112.516 177.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.17 94.29 Favored Glycine 0 N--CA 1.492 2.391 0 CA-C-N 122.684 2.493 . . . . 0.0 118.365 160.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.72 -53.5 44.75 Favored Glycine 0 CA--C 1.553 2.409 0 CA-C-N 119.255 1.527 . . . . 0.0 116.59 164.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -50.75 -45.13 58.67 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 165.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.94 -44.46 82.53 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.261 2.6 tm? -66.44 -38.85 88.31 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 118.251 -0.881 . . . . 0.0 113.047 172.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.7 -39.01 61.57 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 165.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -39.71 98.35 Favored Glycine 0 CA--C 1.55 2.229 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 159.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.15 68.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.29 69.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -59.05 2.75 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.483 1.038 . . . . 0.0 112.272 170.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.78 119.78 6.96 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.717 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 -5.78 16.16 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 N-CA-C 119.467 2.833 . . . . 0.0 119.467 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -125.8 61.29 1.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.192 0.905 . . . . 0.0 110.859 161.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mt -76.9 156.24 32.23 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 121.133 -0.979 . . . . 0.0 112.577 169.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.89 -57.39 9.71 Favored Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.007 -1.949 . . . . 0.0 110.706 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -55.41 -21.26 29.16 Favored 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 124.847 2.767 . . . . 0.0 118.919 165.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tt -66.03 -52.58 47.87 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.678 1.127 . . . . 0.0 113.975 164.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.54 -29.28 70.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.54 -51.3 70.04 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 159.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.261 3.9 m -75.99 -32.94 59.69 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -54.28 -50.54 67.05 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 159.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -49.23 -45.14 44.17 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 162.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' HD13 ' A' ' 31' ' ' LEU . 18.2 m-30 -63.26 -32.89 74.41 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mt -58.43 -52.02 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 119.377 0.99 . . . . 0.0 111.861 163.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.22 -58.74 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 124.073 0.949 . . . . 0.0 112.302 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -56.67 -24.38 48.39 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 171.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -62.22 -82.22 0.08 OUTLIER Glycine 0 C--N 1.355 1.606 0 CA-C-O 116.567 -2.24 . . . . 0.0 111.526 163.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.388 1.6 pt? -58.5 -2.83 0.23 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.26 -40.04 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 159.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -50.03 -44.62 51.44 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.321 1.873 . . . . 0.0 113.666 155.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.9 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 167.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.17 -58.27 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-N 121.03 1.741 . . . . 0.0 113.637 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.9 65.85 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.8 tpp -66.62 -39.67 88.44 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.271 4.8 tt -59.58 -60.3 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.794 1.179 . . . . 0.0 112.997 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -33.86 75.16 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.53 -56.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.679 1.127 . . . . 0.0 111.981 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.04 -33.09 65.48 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.74 -43.18 99.48 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.146 1.473 . . . . 0.0 113.158 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.79 -54.08 6.92 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.929 1.932 . . . . 0.0 117.929 162.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.34 -49.26 70.08 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.95 -47.7 2.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 164.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.1 -42.33 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 C-N-CA 123.943 0.897 . . . . 0.0 112.306 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.53 -48.05 72.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.6 t80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-N 119.518 1.053 . . . . 0.0 113.786 -179.465 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -40.63 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.66 -37.89 74.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.3 mtm -69.13 -38.22 78.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.24 -45.97 86.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.035 1.288 . . . . 0.0 114.324 164.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.62 -42.09 99.38 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -66.27 -55.01 18.16 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.969 0.908 . . . . 0.0 113.321 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -36.68 -64.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 161.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtt -64.88 -49.92 68.61 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.606 -173.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.75 64.24 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 166.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.07 -57.24 8.16 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 121.482 1.946 . . . . 0.0 114.879 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -37.41 78.53 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 77.2 t -65.89 -51.96 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 120.416 1.462 . . . . 0.0 113.574 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 ttt -63.04 -44.76 94.97 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 10.5 mmt -89.4 -9.84 48.76 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.38 -37.82 62.67 Favored Glycine 0 CA--C 1.55 2.226 0 CA-C-N 120.187 1.358 . . . . 0.0 115.895 161.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -41.5 -57.94 3.41 Favored Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 115.227 -2.32 . . . . 0.0 116.364 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -53.38 -24.54 27.97 Favored 'Trans proline' 0 C--N 1.373 1.86 0 N-CA-C 120.719 3.315 . . . . 0.0 120.719 170.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.96 84.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 165.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.86 -53.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 123.87 0.868 . . . . 0.0 111.776 163.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.86 -60.16 8.77 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 118.688 2.235 . . . . 0.0 118.688 -173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.29 -16.73 60.93 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.8 -46.76 77.44 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 160.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.66 -33.14 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 158.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.84 -52.94 35.82 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mm -56.2 -62.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.233 1.517 . . . . 0.0 113.037 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.24 -58.7 10.21 Favored Glycine 0 CA--C 1.552 2.37 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.24 -49.73 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.602 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.257 20.3 mt -77.73 -21.29 52.11 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.737 2.062 . . . . 0.0 115.096 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.0 59.9 Favored Glycine 0 CA--C 1.551 2.31 0 CA-C-N 121.16 1.8 . . . . 0.0 117.043 156.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.06 -50.93 53.33 Favored Glycine 0 CA--C 1.554 2.493 0 N-CA-C 116.804 1.481 . . . . 0.0 116.804 165.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -55.07 -37.78 67.19 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 164.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.39 -44.48 76.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 166.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.277 2.5 tm? -67.12 -43.5 82.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -52.78 -41.97 64.6 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 166.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.45 86.93 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 162.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.47 -37.29 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.82 1.81 . . . . 0.0 114.777 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.26 -39.55 87.17 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 163.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -70.84 -60.13 2.41 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.25 118.52 2.86 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 117.769 -1.11 . . . . 0.0 108.589 171.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.31 -3.1 8.18 Favored 'Trans proline' 0 CA--C 1.566 2.113 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.19 62.29 1.62 Allowed 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 119.488 1.04 . . . . 0.0 110.952 155.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.78 162.73 22.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 111.572 166.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 64.9 mt -63.19 -57.62 19.86 Favored Pre-proline 0 CA--C 1.584 2.258 0 CA-C-O 115.788 -2.053 . . . . 0.0 111.189 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -54.13 -24.59 33.84 Favored 'Trans proline' 0 CA--C 1.567 2.155 0 CA-C-N 124.811 2.754 . . . . 0.0 119.134 165.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.52 -50.57 62.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.262 1.392 . . . . 0.0 113.967 165.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.3 -33.91 71.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -58.22 -54.12 50.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 163.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -68.39 -38.3 81.19 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.303 3.6 pp0? -63.62 -41.11 98.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.99 -47.11 65.05 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -64.27 -31.18 72.29 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -57.04 -51.4 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.842 1.201 . . . . 0.0 112.216 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.71 -67.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.282 0.0 OUTLIER -58.86 -33.62 70.66 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.94 -72.28 0.63 Allowed Glycine 0 C--N 1.353 1.522 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.273 166.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.5 tp -50.02 -21.23 1.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -71.79 -38.14 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 163.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -51.06 -61.46 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 120.891 1.678 . . . . 0.0 111.787 161.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -37.86 -68.69 0.14 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.71 -55.33 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 119.834 1.197 . . . . 0.0 113.684 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.402 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 24.4 mmt -61.36 -51.68 67.8 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.974 174.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.295 2.1 tp -52.73 -50.24 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 121.018 1.735 . . . . 0.0 115.18 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.59 76.8 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.9 -57.26 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 119.898 1.226 . . . . 0.0 112.733 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.44 63.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.23 -42.13 99.03 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.416 1.608 . . . . 0.0 113.43 164.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -55.94 5.82 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 117.68 1.832 . . . . 0.0 117.68 161.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.61 -49.51 76.3 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -42.77 -47.23 5.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -73.17 -42.97 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.528 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.4 mtt -55.26 -53.2 59.07 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 176.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.42 -49.94 73.5 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -58.8 -39.83 82.3 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.49 -45.17 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.08 -36.29 83.83 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.334 3.5 pp -67.47 -43.04 81.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.27 -46.85 86.95 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -41.41 -58.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.705 1.602 . . . . 0.0 114.911 164.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ttt -74.93 -42.91 56.79 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.967 -1.016 . . . . 0.0 113.216 -169.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.97 -36.92 18.66 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 159.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.49 14.59 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 -34.18 70.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 57.9 t -59.93 -50.92 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.667 1.121 . . . . 0.0 112.896 164.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 41.0 ttm -55.74 -39.6 71.38 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.279 0.0 OUTLIER -59.39 -32.96 70.63 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 167.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.62 -30.23 40.74 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.7 tp -37.82 -49.37 2.91 Favored Pre-proline 0 CA--C 1.581 2.17 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -54.77 -21.77 26.85 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 N-CA-C 120.265 3.14 . . . . 0.0 120.265 170.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -32.72 67.96 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.26 -56.08 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 C-N-CA 123.437 0.695 . . . . 0.0 109.865 160.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -66.05 3.04 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 118.643 2.217 . . . . 0.0 118.643 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -76.4 -13.22 60.13 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.41 -51.49 56.47 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 164.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.8 -33.09 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 158.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.54 -67.85 1.8 Allowed Glycine 0 N--CA 1.482 1.763 0 CA-C-N 120.193 1.36 . . . . 0.0 116.19 168.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.2 mm -54.65 -70.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 118.266 1.033 . . . . 0.0 112.438 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.26 -54.22 37.3 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.16 -59.89 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.531 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.31 -1.84 28.67 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.43 -34.58 1.73 Allowed Glycine 0 N--CA 1.48 1.616 0 CA-C-O 116.725 -2.153 . . . . 0.0 117.326 154.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.55 -58.64 12.86 Favored Glycine 0 N--CA 1.49 2.262 0 CA-C-N 122.192 2.996 . . . . 0.0 115.524 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.57 -46.1 73.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 167.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -72.32 -49.45 34.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.37 -35.77 81.19 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 116.76 -1.591 . . . . 0.0 112.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -53.54 -38.37 63.75 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 123.039 2.654 . . . . 0.0 116.047 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.71 -36.0 81.67 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 161.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 5.02 47.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.3 -19.75 66.1 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 165.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -56.34 -46.72 79.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -127.06 112.7 21.77 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.57 -10.03 24.75 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.28 60.93 0.82 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.317 0.962 . . . . 0.0 110.626 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.04 157.98 16.48 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.142 0.977 . . . . 0.0 112.051 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.288 3.6 mp -67.49 -57.47 10.29 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.216 -1.85 . . . . 0.0 109.357 169.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.95 -24.69 1.34 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 N-CA-C 121.472 3.605 . . . . 0.0 121.472 156.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.51 -50.21 68.28 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 121.664 2.029 . . . . 0.0 113.398 162.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.23 -32.1 69.66 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 167.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -66.77 -52.82 39.73 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 120.097 1.317 . . . . 0.0 113.39 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.1 p -57.78 -47.0 83.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -53.32 -47.48 69.25 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.36 -45.84 72.84 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 166.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -52.99 -37.07 61.1 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 169.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -50.39 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 C-N-CA 123.848 0.859 . . . . 0.0 112.78 169.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.63 -45.36 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.882 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.58 -27.31 69.1 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 178.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -64.14 -60.58 7.0 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 118.103 -1.387 . . . . 0.0 111.909 160.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -8.2 0.38 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 170.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 0.3 OUTLIER -92.66 -23.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 162.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.02 -50.08 48.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.965 1.711 . . . . 0.0 112.938 148.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.03 -71.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 165.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.01 -56.03 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 121.183 1.81 . . . . 0.0 114.531 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.42 50.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.2 mmt -65.79 -39.81 91.33 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.265 5.6 tt -62.23 -59.81 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.926 1.239 . . . . 0.0 113.534 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.74 -37.19 84.15 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.04 -50.4 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.889 1.222 . . . . 0.0 112.252 170.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.17 -45.5 61.56 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.76 -42.21 97.86 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.26 1.03 . . . . 0.0 112.825 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.84 -52.42 6.69 Favored Glycine 0 CA--C 1.55 2.261 0 N-CA-C 118.111 2.005 . . . . 0.0 118.111 160.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.16 -54.66 26.29 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -34.73 -49.47 0.42 Allowed 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 162.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.3 p -83.6 -41.78 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.8 mtt -60.14 -38.69 83.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 162.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 t30 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.31 -52.68 62.7 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.979 0.912 . . . . 0.0 113.024 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.42 -34.89 73.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 168.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.2 mtp -62.8 -41.96 99.51 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.64 -40.15 93.88 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.7 -46.41 90.49 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -51.2 50.41 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.014 0.925 . . . . 0.0 113.312 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.21 -60.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 157.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.33 -46.8 69.24 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.671 -170.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.19 -36.02 60.49 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 162.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.29 -48.3 43.4 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -43.24 62.87 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 161.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.79 -48.04 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 163.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -26.5 66.16 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 164.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.4 -36.55 63.02 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.8 tp -42.8 -54.53 8.5 Favored Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 170.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -56.14 -32.22 86.24 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 125.357 2.949 . . . . 0.0 118.858 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.36 69.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.23 -57.84 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 118.626 0.648 . . . . 0.0 110.356 160.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.77 -66.55 2.46 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -167.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.93 -11.74 59.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 118.445 2.757 . . . . 0.0 118.445 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.31 69.64 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 158.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.68 -29.81 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 158.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.91 -60.82 7.52 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-N 119.902 1.228 . . . . 0.0 116.152 166.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -48.27 -69.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-N 118.285 1.042 . . . . 0.0 112.898 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.6 -54.4 37.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -172.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.5 -46.92 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 117.327 -1.321 . . . . 0.0 111.433 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.252 13.5 mt -70.27 -42.54 71.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.483 1.947 . . . . 0.0 112.345 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.11 92.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 165.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -53.95 41.46 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 119.289 1.545 . . . . 0.0 116.584 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.12 -39.16 74.57 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -56.78 -43.66 81.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.269 2.4 tm? -67.69 -38.84 84.22 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.28 0.945 . . . . 0.0 113.135 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.95 -39.24 65.75 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 121.103 1.774 . . . . 0.0 115.513 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.03 -29.74 75.6 Favored Glycine 0 CA--C 1.55 2.268 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 160.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.06 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 119.635 1.717 . . . . 0.0 114.777 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.93 -39.45 71.71 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 162.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.23 -57.32 7.82 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 167.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.5 123.61 2.48 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.941 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 -4.94 15.05 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.56 63.96 1.44 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.462 1.028 . . . . 0.0 110.674 157.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -91.1 166.46 12.97 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.852 0.861 . . . . 0.0 112.244 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 3.8 mp -66.82 -62.31 3.99 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 115.603 -2.142 . . . . 0.0 109.762 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -51.49 -21.21 10.05 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 N-CA-C 119.705 2.925 . . . . 0.0 119.705 164.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.88 -59.97 3.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.003 1.274 . . . . 0.0 113.446 166.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -64.91 -28.67 69.69 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -55.46 -58.82 6.17 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.12 0.873 . . . . 0.0 112.927 162.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -72.02 -28.28 63.28 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.26 -52.58 60.95 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 161.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.03 -38.74 68.34 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 166.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -54.93 -44.1 73.95 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 165.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 mt -57.9 -44.94 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.437 1.017 . . . . 0.0 113.048 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.63 -59.05 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.846 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER -59.33 -34.97 72.99 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 176.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.03 -69.88 1.17 Allowed Glycine 0 C--N 1.355 1.624 0 CA-C-O 117.801 -1.555 . . . . 0.0 112.357 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.52 -14.34 0.11 Allowed 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 171.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.51 -38.34 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 164.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -50.85 -47.82 60.23 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.13 1.786 . . . . 0.0 113.565 156.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -44.8 -67.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.12 -58.04 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.022 1.283 . . . . 0.0 113.17 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 -51.82 64.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.04 -36.07 77.31 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.308 0.4 OUTLIER -66.01 -50.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 120.574 1.534 . . . . 0.0 113.109 173.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.67 92.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.24 -51.7 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.858 1.208 . . . . 0.0 112.528 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 -41.99 84.9 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.03 -43.31 99.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 119.272 1.536 . . . . 0.0 113.65 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.41 -57.73 3.67 Favored Glycine 0 CA--C 1.55 2.24 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 160.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.49 -48.53 48.47 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -40.21 -47.78 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 164.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.88 -39.18 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.821 0 CA-C-O 118.421 -0.8 . . . . 0.0 112.624 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 79.9 mtp -58.12 -47.6 82.8 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 N--CA 1.494 1.752 0 CA-C-N 120.14 1.337 . . . . 0.0 113.591 -178.298 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 CA--C 1.57 1.715 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.7 -53.68 31.1 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -58.72 -39.79 81.86 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.77 -41.53 95.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.02 -41.91 98.6 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 167.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.28 -44.8 95.03 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.59 -54.44 32.02 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -36.6 -63.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 161.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.7 mtp -64.61 -50.42 67.24 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.284 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.16 62.65 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.49 -64.96 0.74 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 116.964 -1.494 . . . . 0.0 114.126 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.61 -35.73 31.7 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.107 2.632 . . . . 0.0 118.107 168.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.271 70.4 t -62.43 -53.1 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.775 1.171 . . . . 0.0 113.552 166.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.15 -28.52 58.31 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 165.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 0.6 OUTLIER -84.1 -13.78 52.09 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 173.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.51 -32.88 36.49 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 156.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 tp -39.25 -45.35 3.37 Favored Pre-proline 0 CA--C 1.582 2.19 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -44.53 -33.11 6.26 Favored 'Trans proline' 0 C--N 1.375 1.948 0 CA-C-N 126.176 3.242 . . . . 0.0 120.184 165.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.71 64.33 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.49 -57.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 118.826 0.739 . . . . 0.0 110.256 160.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -62.96 4.84 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -72.52 -23.7 61.05 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.61 -48.4 66.92 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -57.1 -31.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 159.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.53 -65.13 3.5 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.887 1.221 . . . . 0.0 115.79 167.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -47.66 -73.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 117.945 0.873 . . . . 0.0 113.013 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -56.08 27.21 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 118.5 2.16 . . . . 0.0 118.5 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -81.35 -46.98 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 117.475 -1.25 . . . . 0.0 112.45 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.279 17.5 mt -75.6 -35.7 60.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.181 1.81 . . . . 0.0 112.703 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.81 65.59 Favored Glycine 0 N--CA 1.491 2.318 0 CA-C-N 121.718 2.054 . . . . 0.0 118.005 163.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.33 -53.49 44.47 Favored Glycine 0 N--CA 1.491 2.339 0 CA-C-N 119.561 1.681 . . . . 0.0 116.289 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.99 -43.52 66.5 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.698 2.111 . . . . 0.0 116.698 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -44.3 85.47 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 171.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.276 2.4 tm? -66.56 -38.57 87.37 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.766 1.167 . . . . 0.0 113.231 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 164.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.36 89.04 Favored Glycine 0 CA--C 1.551 2.306 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 160.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -32.05 66.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.15 62.47 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -62.17 1.6 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 119.322 0.965 . . . . 0.0 112.196 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.89 114.96 5.99 Favored Pre-proline 0 CA--C 1.568 1.656 0 CA-C-O 117.961 -1.018 . . . . 0.0 108.303 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.65 -2.02 11.89 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 N-CA-C 119.298 2.768 . . . . 0.0 119.298 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -129.9 62.39 1.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.418 1.008 . . . . 0.0 110.153 159.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.0 162.65 20.33 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 111.48 165.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.258 43.5 mm -67.1 -58.64 8.81 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-O 115.841 -2.028 . . . . 0.0 111.166 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -54.87 -20.55 22.96 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 CA-C-N 124.909 2.789 . . . . 0.0 119.292 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.8 -54.07 31.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 119.755 1.162 . . . . 0.0 113.646 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.29 -22.28 66.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -57.01 -58.18 9.3 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.669 1.122 . . . . 0.0 113.378 157.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -66.66 -33.11 74.92 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -52.41 -51.28 59.93 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 160.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.71 -39.57 74.1 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' HB3' HD13 ' A' ' 31' ' ' LEU . 27.3 m-85 -54.56 -38.92 67.22 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 165.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mt -59.0 -48.83 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 119.392 0.996 . . . . 0.0 112.799 165.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.96 -56.81 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.28 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.262 0.0 OUTLIER -58.35 -31.91 68.04 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 176.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -65.67 -67.84 1.87 Allowed Glycine 0 C--N 1.355 1.627 0 CA-C-O 117.545 -1.697 . . . . 0.0 111.125 166.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.8 tp -46.53 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -80.93 -40.92 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 125.526 1.53 . . . . 0.0 113.823 166.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -49.82 -36.21 25.71 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 121.236 1.834 . . . . 0.0 115.264 158.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.16 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 117.439 -1.267 . . . . 0.0 113.373 160.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.66 -55.96 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-N 120.92 1.691 . . . . 0.0 114.818 -165.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.4 -59.51 5.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.429 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 20.3 mmt -61.27 -49.6 76.42 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 116.641 -1.647 . . . . 0.0 113.994 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.291 5.9 tt -51.43 -56.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 121.508 1.958 . . . . 0.0 114.651 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.85 79.75 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -59.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.617 1.099 . . . . 0.0 113.172 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.2 -17.94 63.76 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 119.614 2.606 . . . . 0.0 119.614 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.66 -43.67 83.93 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.626 2.213 . . . . 0.0 112.074 159.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.36 -51.98 6.27 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 157.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.14 -51.53 66.11 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -42.75 -47.93 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 167.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.56 -40.4 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.661 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -58.59 -49.8 76.15 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.1 t80 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 178.555 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.01 -51.1 51.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.726 0.81 . . . . 0.0 113.032 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -58.74 -40.95 85.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.2 mtt -64.71 -44.1 91.32 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.11 -38.04 87.41 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.63 -47.81 83.73 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.82 -48.58 81.14 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -43.08 -58.92 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.6 -39.64 73.69 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.32 67.1 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 166.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB1' ' HA2' ' A' ' 69' ' ' GLY . . . -59.38 -54.98 40.48 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 165.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.62 -44.82 37.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 165.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.16 -51.38 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 C-N-CA 124.209 1.003 . . . . 0.0 113.065 166.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -44.12 72.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -28.39 67.67 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 169.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.65 -37.3 40.47 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 167.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.7 tp -37.34 -52.7 2.34 Favored Pre-proline 0 CA--C 1.582 2.199 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.43 -25.72 59.23 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 125.273 2.919 . . . . 0.0 119.45 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.13 69.69 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -86.33 -55.34 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 CA-C-N 118.739 0.7 . . . . 0.0 110.57 160.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.62 -65.25 3.45 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -77.63 -13.63 59.85 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.6 -48.69 68.73 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 161.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.7 mm -59.01 -29.6 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 158.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.39 -62.42 6.2 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 120.04 1.291 . . . . 0.0 115.771 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.4 mm -54.32 -65.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 119.037 1.418 . . . . 0.0 112.948 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.05 -56.9 18.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.62 -58.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.793 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.5 mt -75.63 3.49 9.48 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.32 -36.33 1.64 Allowed Glycine 0 N--CA 1.481 1.695 0 CA-C-O 117.176 -1.902 . . . . 0.0 116.749 155.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -59.51 10.68 Favored Glycine 0 N--CA 1.492 2.388 0 CA-C-N 121.305 2.552 . . . . 0.0 115.923 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.86 -43.21 80.95 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 167.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.08 -42.32 72.92 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.255 3.0 tm? -71.14 -36.73 72.19 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.655 1.116 . . . . 0.0 112.549 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -52.18 -39.32 59.92 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 121.776 2.08 . . . . 0.0 115.942 163.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.76 -31.7 73.39 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 118.4 2.12 . . . . 0.0 118.4 161.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -23.58 54.94 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -20.0 15.44 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 118.809 2.892 . . . . 0.0 118.809 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -58.54 -34.93 71.56 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -154.03 129.72 5.25 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-N 119.997 1.271 . . . . 0.0 109.072 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 2.97 3.55 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.7 64.02 1.58 Allowed 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.168 0.894 . . . . 0.0 110.163 152.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.82 172.91 7.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.571 1.177 . . . . 0.0 112.867 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.49 -56.89 30.83 Favored Pre-proline 0 CA--C 1.581 2.155 0 CA-C-O 115.319 -2.277 . . . . 0.0 110.897 163.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.11 -15.13 21.66 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 CA-C-N 125.349 2.946 . . . . 0.0 119.51 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.5 -49.65 52.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.771 1.623 . . . . 0.0 113.662 161.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.93 -29.42 70.21 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -67.66 -45.58 74.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.502 165.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.295 1.2 t -58.81 -47.01 86.26 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 122.131 2.241 . . . . 0.0 114.973 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.23 -49.32 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.55 -58.17 9.2 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -61.02 -39.27 89.13 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.0 mt -64.59 -43.47 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.39 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.77 -47.64 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 120.558 1.526 . . . . 0.0 113.223 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 75.2 mmm -53.0 -43.94 66.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.3 -67.51 2.09 Favored Glycine 0 C--N 1.356 1.646 0 CA-C-O 117.731 -1.594 . . . . 0.0 112.262 166.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.72 -2.63 0.15 Allowed 'General case' 0 CA--C 1.583 2.227 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.93 -25.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.106 1.362 . . . . 0.0 113.726 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -50.88 -43.85 59.64 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 122.087 2.221 . . . . 0.0 113.528 148.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.19 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 159.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.04 -55.94 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.729 1.604 . . . . 0.0 114.559 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 -54.62 33.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.46 -34.44 75.95 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.285 6.8 tt -62.88 -60.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 120.42 1.464 . . . . 0.0 113.45 171.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.53 97.22 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.78 -52.17 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.318 0.963 . . . . 0.0 112.299 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA2' ' HB1' ' A' ' 13' ' ' ALA . . . -67.71 -42.14 87.84 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.88 -43.35 83.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.486 1.143 . . . . 0.0 113.294 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.14 -48.44 10.15 Favored Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.181 2.032 . . . . 0.0 118.181 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.96 -56.19 6.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -40.67 -45.94 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 164.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.06 -43.96 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.503 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.12 -50.47 58.75 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 174.865 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 . . . . . 0 CA--C 1.556 1.199 0 CA-C-O 121.239 0.543 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.94 -45.48 93.49 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.367 1.067 . . . . 0.0 113.861 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.8 -29.3 70.06 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 168.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 45.0 mtm -62.92 -43.67 98.17 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.127 1.33 . . . . 0.0 114.404 163.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.81 -33.43 72.99 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.89 -50.89 70.37 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 168.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.94 -49.31 75.27 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -34.29 -67.27 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 163.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.5 ttt -73.36 -39.29 65.3 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.803 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -37.93 31.03 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.479 2.399 . . . . 0.0 117.479 160.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.78 24.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.76 71.97 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 60.0 t -60.45 -49.75 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.83 1.196 . . . . 0.0 113.145 166.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.8 tpp -58.42 -39.23 79.21 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 166.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.424 ' SD ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -58.37 -30.32 66.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 166.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.88 36.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 170.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 tt -35.88 -50.48 1.56 Allowed Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 167.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -46.87 -30.08 9.04 Favored 'Trans proline' 0 CA--C 1.563 1.934 0 N-CA-C 120.808 3.349 . . . . 0.0 120.808 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.65 -31.86 66.72 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 168.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -85.66 -56.31 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 C-N-CA 123.727 0.811 . . . . 0.0 110.09 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.3 -63.62 4.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -169.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -69.62 -20.66 63.61 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.597 2.814 . . . . 0.0 118.597 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.1 74.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 165.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.5 -32.96 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 159.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.7 -64.8 3.79 Favored Glycine 0 N--CA 1.485 1.909 0 CA-C-N 119.804 1.183 . . . . 0.0 115.864 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.48 -69.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 118.533 1.166 . . . . 0.0 112.703 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.46 -54.6 36.43 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 118.634 2.214 . . . . 0.0 118.634 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.38 -45.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.313 17.8 mt -74.84 -38.54 61.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.99 2.177 . . . . 0.0 112.379 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.81 94.64 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-N 122.176 2.262 . . . . 0.0 118.489 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.41 -52.28 53.71 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 119.384 1.592 . . . . 0.0 116.713 166.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -50.78 -45.37 59.05 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 164.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -54.65 -49.08 71.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.21 -33.63 76.2 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.21 -43.22 67.04 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.75 94.35 Favored Glycine 0 CA--C 1.549 2.213 0 N-CA-C 117.537 1.775 . . . . 0.0 117.537 165.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.07 88.47 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.39 96.4 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.0 -62.68 1.68 Allowed 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -151.16 120.62 3.56 Favored Pre-proline 0 CA--C 1.566 1.577 0 C-N-CA 124.481 1.112 . . . . 0.0 108.096 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 -13.75 38.19 Favored 'Trans proline' 0 CA--C 1.572 2.385 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 168.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -97.62 31.62 2.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.27 144.58 25.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.551 -1.343 . . . . 0.0 113.951 -160.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 67.1 mt -68.28 -57.07 9.46 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-O 115.723 -2.084 . . . . 0.0 111.114 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.48 -19.02 34.36 Favored 'Trans proline' 0 CA--C 1.571 2.339 0 CA-C-N 124.995 2.82 . . . . 0.0 119.171 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.95 -54.2 34.38 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.371 1.441 . . . . 0.0 113.437 161.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.42 -34.26 70.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -57.94 -48.07 81.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.0 m -80.67 -33.72 35.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 117.389 -1.291 . . . . 0.0 114.212 -172.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.336 3.1 pp0? -62.47 -38.46 89.9 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 122.0 2.182 . . . . 0.0 116.649 159.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -51.2 -44.47 61.58 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 158.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.481 ' HB3' HD13 ' A' ' 31' ' ' LEU . 19.1 m-30 -67.0 -29.91 69.87 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.61 -48.09 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-N 119.867 1.212 . . . . 0.0 111.928 162.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.55 -52.51 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.571 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 80.1 mmm -55.09 -40.6 70.61 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.94 -69.21 1.36 Allowed Glycine 0 C--N 1.356 1.668 0 CA-C-O 117.404 -1.775 . . . . 0.0 112.157 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -4.44 0.26 Allowed 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.34 -25.33 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.093 163.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -49.71 -50.08 45.38 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 122.537 2.426 . . . . 0.0 112.905 148.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.83 -68.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 167.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -65.11 -59.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 121.163 1.801 . . . . 0.0 113.129 -173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.87 66.46 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.82 -35.53 74.88 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' SD ' ' A' ' 17' ' ' MET 0.256 4.8 tt -58.35 -57.53 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.944 1.702 . . . . 0.0 113.166 169.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.06 79.17 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.33 -51.49 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.059 1.3 . . . . 0.0 112.506 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.53 -38.88 68.91 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.96 -44.55 84.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.182 1.491 . . . . 0.0 113.299 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.6 -47.75 12.57 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.84 -53.62 47.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -45.12 -44.73 10.79 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.5 -40.8 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.905 0.882 . . . . 0.0 113.058 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -54.22 -42.44 69.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 164.137 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.89 -50.78 69.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -60.7 -40.01 90.65 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.6 mmt -66.58 -41.85 87.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.34 -41.42 89.14 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 165.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.0 mt -62.62 -45.51 92.55 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.9 -56.41 13.47 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -33.15 -65.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 158.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.19 -48.01 59.02 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.036 -167.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.35 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -61.1 2.38 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.537 1.971 . . . . 0.0 114.772 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.91 72.8 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.357 2.355 . . . . 0.0 117.357 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 79.0 t -66.17 -52.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.703 1.592 . . . . 0.0 113.328 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.95 89.13 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.4 mmt -83.83 -12.86 54.99 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.79 59.51 Favored Glycine 0 CA--C 1.548 2.107 0 CA-C-N 120.201 1.364 . . . . 0.0 115.981 164.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -40.33 -55.53 4.1 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.56 -24.87 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 124.124 3.216 . . . . 0.0 120.177 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.1 89.06 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 121.117 1.781 . . . . 0.0 115.443 165.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.79 -52.67 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 C-N-CA 123.928 0.891 . . . . 0.0 111.964 165.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.58 -59.1 10.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.552 2.181 . . . . 0.0 118.552 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.57 -13.47 60.67 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 171.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.34 -46.44 70.17 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 160.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.03 -37.7 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 123.606 0.762 . . . . 0.0 113.025 156.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.58 48.45 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 163.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.41 -63.62 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-N 120.463 2.131 . . . . 0.0 111.815 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.42 -51.83 56.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 119.257 2.463 . . . . 0.0 119.257 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.77 -45.93 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.9 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.55 -50.05 64.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.757 1.617 . . . . 0.0 112.043 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.72 -39.35 76.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -54.29 39.17 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-N 119.075 1.438 . . . . 0.0 116.529 167.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -48.56 -47.25 39.55 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 164.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.9 -51.79 66.36 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.309 1.444 . . . . 0.0 114.698 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.33 -31.72 71.33 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.33 -43.86 67.99 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 155.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.83 97.13 Favored Glycine 0 CA--C 1.551 2.307 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.61 80.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.35 79.08 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -69.97 -66.06 0.64 Allowed 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -145.56 112.42 4.64 Favored Pre-proline 0 CA--C 1.568 1.659 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.7 2.67 5.03 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 N-CA-C 119.519 2.854 . . . . 0.0 119.519 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -131.62 64.67 1.58 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.12 0.873 . . . . 0.0 110.333 157.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 163.77 17.87 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 121.835 0.826 . . . . 0.0 111.53 168.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.256 4.0 mp -66.81 -59.06 8.42 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.849 -2.024 . . . . 0.0 110.48 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -52.62 -23.99 21.45 Favored 'Trans proline' 0 CA--C 1.57 2.299 0 N-CA-C 119.345 2.787 . . . . 0.0 119.345 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.69 -56.01 12.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 168.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.48 -27.53 68.56 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 160.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.2 m -76.27 -33.46 59.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -51.76 -52.33 49.53 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 158.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -51.04 -44.44 61.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -62.9 -36.84 84.68 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -59.15 -54.36 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.871 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.313 10.2 p -60.96 -49.04 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.679 1.581 . . . . 0.0 114.371 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.17 -43.32 87.42 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.83 -69.04 1.39 Allowed Glycine 0 N--CA 1.479 1.548 0 CA-C-O 118.866 -0.964 . . . . 0.0 114.034 165.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.86 -19.63 0.4 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -90.03 -21.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -51.17 -62.62 1.5 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 122.479 2.399 . . . . 0.0 111.178 152.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -39.4 -65.03 0.42 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 168.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.72 -57.38 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.071 0.85 . . . . 0.0 113.05 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.18 75.03 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 mmt -63.71 -52.65 59.64 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.921 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.289 0.4 OUTLIER -57.36 -41.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 121.101 1.773 . . . . 0.0 114.311 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.54 83.57 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.83 -54.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.25 1.386 . . . . 0.0 112.705 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.61 -40.9 90.48 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 118.745 2.258 . . . . 0.0 118.745 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.77 -42.83 84.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.938 1.369 . . . . 0.0 114.015 163.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.05 -54.88 4.35 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 161.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.16 -49.89 68.09 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -42.79 -40.94 3.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -83.86 -32.92 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.3 mmt -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 CA--C 1.578 2.049 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 161.518 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 t30 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.76 -49.5 76.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -58.72 -39.75 81.73 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -65.64 -45.71 82.0 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.21 -33.75 76.52 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.72 -50.35 69.46 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 tp -56.66 -51.62 68.02 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -37.89 -73.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.227 1.811 . . . . 0.0 115.69 163.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.29 -40.22 71.01 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -167.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.7 65.05 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 117.079 2.252 . . . . 0.0 117.079 162.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.31 64.08 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.626 2.012 . . . . 0.0 115.509 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -36.07 82.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.42 -53.46 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 120.728 1.604 . . . . 0.0 113.068 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.7 -52.13 53.89 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -87.16 -16.44 35.41 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.55 -25.39 67.91 Favored Glycine 0 N--CA 1.491 2.344 0 CA-C-N 121.176 1.807 . . . . 0.0 117.486 163.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 tp -50.17 -46.35 82.73 Favored Pre-proline 0 CA--C 1.578 2.05 0 CA-C-O 115.211 -2.328 . . . . 0.0 117.081 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.05 -27.15 2.49 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 121.564 3.64 . . . . 0.0 121.564 164.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.68 74.23 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 164.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.52 -52.66 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 C-N-CA 123.952 0.901 . . . . 0.0 110.904 162.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.91 -66.74 1.36 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 -16.35 61.32 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 119.258 3.059 . . . . 0.0 119.258 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.0 -51.69 51.86 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.8 mt -54.56 -40.28 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 123.418 0.687 . . . . 0.0 112.807 160.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.11 -59.41 6.95 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-O 117.759 -1.578 . . . . 0.0 116.321 167.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 mm -41.83 -51.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.44 -59.9 6.18 Favored Glycine 0 CA--C 1.552 2.351 0 N-CA-C 118.261 2.065 . . . . 0.0 118.261 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.23 -42.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.81 -55.45 34.04 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.444 1.098 . . . . 0.0 112.367 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.42 -39.94 30.04 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 162.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.27 -53.76 43.54 Favored Glycine 0 CA--C 1.554 2.474 0 CA-C-N 119.448 1.624 . . . . 0.0 117.091 166.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -51.57 -49.07 62.8 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -57.58 -42.6 83.46 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.317 0.5 OUTLIER -72.57 -38.96 67.78 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 119.601 1.091 . . . . 0.0 112.58 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.33 -39.27 66.89 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 161.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.21 93.28 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 117.409 1.723 . . . . 0.0 117.409 159.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -37.58 65.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.845 1.823 . . . . 0.0 115.069 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.32 93.34 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 165.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -71.34 -54.08 12.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -154.9 120.1 2.61 Favored Pre-proline 0 CA--C 1.565 1.52 0 CA-C-O 117.674 -1.155 . . . . 0.0 109.106 174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.22 -6.26 12.82 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 N-CA-C 119.676 2.914 . . . . 0.0 119.676 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.63 58.01 1.24 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.19 0.904 . . . . 0.0 111.381 163.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.02 158.9 24.97 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 0.0 113.547 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 4.1 mp -64.36 -57.78 16.25 Favored Pre-proline 0 CA--C 1.582 2.189 0 CA-C-O 116.006 -1.949 . . . . 0.0 110.914 169.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -52.78 -21.59 15.49 Favored 'Trans proline' 0 CA--C 1.57 2.305 0 CA-C-N 125.022 2.829 . . . . 0.0 119.137 164.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.65 -53.33 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.98 -37.32 74.0 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -53.37 -51.59 62.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 162.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.268 5.3 m -86.87 -28.01 23.1 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -170.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.282 10.0 pt20 -61.71 -40.75 96.12 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 121.724 2.056 . . . . 0.0 115.912 157.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.87 -48.29 64.11 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 159.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.21 -40.78 97.25 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.02 -46.25 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 124.962 1.305 . . . . 0.0 114.184 166.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.77 -61.83 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 117.838 -1.077 . . . . 0.0 111.813 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.31 0.0 OUTLIER -65.64 -31.55 72.64 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -176.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.37 -65.72 3.18 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.914 -1.116 . . . . 0.0 113.448 164.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -11.99 5.64 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.32 0.4 OUTLIER -81.81 -22.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 159.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -49.1 -63.15 1.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 121.06 1.755 . . . . 0.0 111.096 151.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.3 -63.96 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -66.95 -54.49 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.568 1.531 . . . . 0.0 113.783 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 -49.92 75.56 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -68.5 -43.38 76.98 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.286 0.4 OUTLIER -57.09 -44.21 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 121.954 2.161 . . . . 0.0 113.31 173.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.12 76.0 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.31 -54.1 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 120.249 1.386 . . . . 0.0 112.793 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.85 -43.79 93.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.45 -48.69 74.09 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.498 1.149 . . . . 0.0 113.919 163.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -51.58 7.81 Favored Glycine 0 CA--C 1.548 2.099 0 N-CA-C 118.621 2.209 . . . . 0.0 118.621 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.33 -54.73 13.09 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -35.02 -54.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 160.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 2.2 p -74.28 -35.94 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 87.7 mmm -62.5 -30.61 71.4 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 163.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 169.796 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -97.93 -78.94 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.7 -42.81 95.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.38 -45.67 92.7 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -57.33 -39.48 75.94 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.4 mtm -68.63 -38.36 80.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -58.18 -45.99 86.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.941 1.246 . . . . 0.0 114.016 166.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.87 -45.2 93.69 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.64 -54.4 32.48 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.893 0.877 . . . . 0.0 113.32 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -36.51 -62.15 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 160.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.96 -48.43 76.52 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.801 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.02 68.64 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -48.04 69.8 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.08 86.66 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 164.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.255 53.5 t -56.65 -50.69 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 119.947 1.249 . . . . 0.0 113.115 164.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -43.65 67.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 165.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.277 0.0 OUTLIER -56.93 -39.0 73.68 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.064 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.66 56.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 118.399 2.119 . . . . 0.0 118.399 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -47.37 -47.84 57.43 Favored Pre-proline 0 CA--C 1.58 2.107 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.14 -30.88 11.07 Favored 'Trans proline' 0 C--N 1.372 1.808 0 N-CA-C 120.81 3.35 . . . . 0.0 120.81 167.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -28.78 66.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.7 mm -85.63 -59.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 CA-C-N 118.803 0.729 . . . . 0.0 110.036 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.53 -65.15 3.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 118.204 2.041 . . . . 0.0 118.204 -168.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.55 -24.05 62.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.15 70.65 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.75 -34.98 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 118.24 -0.886 . . . . 0.0 113.075 159.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.88 -66.18 2.94 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 120.106 1.321 . . . . 0.0 115.595 170.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.44 -66.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 118.227 1.013 . . . . 0.0 113.065 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.04 -59.69 9.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 117.92 1.928 . . . . 0.0 117.92 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.3 -45.68 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 117.012 -1.47 . . . . 0.0 111.693 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.3 -6.07 57.04 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 121.801 2.091 . . . . 0.0 115.088 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 -42.34 17.28 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-N 121.054 1.752 . . . . 0.0 116.436 147.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.03 -53.54 43.76 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 119.383 1.592 . . . . 0.0 116.948 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.28 -36.77 73.8 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 167.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -52.12 -51.68 56.33 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.06 -34.72 76.97 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.51 -43.87 65.35 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 156.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.17 -45.74 95.48 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 117.036 1.574 . . . . 0.0 117.036 166.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.56 85.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.63 89.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 167.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -66.53 -62.32 1.52 Allowed 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -149.36 116.58 3.7 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.18 -12.1 33.18 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 N-CA-C 119.544 2.863 . . . . 0.0 119.544 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.39 62.56 0.81 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.23 0.923 . . . . 0.0 110.689 164.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -96.06 153.48 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.824 0.821 . . . . 0.0 112.643 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mp -66.51 -58.1 10.9 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-O 115.728 -2.082 . . . . 0.0 110.658 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.77 -20.17 34.19 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 124.854 2.769 . . . . 0.0 119.03 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.93 -51.67 66.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 121.106 1.776 . . . . 0.0 114.275 160.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.04 -30.63 71.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -61.91 -59.17 5.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.732 1.151 . . . . 0.0 113.587 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -58.27 -46.38 86.14 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -43.72 93.53 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -48.81 -46.51 41.95 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 162.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.84 -14.48 61.09 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.889 2.551 . . . . 0.0 117.889 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.08 -55.53 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.311 1.414 . . . . 0.0 110.369 160.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.298 12.4 p -68.44 -55.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 85.4 mmm -57.92 -36.42 72.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -60.03 -74.33 0.38 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.354 164.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.88 -13.64 0.79 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -87.36 -28.89 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -50.03 -51.2 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.846 2.112 . . . . 0.0 112.833 152.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.85 -67.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.41 -55.31 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 120.125 1.329 . . . . 0.0 114.182 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.41 53.2 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.9 mmt -68.45 -36.59 79.24 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.296 0.4 OUTLIER -65.18 -50.99 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.664 1.574 . . . . 0.0 112.813 174.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.72 73.3 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.59 -49.2 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.776 1.171 . . . . 0.0 112.534 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.73 -39.51 55.29 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.35 -43.5 94.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.726 1.763 . . . . 0.0 113.112 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.37 -54.67 5.44 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 161.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 -48.75 64.99 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -40.76 -47.96 2.94 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.34 -40.82 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.379 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.02 -49.89 72.44 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -75.85 -55.89 5.19 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.81 -51.17 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.27 -59.94 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 119.343 0.974 . . . . 0.0 111.37 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 123.369 1.557 . . . . 0.0 113.48 174.149 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 119.078 -0.486 . . . . 0.0 111.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.263 9.7 tp10 65.91 80.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -63.83 -25.62 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.94 -47.74 85.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -57.58 -37.04 72.51 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.2 mtt -65.41 -42.41 92.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -57.58 -44.31 85.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -64.99 -44.34 89.61 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -50.58 51.41 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.994 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.98 -63.52 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 157.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.26 -46.85 66.25 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.568 -168.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.57 60.33 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 161.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.72 64.52 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.44 77.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.263 58.3 t -57.85 -50.17 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.711 1.141 . . . . 0.0 113.431 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.93 -36.33 76.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -31.3 71.73 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 167.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.45 -32.37 42.68 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.8 tp -38.07 -46.98 2.74 Favored Pre-proline 0 CA--C 1.582 2.173 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -47.0 -32.15 12.5 Favored 'Trans proline' 0 C--N 1.374 1.897 0 N-CA-C 120.326 3.164 . . . . 0.0 120.326 166.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.53 -30.96 67.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.72 -59.31 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.914 0 C-N-CA 123.657 0.783 . . . . 0.0 109.708 162.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.68 -62.26 4.94 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -167.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.88 -24.24 62.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.9 -46.0 72.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.43 -35.18 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 118.045 -0.979 . . . . 0.0 113.13 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.99 -67.72 2.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.281 1.401 . . . . 0.0 115.174 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 11.0 mm -44.22 -73.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 166.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.12 -55.6 27.0 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 118.528 2.171 . . . . 0.0 118.528 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.22 -44.08 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 116.993 -1.479 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.33 22.0 mt -75.74 -35.59 60.16 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 121.927 2.149 . . . . 0.0 112.516 177.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.17 94.29 Favored Glycine 0 N--CA 1.492 2.391 0 CA-C-N 122.684 2.493 . . . . 0.0 118.365 160.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.72 -53.5 44.75 Favored Glycine 0 CA--C 1.553 2.409 0 CA-C-N 119.255 1.527 . . . . 0.0 116.59 164.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -50.75 -45.13 58.67 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 165.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.94 -44.46 82.53 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.261 2.6 tm? -66.44 -38.85 88.31 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 118.251 -0.881 . . . . 0.0 113.047 172.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.7 -39.01 61.57 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 165.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -39.71 98.35 Favored Glycine 0 CA--C 1.55 2.229 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 159.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.15 68.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.29 69.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -59.05 2.75 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.483 1.038 . . . . 0.0 112.272 170.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.78 119.78 6.96 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.717 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 -5.78 16.16 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 N-CA-C 119.467 2.833 . . . . 0.0 119.467 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -125.8 61.29 1.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.192 0.905 . . . . 0.0 110.859 161.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mt -76.9 156.24 32.23 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 121.133 -0.979 . . . . 0.0 112.577 169.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.89 -57.39 9.71 Favored Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.007 -1.949 . . . . 0.0 110.706 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -55.41 -21.26 29.16 Favored 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 124.847 2.767 . . . . 0.0 118.919 165.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tt -66.03 -52.58 47.87 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.678 1.127 . . . . 0.0 113.975 164.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.54 -29.28 70.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.54 -51.3 70.04 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 159.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.261 3.9 m -75.99 -32.94 59.69 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -54.28 -50.54 67.05 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 159.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -49.23 -45.14 44.17 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 162.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' HD13 ' A' ' 31' ' ' LEU . 18.2 m-30 -63.26 -32.89 74.41 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mt -58.43 -52.02 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 119.377 0.99 . . . . 0.0 111.861 163.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.22 -58.74 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 124.073 0.949 . . . . 0.0 112.302 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -56.67 -24.38 48.39 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 171.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -62.22 -82.22 0.08 OUTLIER Glycine 0 C--N 1.355 1.606 0 CA-C-O 116.567 -2.24 . . . . 0.0 111.526 163.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.388 1.6 pt? -58.5 -2.83 0.23 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.26 -40.04 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 159.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -50.03 -44.62 51.44 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.321 1.873 . . . . 0.0 113.666 155.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.9 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 167.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.17 -58.27 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-N 121.03 1.741 . . . . 0.0 113.637 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.9 65.85 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.8 tpp -66.62 -39.67 88.44 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.271 4.8 tt -59.58 -60.3 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.794 1.179 . . . . 0.0 112.997 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -33.86 75.16 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.53 -56.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.679 1.127 . . . . 0.0 111.981 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.04 -33.09 65.48 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.74 -43.18 99.48 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.146 1.473 . . . . 0.0 113.158 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.79 -54.08 6.92 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.929 1.932 . . . . 0.0 117.929 162.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.34 -49.26 70.08 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.95 -47.7 2.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 164.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.1 -42.33 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 C-N-CA 123.943 0.897 . . . . 0.0 112.306 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.53 -48.05 72.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -78.03 -66.3 0.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.518 1.053 . . . . 0.0 113.786 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.04 28.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.71 -57.7 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 119.472 1.033 . . . . 0.0 111.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 122.861 1.315 . . . . 0.0 110.821 172.44 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.269 0.0 OUTLIER -108.47 -66.31 1.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.486 0.715 . . . . 0.0 110.904 174.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -66.62 -43.33 85.04 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -40.63 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.66 -37.89 74.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.3 mtm -69.13 -38.22 78.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.24 -45.97 86.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.035 1.288 . . . . 0.0 114.324 164.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.62 -42.09 99.38 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -66.27 -55.01 18.16 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.969 0.908 . . . . 0.0 113.321 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -36.68 -64.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 161.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtt -64.88 -49.92 68.61 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.606 -173.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.75 64.24 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 166.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.07 -57.24 8.16 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 121.482 1.946 . . . . 0.0 114.879 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -37.41 78.53 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 77.2 t -65.89 -51.96 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 120.416 1.462 . . . . 0.0 113.574 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 ttt -63.04 -44.76 94.97 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 10.5 mmt -89.4 -9.84 48.76 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.38 -37.82 62.67 Favored Glycine 0 CA--C 1.55 2.226 0 CA-C-N 120.187 1.358 . . . . 0.0 115.895 161.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -41.5 -57.94 3.41 Favored Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 115.227 -2.32 . . . . 0.0 116.364 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -53.38 -24.54 27.97 Favored 'Trans proline' 0 C--N 1.373 1.86 0 N-CA-C 120.719 3.315 . . . . 0.0 120.719 170.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.96 84.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 165.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.86 -53.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 123.87 0.868 . . . . 0.0 111.776 163.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.86 -60.16 8.77 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 118.688 2.235 . . . . 0.0 118.688 -173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.29 -16.73 60.93 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.8 -46.76 77.44 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 160.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.66 -33.14 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 158.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.84 -52.94 35.82 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mm -56.2 -62.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.233 1.517 . . . . 0.0 113.037 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.24 -58.7 10.21 Favored Glycine 0 CA--C 1.552 2.37 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.24 -49.73 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.602 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.257 20.3 mt -77.73 -21.29 52.11 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.737 2.062 . . . . 0.0 115.096 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.0 59.9 Favored Glycine 0 CA--C 1.551 2.31 0 CA-C-N 121.16 1.8 . . . . 0.0 117.043 156.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.06 -50.93 53.33 Favored Glycine 0 CA--C 1.554 2.493 0 N-CA-C 116.804 1.481 . . . . 0.0 116.804 165.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -55.07 -37.78 67.19 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 164.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.39 -44.48 76.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 166.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.277 2.5 tm? -67.12 -43.5 82.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -52.78 -41.97 64.6 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 166.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.45 86.93 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 162.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.47 -37.29 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.82 1.81 . . . . 0.0 114.777 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.26 -39.55 87.17 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 163.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -70.84 -60.13 2.41 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.25 118.52 2.86 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 117.769 -1.11 . . . . 0.0 108.589 171.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.31 -3.1 8.18 Favored 'Trans proline' 0 CA--C 1.566 2.113 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.19 62.29 1.62 Allowed 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 119.488 1.04 . . . . 0.0 110.952 155.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.78 162.73 22.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 111.572 166.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 64.9 mt -63.19 -57.62 19.86 Favored Pre-proline 0 CA--C 1.584 2.258 0 CA-C-O 115.788 -2.053 . . . . 0.0 111.189 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -54.13 -24.59 33.84 Favored 'Trans proline' 0 CA--C 1.567 2.155 0 CA-C-N 124.811 2.754 . . . . 0.0 119.134 165.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.52 -50.57 62.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.262 1.392 . . . . 0.0 113.967 165.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.3 -33.91 71.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -58.22 -54.12 50.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 163.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -68.39 -38.3 81.19 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.303 3.6 pp0? -63.62 -41.11 98.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.99 -47.11 65.05 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -64.27 -31.18 72.29 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -57.04 -51.4 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.842 1.201 . . . . 0.0 112.216 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.71 -67.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.282 0.0 OUTLIER -58.86 -33.62 70.66 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.94 -72.28 0.63 Allowed Glycine 0 C--N 1.353 1.522 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.273 166.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.5 tp -50.02 -21.23 1.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -71.79 -38.14 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 163.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -51.06 -61.46 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 120.891 1.678 . . . . 0.0 111.787 161.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -37.86 -68.69 0.14 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.71 -55.33 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 119.834 1.197 . . . . 0.0 113.684 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.402 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 24.4 mmt -61.36 -51.68 67.8 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.974 174.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.295 2.1 tp -52.73 -50.24 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 121.018 1.735 . . . . 0.0 115.18 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.59 76.8 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.9 -57.26 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 119.898 1.226 . . . . 0.0 112.733 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.44 63.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.23 -42.13 99.03 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.416 1.608 . . . . 0.0 113.43 164.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -55.94 5.82 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 117.68 1.832 . . . . 0.0 117.68 161.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.61 -49.51 76.3 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -42.77 -47.23 5.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -73.17 -42.97 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.528 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.4 mtt -55.26 -53.2 59.07 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -76.87 -30.92 56.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.74 99.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.75 -61.1 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 119.079 0.854 . . . . 0.0 111.545 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 125.086 2.374 . . . . 0.0 108.782 175.237 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.31 -76.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -61.83 -34.67 76.36 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.42 -49.94 73.5 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -58.8 -39.83 82.3 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.49 -45.17 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.08 -36.29 83.83 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.334 3.5 pp -67.47 -43.04 81.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.27 -46.85 86.95 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -41.41 -58.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.705 1.602 . . . . 0.0 114.911 164.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ttt -74.93 -42.91 56.79 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.967 -1.016 . . . . 0.0 113.216 -169.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.97 -36.92 18.66 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 159.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.49 14.59 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 -34.18 70.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 57.9 t -59.93 -50.92 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.667 1.121 . . . . 0.0 112.896 164.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 41.0 ttm -55.74 -39.6 71.38 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.279 0.0 OUTLIER -59.39 -32.96 70.63 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 167.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.62 -30.23 40.74 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.7 tp -37.82 -49.37 2.91 Favored Pre-proline 0 CA--C 1.581 2.17 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -54.77 -21.77 26.85 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 N-CA-C 120.265 3.14 . . . . 0.0 120.265 170.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -32.72 67.96 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.26 -56.08 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 C-N-CA 123.437 0.695 . . . . 0.0 109.865 160.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -66.05 3.04 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 118.643 2.217 . . . . 0.0 118.643 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -76.4 -13.22 60.13 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.41 -51.49 56.47 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 164.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.8 -33.09 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 158.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.54 -67.85 1.8 Allowed Glycine 0 N--CA 1.482 1.763 0 CA-C-N 120.193 1.36 . . . . 0.0 116.19 168.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.2 mm -54.65 -70.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 118.266 1.033 . . . . 0.0 112.438 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.26 -54.22 37.3 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.16 -59.89 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.531 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.31 -1.84 28.67 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.43 -34.58 1.73 Allowed Glycine 0 N--CA 1.48 1.616 0 CA-C-O 116.725 -2.153 . . . . 0.0 117.326 154.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.55 -58.64 12.86 Favored Glycine 0 N--CA 1.49 2.262 0 CA-C-N 122.192 2.996 . . . . 0.0 115.524 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.57 -46.1 73.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 167.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -72.32 -49.45 34.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.37 -35.77 81.19 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 116.76 -1.591 . . . . 0.0 112.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -53.54 -38.37 63.75 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 123.039 2.654 . . . . 0.0 116.047 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.71 -36.0 81.67 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 161.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 5.02 47.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.3 -19.75 66.1 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 165.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -56.34 -46.72 79.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -127.06 112.7 21.77 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.57 -10.03 24.75 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.28 60.93 0.82 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.317 0.962 . . . . 0.0 110.626 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.04 157.98 16.48 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.142 0.977 . . . . 0.0 112.051 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.288 3.6 mp -67.49 -57.47 10.29 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.216 -1.85 . . . . 0.0 109.357 169.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.95 -24.69 1.34 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 N-CA-C 121.472 3.605 . . . . 0.0 121.472 156.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.51 -50.21 68.28 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 121.664 2.029 . . . . 0.0 113.398 162.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.23 -32.1 69.66 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 167.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -66.77 -52.82 39.73 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 120.097 1.317 . . . . 0.0 113.39 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.1 p -57.78 -47.0 83.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -53.32 -47.48 69.25 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.36 -45.84 72.84 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 166.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -52.99 -37.07 61.1 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 169.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -50.39 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 C-N-CA 123.848 0.859 . . . . 0.0 112.78 169.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.63 -45.36 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.882 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.58 -27.31 69.1 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 178.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -64.14 -60.58 7.0 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 118.103 -1.387 . . . . 0.0 111.909 160.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -8.2 0.38 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 170.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 0.3 OUTLIER -92.66 -23.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 162.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.02 -50.08 48.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.965 1.711 . . . . 0.0 112.938 148.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.03 -71.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 165.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.01 -56.03 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 121.183 1.81 . . . . 0.0 114.531 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.42 50.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.2 mmt -65.79 -39.81 91.33 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.265 5.6 tt -62.23 -59.81 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.926 1.239 . . . . 0.0 113.534 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.74 -37.19 84.15 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.04 -50.4 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.889 1.222 . . . . 0.0 112.252 170.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.17 -45.5 61.56 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.76 -42.21 97.86 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.26 1.03 . . . . 0.0 112.825 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.84 -52.42 6.69 Favored Glycine 0 CA--C 1.55 2.261 0 N-CA-C 118.111 2.005 . . . . 0.0 118.111 160.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.16 -54.66 26.29 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -34.73 -49.47 0.42 Allowed 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 162.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.3 p -83.6 -41.78 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.8 mtt -60.14 -38.69 83.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.31 -50.93 70.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 162.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 71.23 86.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.184 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.415 54.1 t 73.72 -62.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 125.319 1.448 . . . . 0.0 114.666 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 123.195 1.474 . . . . 0.0 113.27 -179.395 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.62 -74.38 0.57 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.238 0.615 . . . . 0.0 109.927 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -149.42 -49.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.859 0.863 . . . . 0.0 112.959 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.31 -52.68 62.7 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.979 0.912 . . . . 0.0 113.024 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.42 -34.89 73.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 168.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.2 mtp -62.8 -41.96 99.51 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.64 -40.15 93.88 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.7 -46.41 90.49 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -51.2 50.41 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.014 0.925 . . . . 0.0 113.312 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.21 -60.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 157.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.33 -46.8 69.24 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.671 -170.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.19 -36.02 60.49 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 162.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.29 -48.3 43.4 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -43.24 62.87 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 161.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.79 -48.04 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 163.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -26.5 66.16 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 164.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.4 -36.55 63.02 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.8 tp -42.8 -54.53 8.5 Favored Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 170.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -56.14 -32.22 86.24 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 125.357 2.949 . . . . 0.0 118.858 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.36 69.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.23 -57.84 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 118.626 0.648 . . . . 0.0 110.356 160.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.77 -66.55 2.46 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -167.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.93 -11.74 59.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 118.445 2.757 . . . . 0.0 118.445 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.31 69.64 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 158.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.68 -29.81 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 158.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.91 -60.82 7.52 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-N 119.902 1.228 . . . . 0.0 116.152 166.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -48.27 -69.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-N 118.285 1.042 . . . . 0.0 112.898 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.6 -54.4 37.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -172.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.5 -46.92 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 117.327 -1.321 . . . . 0.0 111.433 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.252 13.5 mt -70.27 -42.54 71.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.483 1.947 . . . . 0.0 112.345 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.11 92.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 165.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -53.95 41.46 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 119.289 1.545 . . . . 0.0 116.584 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.12 -39.16 74.57 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -56.78 -43.66 81.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.269 2.4 tm? -67.69 -38.84 84.22 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.28 0.945 . . . . 0.0 113.135 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.95 -39.24 65.75 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 121.103 1.774 . . . . 0.0 115.513 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.03 -29.74 75.6 Favored Glycine 0 CA--C 1.55 2.268 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 160.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.06 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 119.635 1.717 . . . . 0.0 114.777 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.93 -39.45 71.71 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 162.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.23 -57.32 7.82 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 167.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.5 123.61 2.48 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.941 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 -4.94 15.05 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.56 63.96 1.44 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.462 1.028 . . . . 0.0 110.674 157.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -91.1 166.46 12.97 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.852 0.861 . . . . 0.0 112.244 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 3.8 mp -66.82 -62.31 3.99 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 115.603 -2.142 . . . . 0.0 109.762 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -51.49 -21.21 10.05 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 N-CA-C 119.705 2.925 . . . . 0.0 119.705 164.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.88 -59.97 3.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.003 1.274 . . . . 0.0 113.446 166.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -64.91 -28.67 69.69 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -55.46 -58.82 6.17 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.12 0.873 . . . . 0.0 112.927 162.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -72.02 -28.28 63.28 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.26 -52.58 60.95 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 161.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.03 -38.74 68.34 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 166.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -54.93 -44.1 73.95 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 165.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 mt -57.9 -44.94 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.437 1.017 . . . . 0.0 113.048 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.63 -59.05 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.846 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER -59.33 -34.97 72.99 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 176.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.03 -69.88 1.17 Allowed Glycine 0 C--N 1.355 1.624 0 CA-C-O 117.801 -1.555 . . . . 0.0 112.357 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.52 -14.34 0.11 Allowed 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 171.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.51 -38.34 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 164.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -50.85 -47.82 60.23 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.13 1.786 . . . . 0.0 113.565 156.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -44.8 -67.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.12 -58.04 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.022 1.283 . . . . 0.0 113.17 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 -51.82 64.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.04 -36.07 77.31 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.308 0.4 OUTLIER -66.01 -50.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 120.574 1.534 . . . . 0.0 113.109 173.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.67 92.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.24 -51.7 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.858 1.208 . . . . 0.0 112.528 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 -41.99 84.9 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.03 -43.31 99.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 119.272 1.536 . . . . 0.0 113.65 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.41 -57.73 3.67 Favored Glycine 0 CA--C 1.55 2.24 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 160.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.49 -48.53 48.47 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -40.21 -47.78 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 164.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.88 -39.18 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.821 0 CA-C-O 118.421 -0.8 . . . . 0.0 112.624 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 79.9 mtp -58.12 -47.6 82.8 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -77.85 -67.71 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.14 1.337 . . . . 0.0 113.591 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.59 -47.39 32.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.18 -57.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 119.592 1.087 . . . . 0.0 111.86 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 122.888 1.327 . . . . 0.0 110.865 172.377 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.271 26.5 ptt? . . . . . 0 CA--C 1.558 1.256 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.43 -57.79 4.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.903 0.774 . . . . 0.0 112.931 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.14 -26.91 66.64 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.7 -53.68 31.1 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -58.72 -39.79 81.86 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.77 -41.53 95.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.02 -41.91 98.6 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 167.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.28 -44.8 95.03 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.59 -54.44 32.02 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -36.6 -63.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 161.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.7 mtp -64.61 -50.42 67.24 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.284 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.16 62.65 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.49 -64.96 0.74 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 116.964 -1.494 . . . . 0.0 114.126 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.61 -35.73 31.7 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.107 2.632 . . . . 0.0 118.107 168.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.271 70.4 t -62.43 -53.1 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.775 1.171 . . . . 0.0 113.552 166.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.15 -28.52 58.31 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 165.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 0.6 OUTLIER -84.1 -13.78 52.09 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 173.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.51 -32.88 36.49 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 156.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 tp -39.25 -45.35 3.37 Favored Pre-proline 0 CA--C 1.582 2.19 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -44.53 -33.11 6.26 Favored 'Trans proline' 0 C--N 1.375 1.948 0 CA-C-N 126.176 3.242 . . . . 0.0 120.184 165.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.71 64.33 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.49 -57.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 118.826 0.739 . . . . 0.0 110.256 160.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -62.96 4.84 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -72.52 -23.7 61.05 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.61 -48.4 66.92 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -57.1 -31.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 159.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.53 -65.13 3.5 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.887 1.221 . . . . 0.0 115.79 167.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -47.66 -73.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 117.945 0.873 . . . . 0.0 113.013 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -56.08 27.21 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 118.5 2.16 . . . . 0.0 118.5 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -81.35 -46.98 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 117.475 -1.25 . . . . 0.0 112.45 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.279 17.5 mt -75.6 -35.7 60.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.181 1.81 . . . . 0.0 112.703 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.81 65.59 Favored Glycine 0 N--CA 1.491 2.318 0 CA-C-N 121.718 2.054 . . . . 0.0 118.005 163.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.33 -53.49 44.47 Favored Glycine 0 N--CA 1.491 2.339 0 CA-C-N 119.561 1.681 . . . . 0.0 116.289 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.99 -43.52 66.5 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.698 2.111 . . . . 0.0 116.698 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -44.3 85.47 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 171.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.276 2.4 tm? -66.56 -38.57 87.37 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.766 1.167 . . . . 0.0 113.231 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 164.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.36 89.04 Favored Glycine 0 CA--C 1.551 2.306 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 160.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -32.05 66.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.15 62.47 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -62.17 1.6 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 119.322 0.965 . . . . 0.0 112.196 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.89 114.96 5.99 Favored Pre-proline 0 CA--C 1.568 1.656 0 CA-C-O 117.961 -1.018 . . . . 0.0 108.303 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.65 -2.02 11.89 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 N-CA-C 119.298 2.768 . . . . 0.0 119.298 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -129.9 62.39 1.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.418 1.008 . . . . 0.0 110.153 159.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.0 162.65 20.33 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 111.48 165.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.258 43.5 mm -67.1 -58.64 8.81 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-O 115.841 -2.028 . . . . 0.0 111.166 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -54.87 -20.55 22.96 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 CA-C-N 124.909 2.789 . . . . 0.0 119.292 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.8 -54.07 31.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 119.755 1.162 . . . . 0.0 113.646 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.29 -22.28 66.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -57.01 -58.18 9.3 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.669 1.122 . . . . 0.0 113.378 157.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -66.66 -33.11 74.92 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -52.41 -51.28 59.93 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 160.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.71 -39.57 74.1 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' HB3' HD13 ' A' ' 31' ' ' LEU . 27.3 m-85 -54.56 -38.92 67.22 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 165.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mt -59.0 -48.83 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 119.392 0.996 . . . . 0.0 112.799 165.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.96 -56.81 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.28 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.262 0.0 OUTLIER -58.35 -31.91 68.04 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 176.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -65.67 -67.84 1.87 Allowed Glycine 0 C--N 1.355 1.627 0 CA-C-O 117.545 -1.697 . . . . 0.0 111.125 166.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.8 tp -46.53 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -80.93 -40.92 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 125.526 1.53 . . . . 0.0 113.823 166.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -49.82 -36.21 25.71 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 121.236 1.834 . . . . 0.0 115.264 158.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.16 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 117.439 -1.267 . . . . 0.0 113.373 160.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.66 -55.96 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-N 120.92 1.691 . . . . 0.0 114.818 -165.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.4 -59.51 5.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.429 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 20.3 mmt -61.27 -49.6 76.42 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 116.641 -1.647 . . . . 0.0 113.994 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.291 5.9 tt -51.43 -56.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 121.508 1.958 . . . . 0.0 114.651 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.85 79.75 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -59.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.617 1.099 . . . . 0.0 113.172 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.2 -17.94 63.76 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 119.614 2.606 . . . . 0.0 119.614 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.66 -43.67 83.93 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.626 2.213 . . . . 0.0 112.074 159.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.36 -51.98 6.27 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 157.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.14 -51.53 66.11 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -42.75 -47.93 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 167.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.56 -40.4 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.661 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -58.59 -49.8 76.15 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.02 -44.53 38.92 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.91 -51.43 26.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.4 126.92 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 123.209 1.481 . . . . 0.0 108.613 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 CA--C 1.558 1.265 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -98.56 -75.28 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.464 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -62.49 -32.59 73.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.01 -51.1 51.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.726 0.81 . . . . 0.0 113.032 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -58.74 -40.95 85.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.2 mtt -64.71 -44.1 91.32 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.11 -38.04 87.41 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.63 -47.81 83.73 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.82 -48.58 81.14 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -43.08 -58.92 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.6 -39.64 73.69 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.32 67.1 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 166.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB1' ' HA2' ' A' ' 69' ' ' GLY . . . -59.38 -54.98 40.48 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 165.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.62 -44.82 37.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 165.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.16 -51.38 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 C-N-CA 124.209 1.003 . . . . 0.0 113.065 166.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -44.12 72.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -28.39 67.67 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 169.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.65 -37.3 40.47 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 167.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.7 tp -37.34 -52.7 2.34 Favored Pre-proline 0 CA--C 1.582 2.199 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.43 -25.72 59.23 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 125.273 2.919 . . . . 0.0 119.45 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.13 69.69 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -86.33 -55.34 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 CA-C-N 118.739 0.7 . . . . 0.0 110.57 160.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.62 -65.25 3.45 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -77.63 -13.63 59.85 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.6 -48.69 68.73 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 161.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.7 mm -59.01 -29.6 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 158.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.39 -62.42 6.2 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 120.04 1.291 . . . . 0.0 115.771 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.4 mm -54.32 -65.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 119.037 1.418 . . . . 0.0 112.948 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.05 -56.9 18.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.62 -58.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.793 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.5 mt -75.63 3.49 9.48 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.32 -36.33 1.64 Allowed Glycine 0 N--CA 1.481 1.695 0 CA-C-O 117.176 -1.902 . . . . 0.0 116.749 155.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -59.51 10.68 Favored Glycine 0 N--CA 1.492 2.388 0 CA-C-N 121.305 2.552 . . . . 0.0 115.923 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.86 -43.21 80.95 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 167.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.08 -42.32 72.92 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.255 3.0 tm? -71.14 -36.73 72.19 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.655 1.116 . . . . 0.0 112.549 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -52.18 -39.32 59.92 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 121.776 2.08 . . . . 0.0 115.942 163.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.76 -31.7 73.39 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 118.4 2.12 . . . . 0.0 118.4 161.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -23.58 54.94 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -20.0 15.44 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 118.809 2.892 . . . . 0.0 118.809 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -58.54 -34.93 71.56 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -154.03 129.72 5.25 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-N 119.997 1.271 . . . . 0.0 109.072 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 2.97 3.55 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.7 64.02 1.58 Allowed 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.168 0.894 . . . . 0.0 110.163 152.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.82 172.91 7.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.571 1.177 . . . . 0.0 112.867 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.49 -56.89 30.83 Favored Pre-proline 0 CA--C 1.581 2.155 0 CA-C-O 115.319 -2.277 . . . . 0.0 110.897 163.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.11 -15.13 21.66 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 CA-C-N 125.349 2.946 . . . . 0.0 119.51 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.5 -49.65 52.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.771 1.623 . . . . 0.0 113.662 161.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.93 -29.42 70.21 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -67.66 -45.58 74.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.502 165.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.295 1.2 t -58.81 -47.01 86.26 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 122.131 2.241 . . . . 0.0 114.973 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.23 -49.32 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.55 -58.17 9.2 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -61.02 -39.27 89.13 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.0 mt -64.59 -43.47 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.39 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.77 -47.64 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 120.558 1.526 . . . . 0.0 113.223 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 75.2 mmm -53.0 -43.94 66.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.3 -67.51 2.09 Favored Glycine 0 C--N 1.356 1.646 0 CA-C-O 117.731 -1.594 . . . . 0.0 112.262 166.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.72 -2.63 0.15 Allowed 'General case' 0 CA--C 1.583 2.227 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.93 -25.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.106 1.362 . . . . 0.0 113.726 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -50.88 -43.85 59.64 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 122.087 2.221 . . . . 0.0 113.528 148.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.19 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 159.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.04 -55.94 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.729 1.604 . . . . 0.0 114.559 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 -54.62 33.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.46 -34.44 75.95 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.285 6.8 tt -62.88 -60.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 120.42 1.464 . . . . 0.0 113.45 171.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.53 97.22 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.78 -52.17 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.318 0.963 . . . . 0.0 112.299 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA2' ' HB1' ' A' ' 13' ' ' ALA . . . -67.71 -42.14 87.84 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.88 -43.35 83.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.486 1.143 . . . . 0.0 113.294 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.14 -48.44 10.15 Favored Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.181 2.032 . . . . 0.0 118.181 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.96 -56.19 6.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -40.67 -45.94 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 164.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.06 -43.96 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.503 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.12 -50.47 58.75 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.82 -38.68 80.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.33 -43.74 96.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 172.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.27 -61.19 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 119.028 0.831 . . . . 0.0 111.558 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 125.137 2.398 . . . . 0.0 108.367 174.581 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -116.59 -74.57 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.143 0.577 . . . . 0.0 110.651 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -145.11 -65.42 0.33 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.321 1.048 . . . . 0.0 112.149 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.94 -45.48 93.49 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.367 1.067 . . . . 0.0 113.861 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.8 -29.3 70.06 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 168.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 45.0 mtm -62.92 -43.67 98.17 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.127 1.33 . . . . 0.0 114.404 163.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.81 -33.43 72.99 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.89 -50.89 70.37 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 168.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.94 -49.31 75.27 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -34.29 -67.27 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 163.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.5 ttt -73.36 -39.29 65.3 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.803 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -37.93 31.03 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.479 2.399 . . . . 0.0 117.479 160.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.78 24.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.76 71.97 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 60.0 t -60.45 -49.75 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.83 1.196 . . . . 0.0 113.145 166.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.8 tpp -58.42 -39.23 79.21 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 166.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.424 ' SD ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -58.37 -30.32 66.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 166.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.88 36.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 170.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 tt -35.88 -50.48 1.56 Allowed Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 167.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -46.87 -30.08 9.04 Favored 'Trans proline' 0 CA--C 1.563 1.934 0 N-CA-C 120.808 3.349 . . . . 0.0 120.808 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.65 -31.86 66.72 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 168.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -85.66 -56.31 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 C-N-CA 123.727 0.811 . . . . 0.0 110.09 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.3 -63.62 4.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -169.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -69.62 -20.66 63.61 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.597 2.814 . . . . 0.0 118.597 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.1 74.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 165.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.5 -32.96 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 159.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.7 -64.8 3.79 Favored Glycine 0 N--CA 1.485 1.909 0 CA-C-N 119.804 1.183 . . . . 0.0 115.864 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.48 -69.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 118.533 1.166 . . . . 0.0 112.703 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.46 -54.6 36.43 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 118.634 2.214 . . . . 0.0 118.634 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.38 -45.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.313 17.8 mt -74.84 -38.54 61.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.99 2.177 . . . . 0.0 112.379 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.81 94.64 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-N 122.176 2.262 . . . . 0.0 118.489 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.41 -52.28 53.71 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 119.384 1.592 . . . . 0.0 116.713 166.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -50.78 -45.37 59.05 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 164.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -54.65 -49.08 71.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.21 -33.63 76.2 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.21 -43.22 67.04 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.75 94.35 Favored Glycine 0 CA--C 1.549 2.213 0 N-CA-C 117.537 1.775 . . . . 0.0 117.537 165.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.07 88.47 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.39 96.4 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.0 -62.68 1.68 Allowed 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -151.16 120.62 3.56 Favored Pre-proline 0 CA--C 1.566 1.577 0 C-N-CA 124.481 1.112 . . . . 0.0 108.096 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 -13.75 38.19 Favored 'Trans proline' 0 CA--C 1.572 2.385 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 168.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -97.62 31.62 2.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.27 144.58 25.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.551 -1.343 . . . . 0.0 113.951 -160.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 67.1 mt -68.28 -57.07 9.46 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-O 115.723 -2.084 . . . . 0.0 111.114 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.48 -19.02 34.36 Favored 'Trans proline' 0 CA--C 1.571 2.339 0 CA-C-N 124.995 2.82 . . . . 0.0 119.171 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.95 -54.2 34.38 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.371 1.441 . . . . 0.0 113.437 161.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.42 -34.26 70.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -57.94 -48.07 81.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.0 m -80.67 -33.72 35.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 117.389 -1.291 . . . . 0.0 114.212 -172.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.336 3.1 pp0? -62.47 -38.46 89.9 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 122.0 2.182 . . . . 0.0 116.649 159.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -51.2 -44.47 61.58 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 158.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.481 ' HB3' HD13 ' A' ' 31' ' ' LEU . 19.1 m-30 -67.0 -29.91 69.87 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.61 -48.09 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-N 119.867 1.212 . . . . 0.0 111.928 162.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.55 -52.51 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.571 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 80.1 mmm -55.09 -40.6 70.61 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.94 -69.21 1.36 Allowed Glycine 0 C--N 1.356 1.668 0 CA-C-O 117.404 -1.775 . . . . 0.0 112.157 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -4.44 0.26 Allowed 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.34 -25.33 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.093 163.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -49.71 -50.08 45.38 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 122.537 2.426 . . . . 0.0 112.905 148.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.83 -68.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 167.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -65.11 -59.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 121.163 1.801 . . . . 0.0 113.129 -173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.87 66.46 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.82 -35.53 74.88 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' SD ' ' A' ' 17' ' ' MET 0.256 4.8 tt -58.35 -57.53 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.944 1.702 . . . . 0.0 113.166 169.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.06 79.17 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.33 -51.49 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.059 1.3 . . . . 0.0 112.506 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.53 -38.88 68.91 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.96 -44.55 84.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.182 1.491 . . . . 0.0 113.299 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.6 -47.75 12.57 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.84 -53.62 47.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -45.12 -44.73 10.79 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.5 -40.8 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.905 0.882 . . . . 0.0 113.058 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -54.22 -42.44 69.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.38 -50.15 75.08 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 164.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 64.09 78.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.673 1.189 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.429 52.4 t 73.6 -35.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 124.996 2.331 . . . . 0.0 111.402 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.555 1.138 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -93.02 -76.27 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.989 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.52 -35.65 76.47 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.89 -50.78 69.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -60.7 -40.01 90.65 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.6 mmt -66.58 -41.85 87.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.34 -41.42 89.14 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 165.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.0 mt -62.62 -45.51 92.55 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.9 -56.41 13.47 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -33.15 -65.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 158.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.19 -48.01 59.02 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.036 -167.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.35 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -61.1 2.38 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.537 1.971 . . . . 0.0 114.772 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.91 72.8 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.357 2.355 . . . . 0.0 117.357 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 79.0 t -66.17 -52.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.703 1.592 . . . . 0.0 113.328 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.95 89.13 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.4 mmt -83.83 -12.86 54.99 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.79 59.51 Favored Glycine 0 CA--C 1.548 2.107 0 CA-C-N 120.201 1.364 . . . . 0.0 115.981 164.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -40.33 -55.53 4.1 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.56 -24.87 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 124.124 3.216 . . . . 0.0 120.177 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.1 89.06 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 121.117 1.781 . . . . 0.0 115.443 165.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.79 -52.67 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 C-N-CA 123.928 0.891 . . . . 0.0 111.964 165.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.58 -59.1 10.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.552 2.181 . . . . 0.0 118.552 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.57 -13.47 60.67 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 171.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.34 -46.44 70.17 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 160.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.03 -37.7 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 123.606 0.762 . . . . 0.0 113.025 156.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.58 48.45 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 163.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.41 -63.62 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-N 120.463 2.131 . . . . 0.0 111.815 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.42 -51.83 56.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 119.257 2.463 . . . . 0.0 119.257 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.77 -45.93 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.9 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.55 -50.05 64.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.757 1.617 . . . . 0.0 112.043 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.72 -39.35 76.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -54.29 39.17 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-N 119.075 1.438 . . . . 0.0 116.529 167.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -48.56 -47.25 39.55 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 164.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.9 -51.79 66.36 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.309 1.444 . . . . 0.0 114.698 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.33 -31.72 71.33 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.33 -43.86 67.99 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 155.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.83 97.13 Favored Glycine 0 CA--C 1.551 2.307 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.61 80.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.35 79.08 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -69.97 -66.06 0.64 Allowed 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -145.56 112.42 4.64 Favored Pre-proline 0 CA--C 1.568 1.659 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.7 2.67 5.03 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 N-CA-C 119.519 2.854 . . . . 0.0 119.519 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -131.62 64.67 1.58 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.12 0.873 . . . . 0.0 110.333 157.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 163.77 17.87 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 121.835 0.826 . . . . 0.0 111.53 168.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.256 4.0 mp -66.81 -59.06 8.42 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.849 -2.024 . . . . 0.0 110.48 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -52.62 -23.99 21.45 Favored 'Trans proline' 0 CA--C 1.57 2.299 0 N-CA-C 119.345 2.787 . . . . 0.0 119.345 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.69 -56.01 12.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 168.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.48 -27.53 68.56 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 160.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.2 m -76.27 -33.46 59.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -51.76 -52.33 49.53 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 158.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -51.04 -44.44 61.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -62.9 -36.84 84.68 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -59.15 -54.36 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.871 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.313 10.2 p -60.96 -49.04 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.679 1.581 . . . . 0.0 114.371 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.17 -43.32 87.42 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.83 -69.04 1.39 Allowed Glycine 0 N--CA 1.479 1.548 0 CA-C-O 118.866 -0.964 . . . . 0.0 114.034 165.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.86 -19.63 0.4 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -90.03 -21.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -51.17 -62.62 1.5 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 122.479 2.399 . . . . 0.0 111.178 152.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -39.4 -65.03 0.42 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 168.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.72 -57.38 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.071 0.85 . . . . 0.0 113.05 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.18 75.03 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 mmt -63.71 -52.65 59.64 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.921 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.289 0.4 OUTLIER -57.36 -41.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 121.101 1.773 . . . . 0.0 114.311 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.54 83.57 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.83 -54.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.25 1.386 . . . . 0.0 112.705 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.61 -40.9 90.48 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 118.745 2.258 . . . . 0.0 118.745 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.77 -42.83 84.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.938 1.369 . . . . 0.0 114.015 163.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.05 -54.88 4.35 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 161.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.16 -49.89 68.09 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -42.79 -40.94 3.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -83.86 -32.92 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.3 mmt -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -71.03 -13.54 62.02 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.26 . . 65.47 56.69 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.442 12.5 p 40.57 74.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.812 -166.612 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptp . . . . . 0 CA--C 1.556 1.194 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.69 70.26 0.57 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.744 1.217 . . . . 0.0 113.119 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -58.63 -34.66 71.42 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.76 -49.5 76.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -58.72 -39.75 81.73 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -65.64 -45.71 82.0 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.21 -33.75 76.52 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.72 -50.35 69.46 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 tp -56.66 -51.62 68.02 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -37.89 -73.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.227 1.811 . . . . 0.0 115.69 163.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.29 -40.22 71.01 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -167.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.7 65.05 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 117.079 2.252 . . . . 0.0 117.079 162.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.31 64.08 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.626 2.012 . . . . 0.0 115.509 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -36.07 82.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.42 -53.46 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 120.728 1.604 . . . . 0.0 113.068 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.7 -52.13 53.89 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -87.16 -16.44 35.41 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.55 -25.39 67.91 Favored Glycine 0 N--CA 1.491 2.344 0 CA-C-N 121.176 1.807 . . . . 0.0 117.486 163.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 tp -50.17 -46.35 82.73 Favored Pre-proline 0 CA--C 1.578 2.05 0 CA-C-O 115.211 -2.328 . . . . 0.0 117.081 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.05 -27.15 2.49 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 121.564 3.64 . . . . 0.0 121.564 164.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.68 74.23 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 164.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.52 -52.66 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 C-N-CA 123.952 0.901 . . . . 0.0 110.904 162.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.91 -66.74 1.36 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 -16.35 61.32 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 119.258 3.059 . . . . 0.0 119.258 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.0 -51.69 51.86 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.8 mt -54.56 -40.28 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 123.418 0.687 . . . . 0.0 112.807 160.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.11 -59.41 6.95 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-O 117.759 -1.578 . . . . 0.0 116.321 167.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 mm -41.83 -51.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.44 -59.9 6.18 Favored Glycine 0 CA--C 1.552 2.351 0 N-CA-C 118.261 2.065 . . . . 0.0 118.261 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.23 -42.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.81 -55.45 34.04 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.444 1.098 . . . . 0.0 112.367 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.42 -39.94 30.04 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 162.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.27 -53.76 43.54 Favored Glycine 0 CA--C 1.554 2.474 0 CA-C-N 119.448 1.624 . . . . 0.0 117.091 166.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -51.57 -49.07 62.8 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -57.58 -42.6 83.46 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.317 0.5 OUTLIER -72.57 -38.96 67.78 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 119.601 1.091 . . . . 0.0 112.58 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.33 -39.27 66.89 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 161.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.21 93.28 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 117.409 1.723 . . . . 0.0 117.409 159.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -37.58 65.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.845 1.823 . . . . 0.0 115.069 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.32 93.34 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 165.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -71.34 -54.08 12.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -154.9 120.1 2.61 Favored Pre-proline 0 CA--C 1.565 1.52 0 CA-C-O 117.674 -1.155 . . . . 0.0 109.106 174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.22 -6.26 12.82 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 N-CA-C 119.676 2.914 . . . . 0.0 119.676 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.63 58.01 1.24 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.19 0.904 . . . . 0.0 111.381 163.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.02 158.9 24.97 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 0.0 113.547 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 4.1 mp -64.36 -57.78 16.25 Favored Pre-proline 0 CA--C 1.582 2.189 0 CA-C-O 116.006 -1.949 . . . . 0.0 110.914 169.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -52.78 -21.59 15.49 Favored 'Trans proline' 0 CA--C 1.57 2.305 0 CA-C-N 125.022 2.829 . . . . 0.0 119.137 164.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.65 -53.33 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.98 -37.32 74.0 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -53.37 -51.59 62.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 162.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.268 5.3 m -86.87 -28.01 23.1 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -170.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.282 10.0 pt20 -61.71 -40.75 96.12 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 121.724 2.056 . . . . 0.0 115.912 157.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.87 -48.29 64.11 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 159.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.21 -40.78 97.25 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.02 -46.25 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 124.962 1.305 . . . . 0.0 114.184 166.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.77 -61.83 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 117.838 -1.077 . . . . 0.0 111.813 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.31 0.0 OUTLIER -65.64 -31.55 72.64 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -176.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.37 -65.72 3.18 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.914 -1.116 . . . . 0.0 113.448 164.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -11.99 5.64 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.32 0.4 OUTLIER -81.81 -22.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 159.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -49.1 -63.15 1.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 121.06 1.755 . . . . 0.0 111.096 151.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.3 -63.96 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -66.95 -54.49 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.568 1.531 . . . . 0.0 113.783 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 -49.92 75.56 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -68.5 -43.38 76.98 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.286 0.4 OUTLIER -57.09 -44.21 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 121.954 2.161 . . . . 0.0 113.31 173.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.12 76.0 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.31 -54.1 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 120.249 1.386 . . . . 0.0 112.793 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.85 -43.79 93.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.45 -48.69 74.09 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.498 1.149 . . . . 0.0 113.919 163.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -51.58 7.81 Favored Glycine 0 CA--C 1.548 2.099 0 N-CA-C 118.621 2.209 . . . . 0.0 118.621 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.33 -54.73 13.09 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -35.02 -54.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 160.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 2.2 p -74.28 -35.94 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 87.7 mmm -62.5 -30.61 71.4 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 163.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.91 -52.82 7.77 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.37 61.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.65 121.96 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 163.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 123.119 1.438 . . . . 0.0 112.666 -169.693 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.38 -45.67 92.7 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -57.33 -39.48 75.94 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.4 mtm -68.63 -38.36 80.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -58.18 -45.99 86.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.941 1.246 . . . . 0.0 114.016 166.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.87 -45.2 93.69 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.64 -54.4 32.48 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.893 0.877 . . . . 0.0 113.32 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -36.51 -62.15 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 160.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.96 -48.43 76.52 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.801 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.02 68.64 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -48.04 69.8 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.08 86.66 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 164.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.255 53.5 t -56.65 -50.69 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 119.947 1.249 . . . . 0.0 113.115 164.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -43.65 67.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 165.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.277 0.0 OUTLIER -56.93 -39.0 73.68 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.66 56.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 118.399 2.119 . . . . 0.0 118.399 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -47.37 -47.84 57.43 Favored Pre-proline 0 CA--C 1.58 2.107 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.14 -30.88 11.07 Favored 'Trans proline' 0 C--N 1.372 1.808 0 N-CA-C 120.81 3.35 . . . . 0.0 120.81 167.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -28.78 66.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.7 mm -85.63 -59.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 CA-C-N 118.803 0.729 . . . . 0.0 110.036 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.53 -65.15 3.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 118.204 2.041 . . . . 0.0 118.204 -168.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.55 -24.05 62.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.15 70.65 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.75 -34.98 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 118.24 -0.886 . . . . 0.0 113.075 159.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.88 -66.18 2.94 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 120.106 1.321 . . . . 0.0 115.595 170.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.44 -66.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 118.227 1.013 . . . . 0.0 113.065 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.04 -59.69 9.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 117.92 1.928 . . . . 0.0 117.92 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.3 -45.68 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 117.012 -1.47 . . . . 0.0 111.693 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.3 -6.07 57.04 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 121.801 2.091 . . . . 0.0 115.088 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 -42.34 17.28 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-N 121.054 1.752 . . . . 0.0 116.436 147.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.03 -53.54 43.76 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 119.383 1.592 . . . . 0.0 116.948 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.28 -36.77 73.8 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 167.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -52.12 -51.68 56.33 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.06 -34.72 76.97 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.51 -43.87 65.35 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 156.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.17 -45.74 95.48 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 117.036 1.574 . . . . 0.0 117.036 166.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.56 85.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.63 89.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 167.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -66.53 -62.32 1.52 Allowed 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -149.36 116.58 3.7 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.18 -12.1 33.18 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 N-CA-C 119.544 2.863 . . . . 0.0 119.544 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.39 62.56 0.81 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.23 0.923 . . . . 0.0 110.689 164.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -96.06 153.48 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.824 0.821 . . . . 0.0 112.643 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mp -66.51 -58.1 10.9 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-O 115.728 -2.082 . . . . 0.0 110.658 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.77 -20.17 34.19 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 124.854 2.769 . . . . 0.0 119.03 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.93 -51.67 66.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 121.106 1.776 . . . . 0.0 114.275 160.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.04 -30.63 71.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -61.91 -59.17 5.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.732 1.151 . . . . 0.0 113.587 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -58.27 -46.38 86.14 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -43.72 93.53 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -48.81 -46.51 41.95 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 162.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.84 -14.48 61.09 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.889 2.551 . . . . 0.0 117.889 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.08 -55.53 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.311 1.414 . . . . 0.0 110.369 160.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.298 12.4 p -68.44 -55.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 85.4 mmm -57.92 -36.42 72.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -60.03 -74.33 0.38 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.354 164.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.88 -13.64 0.79 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -87.36 -28.89 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -50.03 -51.2 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.846 2.112 . . . . 0.0 112.833 152.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.85 -67.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.41 -55.31 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 120.125 1.329 . . . . 0.0 114.182 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.41 53.2 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.9 mmt -68.45 -36.59 79.24 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.296 0.4 OUTLIER -65.18 -50.99 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.664 1.574 . . . . 0.0 112.813 174.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.72 73.3 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.59 -49.2 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.776 1.171 . . . . 0.0 112.534 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.73 -39.51 55.29 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.35 -43.5 94.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.726 1.763 . . . . 0.0 113.112 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.37 -54.67 5.44 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 161.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 -48.75 64.99 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -40.76 -47.96 2.94 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.34 -40.82 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.379 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.02 -49.89 72.44 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.3 t80 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 t30 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.94 -47.74 85.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -57.58 -37.04 72.51 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.2 mtt -65.41 -42.41 92.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -57.58 -44.31 85.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -64.99 -44.34 89.61 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -50.58 51.41 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.994 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.98 -63.52 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 157.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.26 -46.85 66.25 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.568 -168.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.57 60.33 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 161.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.72 64.52 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.44 77.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.263 58.3 t -57.85 -50.17 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.711 1.141 . . . . 0.0 113.431 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.93 -36.33 76.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -31.3 71.73 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 167.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.45 -32.37 42.68 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.8 tp -38.07 -46.98 2.74 Favored Pre-proline 0 CA--C 1.582 2.173 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -47.0 -32.15 12.5 Favored 'Trans proline' 0 C--N 1.374 1.897 0 N-CA-C 120.326 3.164 . . . . 0.0 120.326 166.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.53 -30.96 67.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.72 -59.31 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.914 0 C-N-CA 123.657 0.783 . . . . 0.0 109.708 162.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.68 -62.26 4.94 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -167.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.88 -24.24 62.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.9 -46.0 72.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.43 -35.18 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 118.045 -0.979 . . . . 0.0 113.13 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.99 -67.72 2.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.281 1.401 . . . . 0.0 115.174 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 11.0 mm -44.22 -73.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 166.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.12 -55.6 27.0 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 118.528 2.171 . . . . 0.0 118.528 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.22 -44.08 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 116.993 -1.479 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.33 22.0 mt -75.74 -35.59 60.16 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 121.927 2.149 . . . . 0.0 112.516 177.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.17 94.29 Favored Glycine 0 N--CA 1.492 2.391 0 CA-C-N 122.684 2.493 . . . . 0.0 118.365 160.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.72 -53.5 44.75 Favored Glycine 0 CA--C 1.553 2.409 0 CA-C-N 119.255 1.527 . . . . 0.0 116.59 164.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -50.75 -45.13 58.67 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 165.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.94 -44.46 82.53 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.261 2.6 tm? -66.44 -38.85 88.31 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 118.251 -0.881 . . . . 0.0 113.047 172.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.7 -39.01 61.57 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 165.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -39.71 98.35 Favored Glycine 0 CA--C 1.55 2.229 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 159.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.15 68.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.29 69.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -59.05 2.75 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.483 1.038 . . . . 0.0 112.272 170.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.78 119.78 6.96 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.717 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 -5.78 16.16 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 N-CA-C 119.467 2.833 . . . . 0.0 119.467 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -125.8 61.29 1.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.192 0.905 . . . . 0.0 110.859 161.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mt -76.9 156.24 32.23 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 121.133 -0.979 . . . . 0.0 112.577 169.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.89 -57.39 9.71 Favored Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.007 -1.949 . . . . 0.0 110.706 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -55.41 -21.26 29.16 Favored 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 124.847 2.767 . . . . 0.0 118.919 165.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tt -66.03 -52.58 47.87 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.678 1.127 . . . . 0.0 113.975 164.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.54 -29.28 70.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.54 -51.3 70.04 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 159.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.261 3.9 m -75.99 -32.94 59.69 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -54.28 -50.54 67.05 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 159.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -49.23 -45.14 44.17 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 162.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' HD13 ' A' ' 31' ' ' LEU . 18.2 m-30 -63.26 -32.89 74.41 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mt -58.43 -52.02 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 119.377 0.99 . . . . 0.0 111.861 163.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.22 -58.74 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 124.073 0.949 . . . . 0.0 112.302 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -56.67 -24.38 48.39 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 171.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -62.22 -82.22 0.08 OUTLIER Glycine 0 C--N 1.355 1.606 0 CA-C-O 116.567 -2.24 . . . . 0.0 111.526 163.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.388 1.6 pt? -58.5 -2.83 0.23 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.26 -40.04 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 159.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -50.03 -44.62 51.44 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.321 1.873 . . . . 0.0 113.666 155.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.9 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 167.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.17 -58.27 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-N 121.03 1.741 . . . . 0.0 113.637 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.9 65.85 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.8 tpp -66.62 -39.67 88.44 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.271 4.8 tt -59.58 -60.3 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.794 1.179 . . . . 0.0 112.997 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -33.86 75.16 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.53 -56.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.679 1.127 . . . . 0.0 111.981 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.04 -33.09 65.48 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.74 -43.18 99.48 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.146 1.473 . . . . 0.0 113.158 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.79 -54.08 6.92 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.929 1.932 . . . . 0.0 117.929 162.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.34 -49.26 70.08 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.95 -47.7 2.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 164.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.1 -42.33 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 C-N-CA 123.943 0.897 . . . . 0.0 112.306 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.53 -48.05 72.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.6 t80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-N 119.518 1.053 . . . . 0.0 113.786 -179.465 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -40.63 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.66 -37.89 74.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.3 mtm -69.13 -38.22 78.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.24 -45.97 86.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.035 1.288 . . . . 0.0 114.324 164.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.62 -42.09 99.38 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -66.27 -55.01 18.16 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.969 0.908 . . . . 0.0 113.321 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -36.68 -64.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 161.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtt -64.88 -49.92 68.61 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.606 -173.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.75 64.24 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 166.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.07 -57.24 8.16 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 121.482 1.946 . . . . 0.0 114.879 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -37.41 78.53 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 77.2 t -65.89 -51.96 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 120.416 1.462 . . . . 0.0 113.574 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 ttt -63.04 -44.76 94.97 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 10.5 mmt -89.4 -9.84 48.76 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.38 -37.82 62.67 Favored Glycine 0 CA--C 1.55 2.226 0 CA-C-N 120.187 1.358 . . . . 0.0 115.895 161.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -41.5 -57.94 3.41 Favored Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 115.227 -2.32 . . . . 0.0 116.364 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -53.38 -24.54 27.97 Favored 'Trans proline' 0 C--N 1.373 1.86 0 N-CA-C 120.719 3.315 . . . . 0.0 120.719 170.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.96 84.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 165.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.86 -53.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 123.87 0.868 . . . . 0.0 111.776 163.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.86 -60.16 8.77 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 118.688 2.235 . . . . 0.0 118.688 -173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.29 -16.73 60.93 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.8 -46.76 77.44 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 160.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.66 -33.14 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 158.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.84 -52.94 35.82 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mm -56.2 -62.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.233 1.517 . . . . 0.0 113.037 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.24 -58.7 10.21 Favored Glycine 0 CA--C 1.552 2.37 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.24 -49.73 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.602 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.257 20.3 mt -77.73 -21.29 52.11 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.737 2.062 . . . . 0.0 115.096 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.0 59.9 Favored Glycine 0 CA--C 1.551 2.31 0 CA-C-N 121.16 1.8 . . . . 0.0 117.043 156.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.06 -50.93 53.33 Favored Glycine 0 CA--C 1.554 2.493 0 N-CA-C 116.804 1.481 . . . . 0.0 116.804 165.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -55.07 -37.78 67.19 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 164.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.39 -44.48 76.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 166.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.277 2.5 tm? -67.12 -43.5 82.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -52.78 -41.97 64.6 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 166.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.45 86.93 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 162.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.47 -37.29 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.82 1.81 . . . . 0.0 114.777 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.26 -39.55 87.17 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 163.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -70.84 -60.13 2.41 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.25 118.52 2.86 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 117.769 -1.11 . . . . 0.0 108.589 171.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.31 -3.1 8.18 Favored 'Trans proline' 0 CA--C 1.566 2.113 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.19 62.29 1.62 Allowed 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 119.488 1.04 . . . . 0.0 110.952 155.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.78 162.73 22.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 111.572 166.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 64.9 mt -63.19 -57.62 19.86 Favored Pre-proline 0 CA--C 1.584 2.258 0 CA-C-O 115.788 -2.053 . . . . 0.0 111.189 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -54.13 -24.59 33.84 Favored 'Trans proline' 0 CA--C 1.567 2.155 0 CA-C-N 124.811 2.754 . . . . 0.0 119.134 165.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.52 -50.57 62.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.262 1.392 . . . . 0.0 113.967 165.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.3 -33.91 71.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -58.22 -54.12 50.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 163.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -68.39 -38.3 81.19 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.303 3.6 pp0? -63.62 -41.11 98.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.99 -47.11 65.05 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -64.27 -31.18 72.29 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -57.04 -51.4 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.842 1.201 . . . . 0.0 112.216 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.71 -67.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.282 0.0 OUTLIER -58.86 -33.62 70.66 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.94 -72.28 0.63 Allowed Glycine 0 C--N 1.353 1.522 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.273 166.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.5 tp -50.02 -21.23 1.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -71.79 -38.14 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 163.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -51.06 -61.46 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 120.891 1.678 . . . . 0.0 111.787 161.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -37.86 -68.69 0.14 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.71 -55.33 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 119.834 1.197 . . . . 0.0 113.684 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.402 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 24.4 mmt -61.36 -51.68 67.8 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.974 174.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.295 2.1 tp -52.73 -50.24 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 121.018 1.735 . . . . 0.0 115.18 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.59 76.8 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.9 -57.26 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 119.898 1.226 . . . . 0.0 112.733 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.44 63.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.23 -42.13 99.03 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.416 1.608 . . . . 0.0 113.43 164.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -55.94 5.82 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 117.68 1.832 . . . . 0.0 117.68 161.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.61 -49.51 76.3 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -42.77 -47.23 5.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -73.17 -42.97 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.528 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.4 mtt -55.26 -53.2 59.07 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 176.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.42 -49.94 73.5 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -58.8 -39.83 82.3 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.49 -45.17 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.08 -36.29 83.83 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.334 3.5 pp -67.47 -43.04 81.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.27 -46.85 86.95 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -41.41 -58.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.705 1.602 . . . . 0.0 114.911 164.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ttt -74.93 -42.91 56.79 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.967 -1.016 . . . . 0.0 113.216 -169.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.97 -36.92 18.66 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 159.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.49 14.59 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 -34.18 70.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 57.9 t -59.93 -50.92 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.667 1.121 . . . . 0.0 112.896 164.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 41.0 ttm -55.74 -39.6 71.38 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.279 0.0 OUTLIER -59.39 -32.96 70.63 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 167.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.62 -30.23 40.74 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.7 tp -37.82 -49.37 2.91 Favored Pre-proline 0 CA--C 1.581 2.17 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -54.77 -21.77 26.85 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 N-CA-C 120.265 3.14 . . . . 0.0 120.265 170.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -32.72 67.96 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.26 -56.08 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 C-N-CA 123.437 0.695 . . . . 0.0 109.865 160.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -66.05 3.04 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 118.643 2.217 . . . . 0.0 118.643 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -76.4 -13.22 60.13 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.41 -51.49 56.47 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 164.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.8 -33.09 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 158.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.54 -67.85 1.8 Allowed Glycine 0 N--CA 1.482 1.763 0 CA-C-N 120.193 1.36 . . . . 0.0 116.19 168.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.2 mm -54.65 -70.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 118.266 1.033 . . . . 0.0 112.438 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.26 -54.22 37.3 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.16 -59.89 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.531 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.31 -1.84 28.67 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.43 -34.58 1.73 Allowed Glycine 0 N--CA 1.48 1.616 0 CA-C-O 116.725 -2.153 . . . . 0.0 117.326 154.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.55 -58.64 12.86 Favored Glycine 0 N--CA 1.49 2.262 0 CA-C-N 122.192 2.996 . . . . 0.0 115.524 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.57 -46.1 73.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 167.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -72.32 -49.45 34.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.37 -35.77 81.19 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 116.76 -1.591 . . . . 0.0 112.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -53.54 -38.37 63.75 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 123.039 2.654 . . . . 0.0 116.047 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.71 -36.0 81.67 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 161.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 5.02 47.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.3 -19.75 66.1 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 165.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -56.34 -46.72 79.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -127.06 112.7 21.77 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.57 -10.03 24.75 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.28 60.93 0.82 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.317 0.962 . . . . 0.0 110.626 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.04 157.98 16.48 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.142 0.977 . . . . 0.0 112.051 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.288 3.6 mp -67.49 -57.47 10.29 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.216 -1.85 . . . . 0.0 109.357 169.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.95 -24.69 1.34 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 N-CA-C 121.472 3.605 . . . . 0.0 121.472 156.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.51 -50.21 68.28 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 121.664 2.029 . . . . 0.0 113.398 162.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.23 -32.1 69.66 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 167.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -66.77 -52.82 39.73 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 120.097 1.317 . . . . 0.0 113.39 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.1 p -57.78 -47.0 83.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -53.32 -47.48 69.25 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.36 -45.84 72.84 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 166.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -52.99 -37.07 61.1 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 169.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -50.39 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 C-N-CA 123.848 0.859 . . . . 0.0 112.78 169.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.63 -45.36 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.882 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.58 -27.31 69.1 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 178.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -64.14 -60.58 7.0 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 118.103 -1.387 . . . . 0.0 111.909 160.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -8.2 0.38 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 170.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 0.3 OUTLIER -92.66 -23.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 162.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.02 -50.08 48.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.965 1.711 . . . . 0.0 112.938 148.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.03 -71.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 165.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.01 -56.03 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 121.183 1.81 . . . . 0.0 114.531 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.42 50.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.2 mmt -65.79 -39.81 91.33 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.265 5.6 tt -62.23 -59.81 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.926 1.239 . . . . 0.0 113.534 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.74 -37.19 84.15 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.04 -50.4 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.889 1.222 . . . . 0.0 112.252 170.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.17 -45.5 61.56 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.76 -42.21 97.86 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.26 1.03 . . . . 0.0 112.825 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.84 -52.42 6.69 Favored Glycine 0 CA--C 1.55 2.261 0 N-CA-C 118.111 2.005 . . . . 0.0 118.111 160.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.16 -54.66 26.29 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -34.73 -49.47 0.42 Allowed 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 162.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.3 p -83.6 -41.78 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.8 mtt -60.14 -38.69 83.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 162.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 t30 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.31 -52.68 62.7 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.979 0.912 . . . . 0.0 113.024 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.42 -34.89 73.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 168.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.2 mtp -62.8 -41.96 99.51 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.64 -40.15 93.88 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.7 -46.41 90.49 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -51.2 50.41 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.014 0.925 . . . . 0.0 113.312 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.21 -60.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 157.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.33 -46.8 69.24 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.671 -170.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.19 -36.02 60.49 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 162.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.29 -48.3 43.4 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -43.24 62.87 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 161.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.79 -48.04 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 163.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -26.5 66.16 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 164.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.4 -36.55 63.02 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.8 tp -42.8 -54.53 8.5 Favored Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 170.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -56.14 -32.22 86.24 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 125.357 2.949 . . . . 0.0 118.858 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.36 69.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.23 -57.84 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 118.626 0.648 . . . . 0.0 110.356 160.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.77 -66.55 2.46 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -167.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.93 -11.74 59.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 118.445 2.757 . . . . 0.0 118.445 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.31 69.64 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 158.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.68 -29.81 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 158.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.91 -60.82 7.52 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-N 119.902 1.228 . . . . 0.0 116.152 166.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -48.27 -69.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-N 118.285 1.042 . . . . 0.0 112.898 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.6 -54.4 37.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -172.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.5 -46.92 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 117.327 -1.321 . . . . 0.0 111.433 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.252 13.5 mt -70.27 -42.54 71.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.483 1.947 . . . . 0.0 112.345 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.11 92.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 165.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -53.95 41.46 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 119.289 1.545 . . . . 0.0 116.584 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.12 -39.16 74.57 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -56.78 -43.66 81.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.269 2.4 tm? -67.69 -38.84 84.22 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.28 0.945 . . . . 0.0 113.135 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.95 -39.24 65.75 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 121.103 1.774 . . . . 0.0 115.513 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.03 -29.74 75.6 Favored Glycine 0 CA--C 1.55 2.268 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 160.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.06 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 119.635 1.717 . . . . 0.0 114.777 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.93 -39.45 71.71 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 162.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.23 -57.32 7.82 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 167.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.5 123.61 2.48 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.941 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 -4.94 15.05 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.56 63.96 1.44 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.462 1.028 . . . . 0.0 110.674 157.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -91.1 166.46 12.97 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.852 0.861 . . . . 0.0 112.244 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 3.8 mp -66.82 -62.31 3.99 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 115.603 -2.142 . . . . 0.0 109.762 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -51.49 -21.21 10.05 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 N-CA-C 119.705 2.925 . . . . 0.0 119.705 164.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.88 -59.97 3.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.003 1.274 . . . . 0.0 113.446 166.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -64.91 -28.67 69.69 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -55.46 -58.82 6.17 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.12 0.873 . . . . 0.0 112.927 162.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -72.02 -28.28 63.28 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.26 -52.58 60.95 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 161.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.03 -38.74 68.34 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 166.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -54.93 -44.1 73.95 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 165.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 mt -57.9 -44.94 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.437 1.017 . . . . 0.0 113.048 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.63 -59.05 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.846 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER -59.33 -34.97 72.99 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 176.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.03 -69.88 1.17 Allowed Glycine 0 C--N 1.355 1.624 0 CA-C-O 117.801 -1.555 . . . . 0.0 112.357 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.52 -14.34 0.11 Allowed 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 171.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.51 -38.34 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 164.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -50.85 -47.82 60.23 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.13 1.786 . . . . 0.0 113.565 156.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -44.8 -67.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.12 -58.04 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.022 1.283 . . . . 0.0 113.17 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 -51.82 64.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.04 -36.07 77.31 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.308 0.4 OUTLIER -66.01 -50.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 120.574 1.534 . . . . 0.0 113.109 173.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.67 92.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.24 -51.7 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.858 1.208 . . . . 0.0 112.528 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 -41.99 84.9 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.03 -43.31 99.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 119.272 1.536 . . . . 0.0 113.65 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.41 -57.73 3.67 Favored Glycine 0 CA--C 1.55 2.24 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 160.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.49 -48.53 48.47 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -40.21 -47.78 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 164.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.88 -39.18 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.821 0 CA-C-O 118.421 -0.8 . . . . 0.0 112.624 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 79.9 mtp -58.12 -47.6 82.8 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 N--CA 1.494 1.752 0 CA-C-N 120.14 1.337 . . . . 0.0 113.591 -178.298 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 CA--C 1.57 1.715 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.7 -53.68 31.1 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -58.72 -39.79 81.86 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.77 -41.53 95.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.02 -41.91 98.6 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 167.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.28 -44.8 95.03 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.59 -54.44 32.02 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -36.6 -63.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 161.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.7 mtp -64.61 -50.42 67.24 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.284 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.16 62.65 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.49 -64.96 0.74 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 116.964 -1.494 . . . . 0.0 114.126 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.61 -35.73 31.7 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.107 2.632 . . . . 0.0 118.107 168.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.271 70.4 t -62.43 -53.1 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.775 1.171 . . . . 0.0 113.552 166.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.15 -28.52 58.31 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 165.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 0.6 OUTLIER -84.1 -13.78 52.09 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 173.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.51 -32.88 36.49 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 156.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 tp -39.25 -45.35 3.37 Favored Pre-proline 0 CA--C 1.582 2.19 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -44.53 -33.11 6.26 Favored 'Trans proline' 0 C--N 1.375 1.948 0 CA-C-N 126.176 3.242 . . . . 0.0 120.184 165.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.71 64.33 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.49 -57.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 118.826 0.739 . . . . 0.0 110.256 160.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -62.96 4.84 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -72.52 -23.7 61.05 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.61 -48.4 66.92 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -57.1 -31.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 159.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.53 -65.13 3.5 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.887 1.221 . . . . 0.0 115.79 167.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -47.66 -73.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 117.945 0.873 . . . . 0.0 113.013 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -56.08 27.21 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 118.5 2.16 . . . . 0.0 118.5 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -81.35 -46.98 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 117.475 -1.25 . . . . 0.0 112.45 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.279 17.5 mt -75.6 -35.7 60.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.181 1.81 . . . . 0.0 112.703 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.81 65.59 Favored Glycine 0 N--CA 1.491 2.318 0 CA-C-N 121.718 2.054 . . . . 0.0 118.005 163.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.33 -53.49 44.47 Favored Glycine 0 N--CA 1.491 2.339 0 CA-C-N 119.561 1.681 . . . . 0.0 116.289 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.99 -43.52 66.5 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.698 2.111 . . . . 0.0 116.698 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -44.3 85.47 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 171.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.276 2.4 tm? -66.56 -38.57 87.37 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.766 1.167 . . . . 0.0 113.231 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 164.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.36 89.04 Favored Glycine 0 CA--C 1.551 2.306 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 160.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -32.05 66.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.15 62.47 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -62.17 1.6 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 119.322 0.965 . . . . 0.0 112.196 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.89 114.96 5.99 Favored Pre-proline 0 CA--C 1.568 1.656 0 CA-C-O 117.961 -1.018 . . . . 0.0 108.303 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.65 -2.02 11.89 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 N-CA-C 119.298 2.768 . . . . 0.0 119.298 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -129.9 62.39 1.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.418 1.008 . . . . 0.0 110.153 159.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.0 162.65 20.33 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 111.48 165.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.258 43.5 mm -67.1 -58.64 8.81 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-O 115.841 -2.028 . . . . 0.0 111.166 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -54.87 -20.55 22.96 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 CA-C-N 124.909 2.789 . . . . 0.0 119.292 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.8 -54.07 31.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 119.755 1.162 . . . . 0.0 113.646 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.29 -22.28 66.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -57.01 -58.18 9.3 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.669 1.122 . . . . 0.0 113.378 157.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -66.66 -33.11 74.92 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -52.41 -51.28 59.93 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 160.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.71 -39.57 74.1 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' HB3' HD13 ' A' ' 31' ' ' LEU . 27.3 m-85 -54.56 -38.92 67.22 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 165.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mt -59.0 -48.83 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 119.392 0.996 . . . . 0.0 112.799 165.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.96 -56.81 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.28 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.262 0.0 OUTLIER -58.35 -31.91 68.04 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 176.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -65.67 -67.84 1.87 Allowed Glycine 0 C--N 1.355 1.627 0 CA-C-O 117.545 -1.697 . . . . 0.0 111.125 166.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.8 tp -46.53 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -80.93 -40.92 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 125.526 1.53 . . . . 0.0 113.823 166.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -49.82 -36.21 25.71 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 121.236 1.834 . . . . 0.0 115.264 158.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.16 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 117.439 -1.267 . . . . 0.0 113.373 160.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.66 -55.96 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-N 120.92 1.691 . . . . 0.0 114.818 -165.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.4 -59.51 5.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.429 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 20.3 mmt -61.27 -49.6 76.42 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 116.641 -1.647 . . . . 0.0 113.994 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.291 5.9 tt -51.43 -56.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 121.508 1.958 . . . . 0.0 114.651 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.85 79.75 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -59.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.617 1.099 . . . . 0.0 113.172 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.2 -17.94 63.76 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 119.614 2.606 . . . . 0.0 119.614 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.66 -43.67 83.93 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.626 2.213 . . . . 0.0 112.074 159.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.36 -51.98 6.27 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 157.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.14 -51.53 66.11 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -42.75 -47.93 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 167.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.56 -40.4 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.661 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -58.59 -49.8 76.15 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.1 t80 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 178.555 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.01 -51.1 51.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.726 0.81 . . . . 0.0 113.032 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -58.74 -40.95 85.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.2 mtt -64.71 -44.1 91.32 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.11 -38.04 87.41 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.63 -47.81 83.73 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.82 -48.58 81.14 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -43.08 -58.92 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.6 -39.64 73.69 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.32 67.1 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 166.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB1' ' HA2' ' A' ' 69' ' ' GLY . . . -59.38 -54.98 40.48 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 165.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.62 -44.82 37.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 165.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.16 -51.38 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 C-N-CA 124.209 1.003 . . . . 0.0 113.065 166.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -44.12 72.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -28.39 67.67 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 169.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.65 -37.3 40.47 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 167.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.7 tp -37.34 -52.7 2.34 Favored Pre-proline 0 CA--C 1.582 2.199 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.43 -25.72 59.23 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 125.273 2.919 . . . . 0.0 119.45 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.13 69.69 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -86.33 -55.34 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 CA-C-N 118.739 0.7 . . . . 0.0 110.57 160.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.62 -65.25 3.45 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -77.63 -13.63 59.85 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.6 -48.69 68.73 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 161.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.7 mm -59.01 -29.6 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 158.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.39 -62.42 6.2 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 120.04 1.291 . . . . 0.0 115.771 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.4 mm -54.32 -65.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 119.037 1.418 . . . . 0.0 112.948 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.05 -56.9 18.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.62 -58.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.793 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.5 mt -75.63 3.49 9.48 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.32 -36.33 1.64 Allowed Glycine 0 N--CA 1.481 1.695 0 CA-C-O 117.176 -1.902 . . . . 0.0 116.749 155.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -59.51 10.68 Favored Glycine 0 N--CA 1.492 2.388 0 CA-C-N 121.305 2.552 . . . . 0.0 115.923 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.86 -43.21 80.95 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 167.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.08 -42.32 72.92 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.255 3.0 tm? -71.14 -36.73 72.19 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.655 1.116 . . . . 0.0 112.549 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -52.18 -39.32 59.92 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 121.776 2.08 . . . . 0.0 115.942 163.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.76 -31.7 73.39 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 118.4 2.12 . . . . 0.0 118.4 161.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -23.58 54.94 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -20.0 15.44 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 118.809 2.892 . . . . 0.0 118.809 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -58.54 -34.93 71.56 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -154.03 129.72 5.25 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-N 119.997 1.271 . . . . 0.0 109.072 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 2.97 3.55 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.7 64.02 1.58 Allowed 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.168 0.894 . . . . 0.0 110.163 152.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.82 172.91 7.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.571 1.177 . . . . 0.0 112.867 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.49 -56.89 30.83 Favored Pre-proline 0 CA--C 1.581 2.155 0 CA-C-O 115.319 -2.277 . . . . 0.0 110.897 163.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.11 -15.13 21.66 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 CA-C-N 125.349 2.946 . . . . 0.0 119.51 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.5 -49.65 52.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.771 1.623 . . . . 0.0 113.662 161.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.93 -29.42 70.21 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -67.66 -45.58 74.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.502 165.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.295 1.2 t -58.81 -47.01 86.26 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 122.131 2.241 . . . . 0.0 114.973 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.23 -49.32 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.55 -58.17 9.2 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -61.02 -39.27 89.13 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.0 mt -64.59 -43.47 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.39 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.77 -47.64 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 120.558 1.526 . . . . 0.0 113.223 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 75.2 mmm -53.0 -43.94 66.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.3 -67.51 2.09 Favored Glycine 0 C--N 1.356 1.646 0 CA-C-O 117.731 -1.594 . . . . 0.0 112.262 166.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.72 -2.63 0.15 Allowed 'General case' 0 CA--C 1.583 2.227 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.93 -25.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.106 1.362 . . . . 0.0 113.726 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -50.88 -43.85 59.64 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 122.087 2.221 . . . . 0.0 113.528 148.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.19 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 159.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.04 -55.94 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.729 1.604 . . . . 0.0 114.559 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 -54.62 33.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.46 -34.44 75.95 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.285 6.8 tt -62.88 -60.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 120.42 1.464 . . . . 0.0 113.45 171.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.53 97.22 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.78 -52.17 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.318 0.963 . . . . 0.0 112.299 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA2' ' HB1' ' A' ' 13' ' ' ALA . . . -67.71 -42.14 87.84 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.88 -43.35 83.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.486 1.143 . . . . 0.0 113.294 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.14 -48.44 10.15 Favored Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.181 2.032 . . . . 0.0 118.181 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.96 -56.19 6.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -40.67 -45.94 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 164.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.06 -43.96 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.503 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.12 -50.47 58.75 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 174.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 . . . . . 0 CA--C 1.556 1.199 0 CA-C-O 121.239 0.543 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.94 -45.48 93.49 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.367 1.067 . . . . 0.0 113.861 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.8 -29.3 70.06 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 168.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 45.0 mtm -62.92 -43.67 98.17 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.127 1.33 . . . . 0.0 114.404 163.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.81 -33.43 72.99 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.89 -50.89 70.37 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 168.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.94 -49.31 75.27 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -34.29 -67.27 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 163.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.5 ttt -73.36 -39.29 65.3 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.803 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -37.93 31.03 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.479 2.399 . . . . 0.0 117.479 160.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.78 24.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.76 71.97 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 60.0 t -60.45 -49.75 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.83 1.196 . . . . 0.0 113.145 166.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.8 tpp -58.42 -39.23 79.21 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 166.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.424 ' SD ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -58.37 -30.32 66.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 166.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.88 36.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 170.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 tt -35.88 -50.48 1.56 Allowed Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 167.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -46.87 -30.08 9.04 Favored 'Trans proline' 0 CA--C 1.563 1.934 0 N-CA-C 120.808 3.349 . . . . 0.0 120.808 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.65 -31.86 66.72 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 168.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -85.66 -56.31 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 C-N-CA 123.727 0.811 . . . . 0.0 110.09 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.3 -63.62 4.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -169.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -69.62 -20.66 63.61 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.597 2.814 . . . . 0.0 118.597 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.1 74.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 165.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.5 -32.96 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 159.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.7 -64.8 3.79 Favored Glycine 0 N--CA 1.485 1.909 0 CA-C-N 119.804 1.183 . . . . 0.0 115.864 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.48 -69.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 118.533 1.166 . . . . 0.0 112.703 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.46 -54.6 36.43 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 118.634 2.214 . . . . 0.0 118.634 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.38 -45.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.313 17.8 mt -74.84 -38.54 61.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.99 2.177 . . . . 0.0 112.379 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.81 94.64 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-N 122.176 2.262 . . . . 0.0 118.489 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.41 -52.28 53.71 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 119.384 1.592 . . . . 0.0 116.713 166.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -50.78 -45.37 59.05 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 164.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -54.65 -49.08 71.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.21 -33.63 76.2 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.21 -43.22 67.04 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.75 94.35 Favored Glycine 0 CA--C 1.549 2.213 0 N-CA-C 117.537 1.775 . . . . 0.0 117.537 165.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.07 88.47 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.39 96.4 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.0 -62.68 1.68 Allowed 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -151.16 120.62 3.56 Favored Pre-proline 0 CA--C 1.566 1.577 0 C-N-CA 124.481 1.112 . . . . 0.0 108.096 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 -13.75 38.19 Favored 'Trans proline' 0 CA--C 1.572 2.385 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 168.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -97.62 31.62 2.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.27 144.58 25.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.551 -1.343 . . . . 0.0 113.951 -160.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 67.1 mt -68.28 -57.07 9.46 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-O 115.723 -2.084 . . . . 0.0 111.114 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.48 -19.02 34.36 Favored 'Trans proline' 0 CA--C 1.571 2.339 0 CA-C-N 124.995 2.82 . . . . 0.0 119.171 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.95 -54.2 34.38 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.371 1.441 . . . . 0.0 113.437 161.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.42 -34.26 70.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -57.94 -48.07 81.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.0 m -80.67 -33.72 35.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 117.389 -1.291 . . . . 0.0 114.212 -172.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.336 3.1 pp0? -62.47 -38.46 89.9 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 122.0 2.182 . . . . 0.0 116.649 159.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -51.2 -44.47 61.58 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 158.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.481 ' HB3' HD13 ' A' ' 31' ' ' LEU . 19.1 m-30 -67.0 -29.91 69.87 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.61 -48.09 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-N 119.867 1.212 . . . . 0.0 111.928 162.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.55 -52.51 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.571 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 80.1 mmm -55.09 -40.6 70.61 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.94 -69.21 1.36 Allowed Glycine 0 C--N 1.356 1.668 0 CA-C-O 117.404 -1.775 . . . . 0.0 112.157 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -4.44 0.26 Allowed 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.34 -25.33 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.093 163.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -49.71 -50.08 45.38 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 122.537 2.426 . . . . 0.0 112.905 148.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.83 -68.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 167.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -65.11 -59.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 121.163 1.801 . . . . 0.0 113.129 -173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.87 66.46 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.82 -35.53 74.88 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' SD ' ' A' ' 17' ' ' MET 0.256 4.8 tt -58.35 -57.53 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.944 1.702 . . . . 0.0 113.166 169.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.06 79.17 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.33 -51.49 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.059 1.3 . . . . 0.0 112.506 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.53 -38.88 68.91 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.96 -44.55 84.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.182 1.491 . . . . 0.0 113.299 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.6 -47.75 12.57 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.84 -53.62 47.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -45.12 -44.73 10.79 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.5 -40.8 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.905 0.882 . . . . 0.0 113.058 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -54.22 -42.44 69.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 164.137 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.89 -50.78 69.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -60.7 -40.01 90.65 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.6 mmt -66.58 -41.85 87.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.34 -41.42 89.14 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 165.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.0 mt -62.62 -45.51 92.55 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.9 -56.41 13.47 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -33.15 -65.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 158.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.19 -48.01 59.02 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.036 -167.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.35 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -61.1 2.38 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.537 1.971 . . . . 0.0 114.772 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.91 72.8 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.357 2.355 . . . . 0.0 117.357 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 79.0 t -66.17 -52.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.703 1.592 . . . . 0.0 113.328 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.95 89.13 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.4 mmt -83.83 -12.86 54.99 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.79 59.51 Favored Glycine 0 CA--C 1.548 2.107 0 CA-C-N 120.201 1.364 . . . . 0.0 115.981 164.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -40.33 -55.53 4.1 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.56 -24.87 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 124.124 3.216 . . . . 0.0 120.177 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.1 89.06 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 121.117 1.781 . . . . 0.0 115.443 165.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.79 -52.67 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 C-N-CA 123.928 0.891 . . . . 0.0 111.964 165.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.58 -59.1 10.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.552 2.181 . . . . 0.0 118.552 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.57 -13.47 60.67 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 171.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.34 -46.44 70.17 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 160.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.03 -37.7 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 123.606 0.762 . . . . 0.0 113.025 156.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.58 48.45 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 163.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.41 -63.62 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-N 120.463 2.131 . . . . 0.0 111.815 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.42 -51.83 56.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 119.257 2.463 . . . . 0.0 119.257 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.77 -45.93 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.9 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.55 -50.05 64.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.757 1.617 . . . . 0.0 112.043 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.72 -39.35 76.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -54.29 39.17 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-N 119.075 1.438 . . . . 0.0 116.529 167.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -48.56 -47.25 39.55 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 164.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.9 -51.79 66.36 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.309 1.444 . . . . 0.0 114.698 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.33 -31.72 71.33 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.33 -43.86 67.99 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 155.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.83 97.13 Favored Glycine 0 CA--C 1.551 2.307 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.61 80.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.35 79.08 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -69.97 -66.06 0.64 Allowed 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -145.56 112.42 4.64 Favored Pre-proline 0 CA--C 1.568 1.659 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.7 2.67 5.03 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 N-CA-C 119.519 2.854 . . . . 0.0 119.519 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -131.62 64.67 1.58 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.12 0.873 . . . . 0.0 110.333 157.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 163.77 17.87 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 121.835 0.826 . . . . 0.0 111.53 168.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.256 4.0 mp -66.81 -59.06 8.42 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.849 -2.024 . . . . 0.0 110.48 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -52.62 -23.99 21.45 Favored 'Trans proline' 0 CA--C 1.57 2.299 0 N-CA-C 119.345 2.787 . . . . 0.0 119.345 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.69 -56.01 12.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 168.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.48 -27.53 68.56 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 160.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.2 m -76.27 -33.46 59.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -51.76 -52.33 49.53 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 158.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -51.04 -44.44 61.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -62.9 -36.84 84.68 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -59.15 -54.36 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.871 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.313 10.2 p -60.96 -49.04 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.679 1.581 . . . . 0.0 114.371 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.17 -43.32 87.42 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.83 -69.04 1.39 Allowed Glycine 0 N--CA 1.479 1.548 0 CA-C-O 118.866 -0.964 . . . . 0.0 114.034 165.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.86 -19.63 0.4 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -90.03 -21.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -51.17 -62.62 1.5 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 122.479 2.399 . . . . 0.0 111.178 152.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -39.4 -65.03 0.42 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 168.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.72 -57.38 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.071 0.85 . . . . 0.0 113.05 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.18 75.03 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 mmt -63.71 -52.65 59.64 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.921 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.289 0.4 OUTLIER -57.36 -41.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 121.101 1.773 . . . . 0.0 114.311 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.54 83.57 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.83 -54.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.25 1.386 . . . . 0.0 112.705 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.61 -40.9 90.48 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 118.745 2.258 . . . . 0.0 118.745 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.77 -42.83 84.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.938 1.369 . . . . 0.0 114.015 163.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.05 -54.88 4.35 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 161.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.16 -49.89 68.09 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -42.79 -40.94 3.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -83.86 -32.92 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.3 mmt -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 CA--C 1.578 2.049 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 161.518 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 t30 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.76 -49.5 76.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -58.72 -39.75 81.73 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -65.64 -45.71 82.0 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.21 -33.75 76.52 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.72 -50.35 69.46 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 tp -56.66 -51.62 68.02 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -37.89 -73.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.227 1.811 . . . . 0.0 115.69 163.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.29 -40.22 71.01 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -167.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.7 65.05 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 117.079 2.252 . . . . 0.0 117.079 162.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.31 64.08 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.626 2.012 . . . . 0.0 115.509 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -36.07 82.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.42 -53.46 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 120.728 1.604 . . . . 0.0 113.068 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.7 -52.13 53.89 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -87.16 -16.44 35.41 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.55 -25.39 67.91 Favored Glycine 0 N--CA 1.491 2.344 0 CA-C-N 121.176 1.807 . . . . 0.0 117.486 163.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 tp -50.17 -46.35 82.73 Favored Pre-proline 0 CA--C 1.578 2.05 0 CA-C-O 115.211 -2.328 . . . . 0.0 117.081 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.05 -27.15 2.49 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 121.564 3.64 . . . . 0.0 121.564 164.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.68 74.23 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 164.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.52 -52.66 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 C-N-CA 123.952 0.901 . . . . 0.0 110.904 162.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.91 -66.74 1.36 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 -16.35 61.32 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 119.258 3.059 . . . . 0.0 119.258 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.0 -51.69 51.86 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.8 mt -54.56 -40.28 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 123.418 0.687 . . . . 0.0 112.807 160.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.11 -59.41 6.95 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-O 117.759 -1.578 . . . . 0.0 116.321 167.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 mm -41.83 -51.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.44 -59.9 6.18 Favored Glycine 0 CA--C 1.552 2.351 0 N-CA-C 118.261 2.065 . . . . 0.0 118.261 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.23 -42.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.81 -55.45 34.04 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.444 1.098 . . . . 0.0 112.367 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.42 -39.94 30.04 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 162.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.27 -53.76 43.54 Favored Glycine 0 CA--C 1.554 2.474 0 CA-C-N 119.448 1.624 . . . . 0.0 117.091 166.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -51.57 -49.07 62.8 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -57.58 -42.6 83.46 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.317 0.5 OUTLIER -72.57 -38.96 67.78 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 119.601 1.091 . . . . 0.0 112.58 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.33 -39.27 66.89 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 161.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.21 93.28 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 117.409 1.723 . . . . 0.0 117.409 159.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -37.58 65.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.845 1.823 . . . . 0.0 115.069 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.32 93.34 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 165.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -71.34 -54.08 12.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -154.9 120.1 2.61 Favored Pre-proline 0 CA--C 1.565 1.52 0 CA-C-O 117.674 -1.155 . . . . 0.0 109.106 174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.22 -6.26 12.82 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 N-CA-C 119.676 2.914 . . . . 0.0 119.676 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.63 58.01 1.24 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.19 0.904 . . . . 0.0 111.381 163.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.02 158.9 24.97 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 0.0 113.547 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 4.1 mp -64.36 -57.78 16.25 Favored Pre-proline 0 CA--C 1.582 2.189 0 CA-C-O 116.006 -1.949 . . . . 0.0 110.914 169.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -52.78 -21.59 15.49 Favored 'Trans proline' 0 CA--C 1.57 2.305 0 CA-C-N 125.022 2.829 . . . . 0.0 119.137 164.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.65 -53.33 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.98 -37.32 74.0 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -53.37 -51.59 62.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 162.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.268 5.3 m -86.87 -28.01 23.1 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -170.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.282 10.0 pt20 -61.71 -40.75 96.12 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 121.724 2.056 . . . . 0.0 115.912 157.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.87 -48.29 64.11 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 159.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.21 -40.78 97.25 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.02 -46.25 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 124.962 1.305 . . . . 0.0 114.184 166.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.77 -61.83 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 117.838 -1.077 . . . . 0.0 111.813 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.31 0.0 OUTLIER -65.64 -31.55 72.64 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -176.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.37 -65.72 3.18 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.914 -1.116 . . . . 0.0 113.448 164.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -11.99 5.64 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.32 0.4 OUTLIER -81.81 -22.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 159.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -49.1 -63.15 1.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 121.06 1.755 . . . . 0.0 111.096 151.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.3 -63.96 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -66.95 -54.49 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.568 1.531 . . . . 0.0 113.783 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 -49.92 75.56 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -68.5 -43.38 76.98 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.286 0.4 OUTLIER -57.09 -44.21 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 121.954 2.161 . . . . 0.0 113.31 173.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.12 76.0 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.31 -54.1 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 120.249 1.386 . . . . 0.0 112.793 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.85 -43.79 93.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.45 -48.69 74.09 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.498 1.149 . . . . 0.0 113.919 163.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -51.58 7.81 Favored Glycine 0 CA--C 1.548 2.099 0 N-CA-C 118.621 2.209 . . . . 0.0 118.621 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.33 -54.73 13.09 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -35.02 -54.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 160.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 2.2 p -74.28 -35.94 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 87.7 mmm -62.5 -30.61 71.4 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 163.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 169.796 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -97.93 -78.94 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.7 -42.81 95.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.38 -45.67 92.7 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -57.33 -39.48 75.94 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.4 mtm -68.63 -38.36 80.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -58.18 -45.99 86.57 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.941 1.246 . . . . 0.0 114.016 166.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.9 mt -62.87 -45.2 93.69 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.64 -54.4 32.48 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.893 0.877 . . . . 0.0 113.32 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -36.51 -62.15 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 160.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.2 mtt -63.96 -48.43 76.52 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.801 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.02 68.64 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -48.04 69.8 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.08 86.66 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 164.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.255 53.5 t -56.65 -50.69 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 119.947 1.249 . . . . 0.0 113.115 164.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -43.65 67.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 165.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.277 0.0 OUTLIER -56.93 -39.0 73.68 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.66 56.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 118.399 2.119 . . . . 0.0 118.399 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -47.37 -47.84 57.43 Favored Pre-proline 0 CA--C 1.58 2.107 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.14 -30.88 11.07 Favored 'Trans proline' 0 C--N 1.372 1.808 0 N-CA-C 120.81 3.35 . . . . 0.0 120.81 167.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.74 -28.78 66.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.7 mm -85.63 -59.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 CA-C-N 118.803 0.729 . . . . 0.0 110.036 159.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.53 -65.15 3.03 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 118.204 2.041 . . . . 0.0 118.204 -168.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.55 -24.05 62.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.15 70.65 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.75 -34.98 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 118.24 -0.886 . . . . 0.0 113.075 159.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.88 -66.18 2.94 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 120.106 1.321 . . . . 0.0 115.595 170.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.44 -66.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 118.227 1.013 . . . . 0.0 113.065 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.04 -59.69 9.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 117.92 1.928 . . . . 0.0 117.92 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.3 -45.68 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 117.012 -1.47 . . . . 0.0 111.693 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.3 -6.07 57.04 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 121.801 2.091 . . . . 0.0 115.088 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 -42.34 17.28 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-N 121.054 1.752 . . . . 0.0 116.436 147.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.03 -53.54 43.76 Favored Glycine 0 N--CA 1.492 2.428 0 CA-C-N 119.383 1.592 . . . . 0.0 116.948 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.28 -36.77 73.8 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 167.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -52.12 -51.68 56.33 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.06 -34.72 76.97 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.51 -43.87 65.35 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 156.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.17 -45.74 95.48 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 117.036 1.574 . . . . 0.0 117.036 166.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.56 85.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.63 89.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 167.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -66.53 -62.32 1.52 Allowed 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -149.36 116.58 3.7 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.18 -12.1 33.18 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 N-CA-C 119.544 2.863 . . . . 0.0 119.544 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.39 62.56 0.81 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.23 0.923 . . . . 0.0 110.689 164.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -96.06 153.48 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.824 0.821 . . . . 0.0 112.643 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mp -66.51 -58.1 10.9 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-O 115.728 -2.082 . . . . 0.0 110.658 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.77 -20.17 34.19 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 124.854 2.769 . . . . 0.0 119.03 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.93 -51.67 66.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 121.106 1.776 . . . . 0.0 114.275 160.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.04 -30.63 71.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -61.91 -59.17 5.52 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.732 1.151 . . . . 0.0 113.587 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -58.27 -46.38 86.14 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -43.72 93.53 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -48.81 -46.51 41.95 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 162.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.84 -14.48 61.09 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.889 2.551 . . . . 0.0 117.889 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.08 -55.53 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.311 1.414 . . . . 0.0 110.369 160.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.298 12.4 p -68.44 -55.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 85.4 mmm -57.92 -36.42 72.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -60.03 -74.33 0.38 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-O 117.52 -1.711 . . . . 0.0 112.354 164.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.88 -13.64 0.79 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -87.36 -28.89 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -50.03 -51.2 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.846 2.112 . . . . 0.0 112.833 152.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.85 -67.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -57.41 -55.31 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 120.125 1.329 . . . . 0.0 114.182 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.41 53.2 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.9 mmt -68.45 -36.59 79.24 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.296 0.4 OUTLIER -65.18 -50.99 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.664 1.574 . . . . 0.0 112.813 174.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.72 73.3 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.59 -49.2 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.776 1.171 . . . . 0.0 112.534 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.73 -39.51 55.29 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 119.397 2.519 . . . . 0.0 119.397 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.35 -43.5 94.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.726 1.763 . . . . 0.0 113.112 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.37 -54.67 5.44 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 161.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 -48.75 64.99 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -40.76 -47.96 2.94 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.34 -40.82 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.379 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.02 -49.89 72.44 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -75.85 -55.89 5.19 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.81 -51.17 14.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.27 -59.94 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 119.343 0.974 . . . . 0.0 111.37 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 123.369 1.557 . . . . 0.0 113.48 174.149 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 119.078 -0.486 . . . . 0.0 111.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.263 9.7 tp10 65.91 80.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -63.83 -25.62 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.94 -47.74 85.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -57.58 -37.04 72.51 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.2 mtt -65.41 -42.41 92.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -57.58 -44.31 85.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -64.99 -44.34 89.61 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -50.58 51.41 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.994 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.98 -63.52 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 157.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.26 -46.85 66.25 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.568 -168.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.69 -40.57 60.33 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 161.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.72 64.52 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.44 77.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 164.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.263 58.3 t -57.85 -50.17 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.711 1.141 . . . . 0.0 113.431 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.93 -36.33 76.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -31.3 71.73 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 167.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.45 -32.37 42.68 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.8 tp -38.07 -46.98 2.74 Favored Pre-proline 0 CA--C 1.582 2.173 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -47.0 -32.15 12.5 Favored 'Trans proline' 0 C--N 1.374 1.897 0 N-CA-C 120.326 3.164 . . . . 0.0 120.326 166.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.53 -30.96 67.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 168.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.72 -59.31 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.914 0 C-N-CA 123.657 0.783 . . . . 0.0 109.708 162.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.68 -62.26 4.94 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -167.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -70.88 -24.24 62.45 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.9 -46.0 72.86 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.43 -35.18 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 118.045 -0.979 . . . . 0.0 113.13 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.99 -67.72 2.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.281 1.401 . . . . 0.0 115.174 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 11.0 mm -44.22 -73.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 166.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.12 -55.6 27.0 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 118.528 2.171 . . . . 0.0 118.528 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.22 -44.08 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 116.993 -1.479 . . . . 0.0 111.482 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.33 22.0 mt -75.74 -35.59 60.16 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 121.927 2.149 . . . . 0.0 112.516 177.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.17 94.29 Favored Glycine 0 N--CA 1.492 2.391 0 CA-C-N 122.684 2.493 . . . . 0.0 118.365 160.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.72 -53.5 44.75 Favored Glycine 0 CA--C 1.553 2.409 0 CA-C-N 119.255 1.527 . . . . 0.0 116.59 164.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -50.75 -45.13 58.67 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 165.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.94 -44.46 82.53 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.261 2.6 tm? -66.44 -38.85 88.31 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 118.251 -0.881 . . . . 0.0 113.047 172.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.7 -39.01 61.57 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 165.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -39.71 98.35 Favored Glycine 0 CA--C 1.55 2.229 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 159.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.15 68.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.29 69.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -59.05 2.75 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.483 1.038 . . . . 0.0 112.272 170.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.78 119.78 6.96 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.717 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 -5.78 16.16 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 N-CA-C 119.467 2.833 . . . . 0.0 119.467 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -125.8 61.29 1.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.192 0.905 . . . . 0.0 110.859 161.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mt -76.9 156.24 32.23 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 121.133 -0.979 . . . . 0.0 112.577 169.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.89 -57.39 9.71 Favored Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.007 -1.949 . . . . 0.0 110.706 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -55.41 -21.26 29.16 Favored 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 124.847 2.767 . . . . 0.0 118.919 165.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tt -66.03 -52.58 47.87 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.678 1.127 . . . . 0.0 113.975 164.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.54 -29.28 70.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.54 -51.3 70.04 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 159.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.261 3.9 m -75.99 -32.94 59.69 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -54.28 -50.54 67.05 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 159.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -49.23 -45.14 44.17 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 162.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' HD13 ' A' ' 31' ' ' LEU . 18.2 m-30 -63.26 -32.89 74.41 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mt -58.43 -52.02 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 119.377 0.99 . . . . 0.0 111.861 163.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.22 -58.74 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 124.073 0.949 . . . . 0.0 112.302 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -56.67 -24.38 48.39 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 171.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -62.22 -82.22 0.08 OUTLIER Glycine 0 C--N 1.355 1.606 0 CA-C-O 116.567 -2.24 . . . . 0.0 111.526 163.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.388 1.6 pt? -58.5 -2.83 0.23 Allowed 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.26 -40.04 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 159.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -50.03 -44.62 51.44 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.321 1.873 . . . . 0.0 113.666 155.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.9 -73.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 167.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.17 -58.27 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-N 121.03 1.741 . . . . 0.0 113.637 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.9 65.85 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.8 tpp -66.62 -39.67 88.44 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.271 4.8 tt -59.58 -60.3 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.794 1.179 . . . . 0.0 112.997 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -33.86 75.16 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.53 -56.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.679 1.127 . . . . 0.0 111.981 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.04 -33.09 65.48 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.74 -43.18 99.48 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.146 1.473 . . . . 0.0 113.158 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.79 -54.08 6.92 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.929 1.932 . . . . 0.0 117.929 162.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.34 -49.26 70.08 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.95 -47.7 2.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 164.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.1 -42.33 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 C-N-CA 123.943 0.897 . . . . 0.0 112.306 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.53 -48.05 72.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -78.03 -66.3 0.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.518 1.053 . . . . 0.0 113.786 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.04 28.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.71 -57.7 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 119.472 1.033 . . . . 0.0 111.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 122.861 1.315 . . . . 0.0 110.821 172.44 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.269 0.0 OUTLIER -108.47 -66.31 1.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.486 0.715 . . . . 0.0 110.904 174.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -66.62 -43.33 85.04 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -40.63 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -57.66 -37.89 74.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 75.3 mtm -69.13 -38.22 78.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.24 -45.97 86.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.035 1.288 . . . . 0.0 114.324 164.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.62 -42.09 99.38 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -66.27 -55.01 18.16 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.969 0.908 . . . . 0.0 113.321 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -36.68 -64.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 161.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtt -64.88 -49.92 68.61 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.606 -173.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.75 64.24 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 166.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.07 -57.24 8.16 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 121.482 1.946 . . . . 0.0 114.879 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -37.41 78.53 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 77.2 t -65.89 -51.96 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 120.416 1.462 . . . . 0.0 113.574 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 ttt -63.04 -44.76 94.97 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 10.5 mmt -89.4 -9.84 48.76 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.38 -37.82 62.67 Favored Glycine 0 CA--C 1.55 2.226 0 CA-C-N 120.187 1.358 . . . . 0.0 115.895 161.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -41.5 -57.94 3.41 Favored Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 115.227 -2.32 . . . . 0.0 116.364 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -53.38 -24.54 27.97 Favored 'Trans proline' 0 C--N 1.373 1.86 0 N-CA-C 120.719 3.315 . . . . 0.0 120.719 170.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.96 84.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 165.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.86 -53.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 123.87 0.868 . . . . 0.0 111.776 163.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.86 -60.16 8.77 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 118.688 2.235 . . . . 0.0 118.688 -173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.29 -16.73 60.93 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.8 -46.76 77.44 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 160.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.66 -33.14 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 158.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.84 -52.94 35.82 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mm -56.2 -62.99 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.233 1.517 . . . . 0.0 113.037 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.24 -58.7 10.21 Favored Glycine 0 CA--C 1.552 2.37 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.24 -49.73 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.602 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.257 20.3 mt -77.73 -21.29 52.11 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.737 2.062 . . . . 0.0 115.096 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.0 59.9 Favored Glycine 0 CA--C 1.551 2.31 0 CA-C-N 121.16 1.8 . . . . 0.0 117.043 156.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.06 -50.93 53.33 Favored Glycine 0 CA--C 1.554 2.493 0 N-CA-C 116.804 1.481 . . . . 0.0 116.804 165.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -55.07 -37.78 67.19 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 164.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.39 -44.48 76.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 166.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.277 2.5 tm? -67.12 -43.5 82.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -52.78 -41.97 64.6 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 166.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.45 86.93 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 162.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.47 -37.29 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.82 1.81 . . . . 0.0 114.777 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.26 -39.55 87.17 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 163.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -70.84 -60.13 2.41 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.25 118.52 2.86 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 117.769 -1.11 . . . . 0.0 108.589 171.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.31 -3.1 8.18 Favored 'Trans proline' 0 CA--C 1.566 2.113 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.19 62.29 1.62 Allowed 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 119.488 1.04 . . . . 0.0 110.952 155.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.78 162.73 22.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 111.572 166.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 64.9 mt -63.19 -57.62 19.86 Favored Pre-proline 0 CA--C 1.584 2.258 0 CA-C-O 115.788 -2.053 . . . . 0.0 111.189 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -54.13 -24.59 33.84 Favored 'Trans proline' 0 CA--C 1.567 2.155 0 CA-C-N 124.811 2.754 . . . . 0.0 119.134 165.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.52 -50.57 62.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.262 1.392 . . . . 0.0 113.967 165.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.3 -33.91 71.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -58.22 -54.12 50.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 163.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -68.39 -38.3 81.19 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.303 3.6 pp0? -63.62 -41.11 98.31 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 163.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.99 -47.11 65.05 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 162.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -64.27 -31.18 72.29 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -57.04 -51.4 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.842 1.201 . . . . 0.0 112.216 163.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.71 -67.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.105 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.282 0.0 OUTLIER -58.86 -33.62 70.66 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.94 -72.28 0.63 Allowed Glycine 0 C--N 1.353 1.522 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.273 166.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.5 tp -50.02 -21.23 1.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -71.79 -38.14 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 163.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -51.06 -61.46 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 120.891 1.678 . . . . 0.0 111.787 161.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -37.86 -68.69 0.14 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.71 -55.33 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 119.834 1.197 . . . . 0.0 113.684 -170.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.402 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 24.4 mmt -61.36 -51.68 67.8 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.974 174.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.295 2.1 tp -52.73 -50.24 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 121.018 1.735 . . . . 0.0 115.18 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.59 76.8 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.9 -57.26 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 119.898 1.226 . . . . 0.0 112.733 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.44 63.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.23 -42.13 99.03 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.416 1.608 . . . . 0.0 113.43 164.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -55.94 5.82 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 117.68 1.832 . . . . 0.0 117.68 161.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.61 -49.51 76.3 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -42.77 -47.23 5.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -73.17 -42.97 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.528 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.4 mtt -55.26 -53.2 59.07 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -76.87 -30.92 56.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.74 99.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.75 -61.1 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 119.079 0.854 . . . . 0.0 111.545 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 125.086 2.374 . . . . 0.0 108.782 175.237 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -97.31 -76.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -61.83 -34.67 76.36 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.42 -49.94 73.5 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -58.8 -39.83 82.3 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.49 -45.17 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.08 -36.29 83.83 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.334 3.5 pp -67.47 -43.04 81.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 168.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.27 -46.85 86.95 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -41.41 -58.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.705 1.602 . . . . 0.0 114.911 164.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.9 ttt -74.93 -42.91 56.79 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.967 -1.016 . . . . 0.0 113.216 -169.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.97 -36.92 18.66 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 159.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.49 14.59 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 -34.18 70.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 57.9 t -59.93 -50.92 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.667 1.121 . . . . 0.0 112.896 164.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 41.0 ttm -55.74 -39.6 71.38 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . 0.279 0.0 OUTLIER -59.39 -32.96 70.63 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 167.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.62 -30.23 40.74 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.7 tp -37.82 -49.37 2.91 Favored Pre-proline 0 CA--C 1.581 2.17 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -54.77 -21.77 26.85 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 N-CA-C 120.265 3.14 . . . . 0.0 120.265 170.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -32.72 67.96 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.26 -56.08 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 C-N-CA 123.437 0.695 . . . . 0.0 109.865 160.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -66.05 3.04 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 118.643 2.217 . . . . 0.0 118.643 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -76.4 -13.22 60.13 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.41 -51.49 56.47 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 164.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.8 -33.09 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.118 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 158.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.54 -67.85 1.8 Allowed Glycine 0 N--CA 1.482 1.763 0 CA-C-N 120.193 1.36 . . . . 0.0 116.19 168.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.2 mm -54.65 -70.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 118.266 1.033 . . . . 0.0 112.438 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.26 -54.22 37.3 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.16 -59.89 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.531 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.31 -1.84 28.67 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.43 -34.58 1.73 Allowed Glycine 0 N--CA 1.48 1.616 0 CA-C-O 116.725 -2.153 . . . . 0.0 117.326 154.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.55 -58.64 12.86 Favored Glycine 0 N--CA 1.49 2.262 0 CA-C-N 122.192 2.996 . . . . 0.0 115.524 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.57 -46.1 73.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 167.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -72.32 -49.45 34.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.37 -35.77 81.19 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 116.76 -1.591 . . . . 0.0 112.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -53.54 -38.37 63.75 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 123.039 2.654 . . . . 0.0 116.047 166.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.71 -36.0 81.67 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 161.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 5.02 47.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.3 -19.75 66.1 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 165.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -56.34 -46.72 79.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -127.06 112.7 21.77 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.57 -10.03 24.75 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -119.28 60.93 0.82 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.317 0.962 . . . . 0.0 110.626 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.04 157.98 16.48 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.142 0.977 . . . . 0.0 112.051 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.288 3.6 mp -67.49 -57.47 10.29 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-O 116.216 -1.85 . . . . 0.0 109.357 169.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.95 -24.69 1.34 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 N-CA-C 121.472 3.605 . . . . 0.0 121.472 156.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.51 -50.21 68.28 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 121.664 2.029 . . . . 0.0 113.398 162.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.23 -32.1 69.66 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 167.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -66.77 -52.82 39.73 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 120.097 1.317 . . . . 0.0 113.39 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.1 p -57.78 -47.0 83.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -53.32 -47.48 69.25 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.36 -45.84 72.84 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 166.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -52.99 -37.07 61.1 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 169.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -50.39 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.917 0 C-N-CA 123.848 0.859 . . . . 0.0 112.78 169.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.63 -45.36 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 117.19 -1.386 . . . . 0.0 113.882 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.291 0.0 OUTLIER -62.58 -27.31 69.1 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 178.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -64.14 -60.58 7.0 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-O 118.103 -1.387 . . . . 0.0 111.909 160.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -8.2 0.38 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 170.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 0.3 OUTLIER -92.66 -23.14 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 162.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.02 -50.08 48.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.965 1.711 . . . . 0.0 112.938 148.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.03 -71.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 165.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.01 -56.03 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 121.183 1.81 . . . . 0.0 114.531 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.42 50.54 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.2 mmt -65.79 -39.81 91.33 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.265 5.6 tt -62.23 -59.81 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.926 1.239 . . . . 0.0 113.534 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.74 -37.19 84.15 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.04 -50.4 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.889 1.222 . . . . 0.0 112.252 170.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.17 -45.5 61.56 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.76 -42.21 97.86 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.26 1.03 . . . . 0.0 112.825 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.84 -52.42 6.69 Favored Glycine 0 CA--C 1.55 2.261 0 N-CA-C 118.111 2.005 . . . . 0.0 118.111 160.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.16 -54.66 26.29 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -34.73 -49.47 0.42 Allowed 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 162.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.3 p -83.6 -41.78 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.8 mtt -60.14 -38.69 83.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.31 -50.93 70.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 162.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 71.23 86.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.184 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.415 54.1 t 73.72 -62.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 125.319 1.448 . . . . 0.0 114.666 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 123.195 1.474 . . . . 0.0 113.27 -179.395 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.62 -74.38 0.57 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.238 0.615 . . . . 0.0 109.927 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -149.42 -49.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.859 0.863 . . . . 0.0 112.959 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.31 -52.68 62.7 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.979 0.912 . . . . 0.0 113.024 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -59.42 -34.89 73.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 168.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.2 mtp -62.8 -41.96 99.51 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.64 -40.15 93.88 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.7 -46.41 90.49 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -51.2 50.41 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.014 0.925 . . . . 0.0 113.312 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -34.21 -60.46 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 157.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.33 -46.8 69.24 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.671 -170.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.19 -36.02 60.49 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 162.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.29 -48.3 43.4 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -43.24 62.87 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 161.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.79 -48.04 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 163.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.4 tpp -59.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -26.5 66.16 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 164.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.4 -36.55 63.02 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.8 tp -42.8 -54.53 8.5 Favored Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 170.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -56.14 -32.22 86.24 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 125.357 2.949 . . . . 0.0 118.858 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.36 69.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.23 -57.84 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.851 0 CA-C-N 118.626 0.648 . . . . 0.0 110.356 160.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.77 -66.55 2.46 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -167.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.93 -11.74 59.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 118.445 2.757 . . . . 0.0 118.445 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.7 -48.31 69.64 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 158.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.68 -29.81 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 158.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.91 -60.82 7.52 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-N 119.902 1.228 . . . . 0.0 116.152 166.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -48.27 -69.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-N 118.285 1.042 . . . . 0.0 112.898 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.6 -54.4 37.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -172.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.5 -46.92 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 117.327 -1.321 . . . . 0.0 111.433 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.252 13.5 mt -70.27 -42.54 71.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.483 1.947 . . . . 0.0 112.345 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.11 92.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 165.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -53.95 41.46 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 119.289 1.545 . . . . 0.0 116.584 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.12 -39.16 74.57 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -56.78 -43.66 81.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.269 2.4 tm? -67.69 -38.84 84.22 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 119.28 0.945 . . . . 0.0 113.135 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.95 -39.24 65.75 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 121.103 1.774 . . . . 0.0 115.513 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.03 -29.74 75.6 Favored Glycine 0 CA--C 1.55 2.268 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 160.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.06 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 119.635 1.717 . . . . 0.0 114.777 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.93 -39.45 71.71 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 162.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.23 -57.32 7.82 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 167.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.5 123.61 2.48 Favored Pre-proline 0 CA--C 1.568 1.664 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.941 173.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 -4.94 15.05 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.56 63.96 1.44 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.462 1.028 . . . . 0.0 110.674 157.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 tp -91.1 166.46 12.97 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.852 0.861 . . . . 0.0 112.244 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.284 3.8 mp -66.82 -62.31 3.99 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 115.603 -2.142 . . . . 0.0 109.762 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -51.49 -21.21 10.05 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 N-CA-C 119.705 2.925 . . . . 0.0 119.705 164.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.88 -59.97 3.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.003 1.274 . . . . 0.0 113.446 166.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.3 mt -64.91 -28.67 69.69 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -55.46 -58.82 6.17 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.12 0.873 . . . . 0.0 112.927 162.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -72.02 -28.28 63.28 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.26 -52.58 60.95 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 161.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.03 -38.74 68.34 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 166.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -54.93 -44.1 73.95 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 165.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 mt -57.9 -44.94 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.437 1.017 . . . . 0.0 113.048 168.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.63 -59.05 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.846 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER -59.33 -34.97 72.99 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 176.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.03 -69.88 1.17 Allowed Glycine 0 C--N 1.355 1.624 0 CA-C-O 117.801 -1.555 . . . . 0.0 112.357 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.52 -14.34 0.11 Allowed 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 118.774 2.879 . . . . 0.0 118.774 171.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.51 -38.34 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 164.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -50.85 -47.82 60.23 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.13 1.786 . . . . 0.0 113.565 156.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -44.8 -67.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 165.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.12 -58.04 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.022 1.283 . . . . 0.0 113.17 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.21 -51.82 64.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.8 mmt -69.04 -36.07 77.31 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.308 0.4 OUTLIER -66.01 -50.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 120.574 1.534 . . . . 0.0 113.109 173.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.67 92.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.24 -51.7 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.858 1.208 . . . . 0.0 112.528 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 -41.99 84.9 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.03 -43.31 99.03 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 119.272 1.536 . . . . 0.0 113.65 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.41 -57.73 3.67 Favored Glycine 0 CA--C 1.55 2.24 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 160.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.49 -48.53 48.47 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -40.21 -47.78 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 164.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.88 -39.18 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.821 0 CA-C-O 118.421 -0.8 . . . . 0.0 112.624 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 79.9 mtp -58.12 -47.6 82.8 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -77.85 -67.71 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.14 1.337 . . . . 0.0 113.591 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.59 -47.39 32.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.18 -57.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 119.592 1.087 . . . . 0.0 111.86 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 122.888 1.327 . . . . 0.0 110.865 172.377 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.271 26.5 ptt? . . . . . 0 CA--C 1.558 1.256 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.43 -57.79 4.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.903 0.774 . . . . 0.0 112.931 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.14 -26.91 66.64 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.7 -53.68 31.1 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -58.72 -39.79 81.86 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.77 -41.53 95.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -62.02 -41.91 98.6 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 167.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.28 -44.8 95.03 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.59 -54.44 32.02 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -36.6 -63.27 0.41 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 161.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.7 mtp -64.61 -50.42 67.24 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.284 -173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.16 62.65 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.49 -64.96 0.74 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 116.964 -1.494 . . . . 0.0 114.126 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.61 -35.73 31.7 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.107 2.632 . . . . 0.0 118.107 168.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.271 70.4 t -62.43 -53.1 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.775 1.171 . . . . 0.0 113.552 166.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.15 -28.52 58.31 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 165.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 65' ' ' MET . 0.6 OUTLIER -84.1 -13.78 52.09 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 173.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.51 -32.88 36.49 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 156.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.6 tp -39.25 -45.35 3.37 Favored Pre-proline 0 CA--C 1.582 2.19 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -44.53 -33.11 6.26 Favored 'Trans proline' 0 C--N 1.375 1.948 0 CA-C-N 126.176 3.242 . . . . 0.0 120.184 165.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.71 64.33 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.49 -57.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 118.826 0.739 . . . . 0.0 110.256 160.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -62.96 4.84 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -72.52 -23.7 61.05 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.61 -48.4 66.92 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -57.1 -31.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 159.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.53 -65.13 3.5 Favored Glycine 0 N--CA 1.486 1.984 0 CA-C-N 119.887 1.221 . . . . 0.0 115.79 167.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.2 mm -47.66 -73.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 117.945 0.873 . . . . 0.0 113.013 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -56.08 27.21 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 118.5 2.16 . . . . 0.0 118.5 -170.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -81.35 -46.98 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 117.475 -1.25 . . . . 0.0 112.45 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.279 17.5 mt -75.6 -35.7 60.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.181 1.81 . . . . 0.0 112.703 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.81 65.59 Favored Glycine 0 N--CA 1.491 2.318 0 CA-C-N 121.718 2.054 . . . . 0.0 118.005 163.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.33 -53.49 44.47 Favored Glycine 0 N--CA 1.491 2.339 0 CA-C-N 119.561 1.681 . . . . 0.0 116.289 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.99 -43.52 66.5 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.698 2.111 . . . . 0.0 116.698 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -44.3 85.47 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 171.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.276 2.4 tm? -66.56 -38.57 87.37 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 119.766 1.167 . . . . 0.0 113.231 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 164.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.36 89.04 Favored Glycine 0 CA--C 1.551 2.306 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 160.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -32.05 66.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.15 62.47 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 162.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -62.17 1.6 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 119.322 0.965 . . . . 0.0 112.196 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.89 114.96 5.99 Favored Pre-proline 0 CA--C 1.568 1.656 0 CA-C-O 117.961 -1.018 . . . . 0.0 108.303 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.65 -2.02 11.89 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 N-CA-C 119.298 2.768 . . . . 0.0 119.298 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -129.9 62.39 1.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.418 1.008 . . . . 0.0 110.153 159.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.0 162.65 20.33 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 111.48 165.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.258 43.5 mm -67.1 -58.64 8.81 Favored Pre-proline 0 N--CA 1.502 2.147 0 CA-C-O 115.841 -2.028 . . . . 0.0 111.166 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -54.87 -20.55 22.96 Favored 'Trans proline' 0 CA--C 1.57 2.297 0 CA-C-N 124.909 2.789 . . . . 0.0 119.292 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.8 -54.07 31.79 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 119.755 1.162 . . . . 0.0 113.646 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.29 -22.28 66.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -57.01 -58.18 9.3 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.669 1.122 . . . . 0.0 113.378 157.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -66.66 -33.11 74.92 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -52.41 -51.28 59.93 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 160.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.71 -39.57 74.1 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' HB3' HD13 ' A' ' 31' ' ' LEU . 27.3 m-85 -54.56 -38.92 67.22 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 165.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mt -59.0 -48.83 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 119.392 0.996 . . . . 0.0 112.799 165.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.96 -56.81 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.28 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.262 0.0 OUTLIER -58.35 -31.91 68.04 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 176.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -65.67 -67.84 1.87 Allowed Glycine 0 C--N 1.355 1.627 0 CA-C-O 117.545 -1.697 . . . . 0.0 111.125 166.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.8 tp -46.53 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -80.93 -40.92 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 125.526 1.53 . . . . 0.0 113.823 166.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -49.82 -36.21 25.71 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 121.236 1.834 . . . . 0.0 115.264 158.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.16 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 117.439 -1.267 . . . . 0.0 113.373 160.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.66 -55.96 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-N 120.92 1.691 . . . . 0.0 114.818 -165.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.4 -59.51 5.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.429 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 20.3 mmt -61.27 -49.6 76.42 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 116.641 -1.647 . . . . 0.0 113.994 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.291 5.9 tt -51.43 -56.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 121.508 1.958 . . . . 0.0 114.651 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.85 79.75 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.46 -59.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.617 1.099 . . . . 0.0 113.172 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.2 -17.94 63.76 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 119.614 2.606 . . . . 0.0 119.614 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.66 -43.67 83.93 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.626 2.213 . . . . 0.0 112.074 159.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.36 -51.98 6.27 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 157.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -63.14 -51.53 66.11 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -42.75 -47.93 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 167.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.56 -40.4 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.661 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -58.59 -49.8 76.15 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.02 -44.53 38.92 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.91 -51.43 26.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.4 126.92 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 123.209 1.481 . . . . 0.0 108.613 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 CA--C 1.558 1.265 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -98.56 -75.28 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.464 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -62.49 -32.59 73.52 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.01 -51.1 51.05 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.726 0.81 . . . . 0.0 113.032 170.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -58.74 -40.95 85.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.2 mtt -64.71 -44.1 91.32 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.11 -38.04 87.41 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.63 -47.81 83.73 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.82 -48.58 81.14 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -43.08 -58.92 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.6 -39.64 73.69 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.32 67.1 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 166.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB1' ' HA2' ' A' ' 69' ' ' GLY . . . -59.38 -54.98 40.48 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 165.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.62 -44.82 37.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 165.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.16 -51.38 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 C-N-CA 124.209 1.003 . . . . 0.0 113.065 166.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -44.12 72.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -28.39 67.67 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 169.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.65 -37.3 40.47 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 167.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.7 tp -37.34 -52.7 2.34 Favored Pre-proline 0 CA--C 1.582 2.199 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.43 -25.72 59.23 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 125.273 2.919 . . . . 0.0 119.45 171.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.13 69.69 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -86.33 -55.34 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.847 0 CA-C-N 118.739 0.7 . . . . 0.0 110.57 160.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.62 -65.25 3.45 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -77.63 -13.63 59.85 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.6 -48.69 68.73 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 161.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.7 mm -59.01 -29.6 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 158.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.39 -62.42 6.2 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 120.04 1.291 . . . . 0.0 115.771 167.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.4 mm -54.32 -65.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 119.037 1.418 . . . . 0.0 112.948 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.05 -56.9 18.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.62 -58.67 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.793 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.5 mt -75.63 3.49 9.48 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.32 -36.33 1.64 Allowed Glycine 0 N--CA 1.481 1.695 0 CA-C-O 117.176 -1.902 . . . . 0.0 116.749 155.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.06 -59.51 10.68 Favored Glycine 0 N--CA 1.492 2.388 0 CA-C-N 121.305 2.552 . . . . 0.0 115.923 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.86 -43.21 80.95 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 167.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.08 -42.32 72.92 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.255 3.0 tm? -71.14 -36.73 72.19 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.655 1.116 . . . . 0.0 112.549 172.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -52.18 -39.32 59.92 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 121.776 2.08 . . . . 0.0 115.942 163.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.76 -31.7 73.39 Favored Glycine 0 CA--C 1.552 2.394 0 N-CA-C 118.4 2.12 . . . . 0.0 118.4 161.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -23.58 54.94 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -20.0 15.44 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 118.809 2.892 . . . . 0.0 118.809 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -58.54 -34.93 71.56 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -154.03 129.72 5.25 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-N 119.997 1.271 . . . . 0.0 109.072 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 2.97 3.55 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 N-CA-C 119.1 2.692 . . . . 0.0 119.1 171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.7 64.02 1.58 Allowed 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.168 0.894 . . . . 0.0 110.163 152.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.82 172.91 7.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.571 1.177 . . . . 0.0 112.867 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.49 -56.89 30.83 Favored Pre-proline 0 CA--C 1.581 2.155 0 CA-C-O 115.319 -2.277 . . . . 0.0 110.897 163.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.11 -15.13 21.66 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 CA-C-N 125.349 2.946 . . . . 0.0 119.51 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.5 -49.65 52.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.771 1.623 . . . . 0.0 113.662 161.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.93 -29.42 70.21 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -67.66 -45.58 74.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.502 165.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.295 1.2 t -58.81 -47.01 86.26 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 122.131 2.241 . . . . 0.0 114.973 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -55.23 -49.32 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.55 -58.17 9.2 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -61.02 -39.27 89.13 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.0 mt -64.59 -43.47 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.39 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.77 -47.64 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 120.558 1.526 . . . . 0.0 113.223 172.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 75.2 mmm -53.0 -43.94 66.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.3 -67.51 2.09 Favored Glycine 0 C--N 1.356 1.646 0 CA-C-O 117.731 -1.594 . . . . 0.0 112.262 166.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.72 -2.63 0.15 Allowed 'General case' 0 CA--C 1.583 2.227 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.93 -25.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.106 1.362 . . . . 0.0 113.726 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -50.88 -43.85 59.64 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 122.087 2.221 . . . . 0.0 113.528 148.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.19 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 159.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.04 -55.94 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.729 1.604 . . . . 0.0 114.559 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.44 -54.62 33.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.46 -34.44 75.95 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.285 6.8 tt -62.88 -60.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 120.42 1.464 . . . . 0.0 113.45 171.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.53 97.22 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.78 -52.17 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 119.318 0.963 . . . . 0.0 112.299 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA2' ' HB1' ' A' ' 13' ' ' ALA . . . -67.71 -42.14 87.84 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.88 -43.35 83.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.486 1.143 . . . . 0.0 113.294 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.14 -48.44 10.15 Favored Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.181 2.032 . . . . 0.0 118.181 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.96 -56.19 6.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -40.67 -45.94 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 164.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.06 -43.96 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.503 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.12 -50.47 58.75 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.82 -38.68 80.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.33 -43.74 96.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 172.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.27 -61.19 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 119.028 0.831 . . . . 0.0 111.558 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 125.137 2.398 . . . . 0.0 108.367 174.581 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -116.59 -74.57 0.6 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.143 0.577 . . . . 0.0 110.651 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -145.11 -65.42 0.33 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.321 1.048 . . . . 0.0 112.149 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.94 -45.48 93.49 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.367 1.067 . . . . 0.0 113.861 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -61.8 -29.3 70.06 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 168.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 45.0 mtm -62.92 -43.67 98.17 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.127 1.33 . . . . 0.0 114.404 163.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.81 -33.43 72.99 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.89 -50.89 70.37 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 168.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.94 -49.31 75.27 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -34.29 -67.27 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 163.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.5 ttt -73.36 -39.29 65.3 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 117.836 -1.078 . . . . 0.0 113.803 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -37.93 31.03 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.479 2.399 . . . . 0.0 117.479 160.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.78 24.77 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.76 71.97 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 60.0 t -60.45 -49.75 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.83 1.196 . . . . 0.0 113.145 166.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.8 tpp -58.42 -39.23 79.21 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 166.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.424 ' SD ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -58.37 -30.32 66.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 166.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.88 36.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 170.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 tt -35.88 -50.48 1.56 Allowed Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 167.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -46.87 -30.08 9.04 Favored 'Trans proline' 0 CA--C 1.563 1.934 0 N-CA-C 120.808 3.349 . . . . 0.0 120.808 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.65 -31.86 66.72 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 168.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -85.66 -56.31 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 C-N-CA 123.727 0.811 . . . . 0.0 110.09 162.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.3 -63.62 4.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -169.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLY . . . -69.62 -20.66 63.61 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 118.597 2.814 . . . . 0.0 118.597 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.1 74.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 165.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.5 mt -57.5 -32.96 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 159.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.7 -64.8 3.79 Favored Glycine 0 N--CA 1.485 1.909 0 CA-C-N 119.804 1.183 . . . . 0.0 115.864 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.48 -69.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 118.533 1.166 . . . . 0.0 112.703 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.46 -54.6 36.43 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 118.634 2.214 . . . . 0.0 118.634 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.38 -45.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 116.913 -1.518 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 54' ' ' PHE 0.313 17.8 mt -74.84 -38.54 61.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.99 2.177 . . . . 0.0 112.379 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.81 94.64 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-N 122.176 2.262 . . . . 0.0 118.489 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.41 -52.28 53.71 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 119.384 1.592 . . . . 0.0 116.713 166.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -50.78 -45.37 59.05 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 164.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -54.65 -49.08 71.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.21 -33.63 76.2 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -53.21 -43.22 67.04 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 156.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.75 94.35 Favored Glycine 0 CA--C 1.549 2.213 0 N-CA-C 117.537 1.775 . . . . 0.0 117.537 165.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.07 88.47 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.39 96.4 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.0 -62.68 1.68 Allowed 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -151.16 120.62 3.56 Favored Pre-proline 0 CA--C 1.566 1.577 0 C-N-CA 124.481 1.112 . . . . 0.0 108.096 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 -13.75 38.19 Favored 'Trans proline' 0 CA--C 1.572 2.385 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 168.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -97.62 31.62 2.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.27 144.58 25.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.551 -1.343 . . . . 0.0 113.951 -160.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 67.1 mt -68.28 -57.07 9.46 Favored Pre-proline 0 CA--C 1.579 2.091 0 CA-C-O 115.723 -2.084 . . . . 0.0 111.114 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.48 -19.02 34.36 Favored 'Trans proline' 0 CA--C 1.571 2.339 0 CA-C-N 124.995 2.82 . . . . 0.0 119.171 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.95 -54.2 34.38 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.371 1.441 . . . . 0.0 113.437 161.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.42 -34.26 70.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -57.94 -48.07 81.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.0 m -80.67 -33.72 35.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 117.389 -1.291 . . . . 0.0 114.212 -172.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.336 3.1 pp0? -62.47 -38.46 89.9 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 122.0 2.182 . . . . 0.0 116.649 159.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -51.2 -44.47 61.58 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 158.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.481 ' HB3' HD13 ' A' ' 31' ' ' LEU . 19.1 m-30 -67.0 -29.91 69.87 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.61 -48.09 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-N 119.867 1.212 . . . . 0.0 111.928 162.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.55 -52.51 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 118.07 -0.967 . . . . 0.0 112.571 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 80.1 mmm -55.09 -40.6 70.61 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -61.94 -69.21 1.36 Allowed Glycine 0 C--N 1.356 1.668 0 CA-C-O 117.404 -1.775 . . . . 0.0 112.157 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -4.44 0.26 Allowed 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.34 -25.33 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.093 163.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -49.71 -50.08 45.38 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 122.537 2.426 . . . . 0.0 112.905 148.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.83 -68.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 167.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -65.11 -59.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 121.163 1.801 . . . . 0.0 113.129 -173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.87 66.46 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.82 -35.53 74.88 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' SD ' ' A' ' 17' ' ' MET 0.256 4.8 tt -58.35 -57.53 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.944 1.702 . . . . 0.0 113.166 169.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.06 79.17 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.33 -51.49 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.059 1.3 . . . . 0.0 112.506 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.53 -38.88 68.91 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.96 -44.55 84.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.182 1.491 . . . . 0.0 113.299 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.6 -47.75 12.57 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.087 1.995 . . . . 0.0 118.087 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.84 -53.62 47.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -45.12 -44.73 10.79 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.5 -40.8 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.905 0.882 . . . . 0.0 113.058 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -54.22 -42.44 69.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 167.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.38 -50.15 75.08 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 164.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 64.09 78.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.673 1.189 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.429 52.4 t 73.6 -35.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 124.996 2.331 . . . . 0.0 111.402 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.555 1.138 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -93.02 -76.27 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.989 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.52 -35.65 76.47 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.89 -50.78 69.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -60.7 -40.01 90.65 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.6 mmt -66.58 -41.85 87.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.34 -41.42 89.14 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 165.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.0 mt -62.62 -45.51 92.55 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.9 -56.41 13.47 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -33.15 -65.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 158.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.19 -48.01 59.02 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.036 -167.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.35 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 162.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -61.1 2.38 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.537 1.971 . . . . 0.0 114.772 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.91 72.8 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.357 2.355 . . . . 0.0 117.357 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.261 79.0 t -66.17 -52.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.703 1.592 . . . . 0.0 113.328 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.95 89.13 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.4 mmt -83.83 -12.86 54.99 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.79 59.51 Favored Glycine 0 CA--C 1.548 2.107 0 CA-C-N 120.201 1.364 . . . . 0.0 115.981 164.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 tp -40.33 -55.53 4.1 Favored Pre-proline 0 CA--C 1.582 2.177 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 168.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.56 -24.87 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 124.124 3.216 . . . . 0.0 120.177 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -43.1 89.06 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 121.117 1.781 . . . . 0.0 115.443 165.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -74.79 -52.67 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 C-N-CA 123.928 0.891 . . . . 0.0 111.964 165.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.58 -59.1 10.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.552 2.181 . . . . 0.0 118.552 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -74.57 -13.47 60.67 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 171.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.34 -46.44 70.17 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 160.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.03 -37.7 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 123.606 0.762 . . . . 0.0 113.025 156.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.0 -49.58 48.45 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 163.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 mt -49.41 -63.62 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-N 120.463 2.131 . . . . 0.0 111.815 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.42 -51.83 56.36 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 119.257 2.463 . . . . 0.0 119.257 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.77 -45.93 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.9 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.55 -50.05 64.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.757 1.617 . . . . 0.0 112.043 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.72 -39.35 76.08 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -54.29 39.17 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-N 119.075 1.438 . . . . 0.0 116.529 167.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -48.56 -47.25 39.55 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 164.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.9 -51.79 66.36 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.309 1.444 . . . . 0.0 114.698 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.33 -31.72 71.33 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.33 -43.86 67.99 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 155.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.83 97.13 Favored Glycine 0 CA--C 1.551 2.307 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.61 80.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.35 79.08 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -69.97 -66.06 0.64 Allowed 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -145.56 112.42 4.64 Favored Pre-proline 0 CA--C 1.568 1.659 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.7 2.67 5.03 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 N-CA-C 119.519 2.854 . . . . 0.0 119.519 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -131.62 64.67 1.58 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.12 0.873 . . . . 0.0 110.333 157.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 163.77 17.87 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 121.835 0.826 . . . . 0.0 111.53 168.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.256 4.0 mp -66.81 -59.06 8.42 Favored Pre-proline 0 CA--C 1.584 2.278 0 CA-C-O 115.849 -2.024 . . . . 0.0 110.48 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -52.62 -23.99 21.45 Favored 'Trans proline' 0 CA--C 1.57 2.299 0 N-CA-C 119.345 2.787 . . . . 0.0 119.345 164.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.69 -56.01 12.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 168.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.6 mt -65.48 -27.53 68.56 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 160.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.269 3.2 m -76.27 -33.46 59.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -51.76 -52.33 49.53 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 158.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -51.04 -44.44 61.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 165.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -62.9 -36.84 84.68 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -59.15 -54.36 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.871 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.313 10.2 p -60.96 -49.04 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.679 1.581 . . . . 0.0 114.371 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.17 -43.32 87.42 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.83 -69.04 1.39 Allowed Glycine 0 N--CA 1.479 1.548 0 CA-C-O 118.866 -0.964 . . . . 0.0 114.034 165.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.86 -19.63 0.4 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -90.03 -21.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -51.17 -62.62 1.5 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 122.479 2.399 . . . . 0.0 111.178 152.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -39.4 -65.03 0.42 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 168.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.72 -57.38 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.071 0.85 . . . . 0.0 113.05 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.18 75.03 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 mmt -63.71 -52.65 59.64 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 117.023 -1.465 . . . . 0.0 113.921 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.289 0.4 OUTLIER -57.36 -41.56 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 121.101 1.773 . . . . 0.0 114.311 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.54 83.57 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.83 -54.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.25 1.386 . . . . 0.0 112.705 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.61 -40.9 90.48 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 118.745 2.258 . . . . 0.0 118.745 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.77 -42.83 84.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.938 1.369 . . . . 0.0 114.015 163.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -42.05 -54.88 4.35 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 161.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.8 tp -65.16 -49.89 68.09 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -42.79 -40.94 3.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.271 4.9 p -83.86 -32.92 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.3 mmt -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -71.03 -13.54 62.02 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.26 . . 65.47 56.69 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.442 12.5 p 40.57 74.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.812 -166.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptp . . . . . 0 CA--C 1.556 1.194 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.69 70.26 0.57 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.744 1.217 . . . . 0.0 113.119 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -58.63 -34.66 71.42 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 118.313 2.709 . . . . 0.0 118.313 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.76 -49.5 76.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -58.72 -39.75 81.73 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -65.64 -45.71 82.0 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.21 -33.75 76.52 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.72 -50.35 69.46 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 tp -56.66 -51.62 68.02 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -37.89 -73.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.227 1.811 . . . . 0.0 115.69 163.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.29 -40.22 71.01 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -167.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.7 65.05 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 117.079 2.252 . . . . 0.0 117.079 162.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.31 64.08 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.626 2.012 . . . . 0.0 115.509 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -36.07 82.8 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.42 -53.46 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 120.728 1.604 . . . . 0.0 113.068 167.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.7 -52.13 53.89 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -87.16 -16.44 35.41 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.55 -25.39 67.91 Favored Glycine 0 N--CA 1.491 2.344 0 CA-C-N 121.176 1.807 . . . . 0.0 117.486 163.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.3 tp -50.17 -46.35 82.73 Favored Pre-proline 0 CA--C 1.578 2.05 0 CA-C-O 115.211 -2.328 . . . . 0.0 117.081 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.05 -27.15 2.49 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 121.564 3.64 . . . . 0.0 121.564 164.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.68 74.23 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 164.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.5 mt -78.52 -52.66 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 C-N-CA 123.952 0.901 . . . . 0.0 110.904 162.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.91 -66.74 1.36 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 -16.35 61.32 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 119.258 3.059 . . . . 0.0 119.258 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.0 -51.69 51.86 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.8 mt -54.56 -40.28 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 123.418 0.687 . . . . 0.0 112.807 160.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.11 -59.41 6.95 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-O 117.759 -1.578 . . . . 0.0 116.321 167.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 mm -41.83 -51.39 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.44 -59.9 6.18 Favored Glycine 0 CA--C 1.552 2.351 0 N-CA-C 118.261 2.065 . . . . 0.0 118.261 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.23 -42.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.7 mt -59.81 -55.45 34.04 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.444 1.098 . . . . 0.0 112.367 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.42 -39.94 30.04 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 162.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.27 -53.76 43.54 Favored Glycine 0 CA--C 1.554 2.474 0 CA-C-N 119.448 1.624 . . . . 0.0 117.091 166.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -51.57 -49.07 62.8 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -57.58 -42.6 83.46 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.317 0.5 OUTLIER -72.57 -38.96 67.78 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 119.601 1.091 . . . . 0.0 112.58 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.33 -39.27 66.89 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 161.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.21 93.28 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 117.409 1.723 . . . . 0.0 117.409 159.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -37.58 65.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.845 1.823 . . . . 0.0 115.069 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.34 -41.32 93.34 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 165.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -71.34 -54.08 12.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -154.9 120.1 2.61 Favored Pre-proline 0 CA--C 1.565 1.52 0 CA-C-O 117.674 -1.155 . . . . 0.0 109.106 174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.22 -6.26 12.82 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 N-CA-C 119.676 2.914 . . . . 0.0 119.676 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.63 58.01 1.24 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.19 0.904 . . . . 0.0 111.381 163.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.02 158.9 24.97 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 0.0 113.547 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.251 4.1 mp -64.36 -57.78 16.25 Favored Pre-proline 0 CA--C 1.582 2.189 0 CA-C-O 116.006 -1.949 . . . . 0.0 110.914 169.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -52.78 -21.59 15.49 Favored 'Trans proline' 0 CA--C 1.57 2.305 0 CA-C-N 125.022 2.829 . . . . 0.0 119.137 164.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.65 -53.33 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.98 -37.32 74.0 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -53.37 -51.59 62.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 162.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.268 5.3 m -86.87 -28.01 23.1 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -170.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.282 10.0 pt20 -61.71 -40.75 96.12 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 121.724 2.056 . . . . 0.0 115.912 157.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.87 -48.29 64.11 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 159.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.21 -40.78 97.25 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.02 -46.25 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 124.962 1.305 . . . . 0.0 114.184 166.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.77 -61.83 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 117.838 -1.077 . . . . 0.0 111.813 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . 0.31 0.0 OUTLIER -65.64 -31.55 72.64 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -176.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.37 -65.72 3.18 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.914 -1.116 . . . . 0.0 113.448 164.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -11.99 5.64 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.32 0.4 OUTLIER -81.81 -22.91 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 159.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -49.1 -63.15 1.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 121.06 1.755 . . . . 0.0 111.096 151.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.3 -63.96 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.2 mm -66.95 -54.49 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 120.568 1.531 . . . . 0.0 113.783 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.71 -49.92 75.56 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -68.5 -43.38 76.98 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.286 0.4 OUTLIER -57.09 -44.21 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 121.954 2.161 . . . . 0.0 113.31 173.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.12 76.0 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 167.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.31 -54.1 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 120.249 1.386 . . . . 0.0 112.793 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.85 -43.79 93.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.45 -48.69 74.09 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.498 1.149 . . . . 0.0 113.919 163.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.53 -51.58 7.81 Favored Glycine 0 CA--C 1.548 2.099 0 N-CA-C 118.621 2.209 . . . . 0.0 118.621 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.33 -54.73 13.09 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -35.02 -54.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 160.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 2.2 p -74.28 -35.94 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 87.7 mmm -62.5 -30.61 71.4 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 163.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -78.91 -52.82 7.77 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.37 61.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.65 121.96 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 163.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 123.119 1.438 . . . . 0.0 112.666 -169.693 . . . . . . . . 0 0 . 1 stop_ save_